
<html lang="en"     class="pb-page"  data-request-id="e6a4a603-6fd2-4650-abb0-ce439ebe4f1c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm800851u;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2008.51.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease" /></meta><meta name="dc.Creator" content="Xiaohu  Zhang" /></meta><meta name="dc.Creator" content="John E.  Tellew" /></meta><meta name="dc.Creator" content="Zhiyong  Luo" /></meta><meta name="dc.Creator" content="Manisha  Moorjani" /></meta><meta name="dc.Creator" content="Emily  Lin" /></meta><meta name="dc.Creator" content="Marion C.  Lanier" /></meta><meta name="dc.Creator" content="Yongsheng  Chen" /></meta><meta name="dc.Creator" content="John P.  Williams" /></meta><meta name="dc.Creator" content="John  Saunders" /></meta><meta name="dc.Creator" content="Sandra M.  Lechner" /></meta><meta name="dc.Creator" content="Stacy  Markison" /></meta><meta name="dc.Creator" content="Tanya  Joswig" /></meta><meta name="dc.Creator" content="Robert  Petroski" /></meta><meta name="dc.Creator" content="Jaime  Piercey" /></meta><meta name="dc.Creator" content="William  Kargo" /></meta><meta name="dc.Creator" content="Siobhan  Malany" /></meta><meta name="dc.Creator" content="Mark  Santos" /></meta><meta name="dc.Creator" content="Raymond S.  Gross" /></meta><meta name="dc.Creator" content="Jenny  Wen" /></meta><meta name="dc.Creator" content="Kayvon  Jalali" /></meta><meta name="dc.Creator" content="Zhihong  O’Brien" /></meta><meta name="dc.Creator" content="Carol E.  Stotz" /></meta><meta name="dc.Creator" content="María I.  Crespo" /></meta><meta name="dc.Creator" content="José-Luis  Díaz" /></meta><meta name="dc.Creator" content="Deborah H.  Slee" /></meta><meta name="dc.Description" content="4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-pyrimidines bearing substituted pyridyl groups as C-6 substituents were prepared as selective adenosine hA2A receptor antagonists for the treatment of Par..." /></meta><meta name="Description" content="4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-pyrimidines bearing substituted pyridyl groups as C-6 substituents were prepared as selective adenosine hA2A receptor antagonists for the treatment of Par..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 24, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800851u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800851u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800851u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800851u" /></link>
        
    
    

<title>Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800851u" /></meta><meta property="og:title" content="Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0001.jpeg" /></meta><meta property="og:description" content=" 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-pyrimidines bearing substituted pyridyl groups as C-6 substituents were prepared as selective adenosine hA2A receptor antagonists for the treatment of Parkinson’s disease. The 5-methoxy-3-pyridyl derivative 6g (hA2A Ki 2.3 nM, hA1 Ki 190 nM) was orally active at 3 mg/kg in a rat HIC model but exposure was poor in nonrodent species, presumably due to poor aqueous solubility. Follow-on compound 16a (hA2A Ki 0.83 nM, hA1 Ki 130 nM), bearing a 6-(morpholin-4-yl)-2-pyridyl substituent at C-6, had improved solubility and was orally efficacious (3 mg/kg, HIC) but showed time-dependent cytochrome P450 3A4 inhibition, possibly related to morpholine ring metabolism. Compound 16j (hA2A Ki 0.44 nM, hA1 Ki 80 nM), bearing a 6-(4-methoxypiperidin-1-yl)-2-pyridyl substituent at C-6, was sparingly soluble but had good oral exposure in rodent and nonrodent species, had no cytochrome P450 or human ether-a-go-go related gene channel issues, and was orally efficacious at 1 mg/kg in HIC and at 3 mg/kg for potentiation of l-dopa-induced contralateral rotations in 6-hydroxydopamine-lesioned rats." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800851u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800851u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800851u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800851u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800851u&amp;href=/doi/10.1021/jm800851u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7099-7110</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm8007618" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm8006992" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A<sub>2A</sub> Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaohu++Zhang">Xiaohu Zhang</a></span><span class="author-xref-symbol "><sup>†</sup></span><span class="author-xref-symbol "><sup>▲</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+E.++Tellew">John E. Tellew</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhiyong++Luo">Zhiyong Luo</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manisha++Moorjani">Manisha Moorjani</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emily++Lin">Emily Lin</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marion+C.++Lanier">Marion C. Lanier</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongsheng++Chen">Yongsheng Chen</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+P.++Williams">John P. Williams</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Saunders">John Saunders</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra+M.++Lechner">Sandra M. Lechner</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stacy++Markison">Stacy Markison</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tanya++Joswig">Tanya Joswig</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Petroski">Robert Petroski</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jaime++Piercey">Jaime Piercey</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William++Kargo">William Kargo</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Siobhan++Malany">Siobhan Malany</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Santos">Mark Santos</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raymond+S.++Gross">Raymond S. Gross</a></span><span class="author-xref-symbol "><sup>†</sup></span><span class="author-xref-symbol "><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenny++Wen">Jenny Wen</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kayvon++Jalali">Kayvon Jalali</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhihong++O%E2%80%99Brien">Zhihong O’Brien</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carol+E.++Stotz">Carol E. Stotz</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+I.++Crespo">María I. Crespo</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9-Luis++D%C3%ADaz">José-Luis Díaz</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah+H.++Slee">Deborah H. Slee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. For D.H.S.: phone, 858-617-7849; fax, 858-617-7925; E-mail: <a href="/cdn-cgi/l/email-protection#b7d3c4dbd2d2f7d9d2c2c5d8d4c5ded9d299d4d8da"><span class="__cf_email__" data-cfemail="0662756a636346686373746965746f68632865696b">[email protected]</span></a>. For J.E.T.: phone, 858-812-1628; fax, 858-332-4513; E-mail: <a href="/cdn-cgi/l/email-protection#315b45545d5d544671565f571f5e4356"><span class="__cf_email__" data-cfemail="a3c9d7c6cfcfc6d4e3c4cdc58dccd1c4">[email protected]</span></a>; current address, Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121.</div><div class="corresp-fn" id="afn1">†Department of Medicinal Chemistry, Neurocrine Biosciences.</div><div class="corresp-fn" id="afn7">▲Present address: BioDuro Co., No.29 Life Science Park Road, Changping District, Beijing, P.R.China 102206. Email: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="b1c9d8d0ded9c49fcbd9d0dfd6f1d3d8ded5c4c3de9fd2dedc9f">[email protected]</a></div><div class="corresp-fn" id="afn8">▽Department of Chemical Development, Neurocrine Biosciences.</div><div class="corresp-fn" id="afn2">‡Department of Neuroscience, Neurocrine Biosciences.</div><div class="corresp-fn" id="afn3">§Department of Pharmacology, Neurocrine Biosciences.</div><div class="corresp-fn" id="afn4">∥Department of Preclinical Development, Neurocrine Biosciences.</div><div class="corresp-fn" id="afn5">⊥Department of Pharmaceutical Development, Neurocrine Biosciences.</div><div class="corresp-fn" id="afn6">#Almirall Research Center.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800851u&amp;href=/doi/10.1021%2Fjm800851u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7099–7110</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 23, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 July 2008</li><li><span class="item_label"><b>Published</b> online</span>24 October 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 November 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800851u" title="DOI URL">https://doi.org/10.1021/jm800851u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7099%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaohu%2BZhang%252C%2BJohn%2BE.%2BTellew%252C%2BZhiyong%2BLuo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D22%26contentID%3Djm800851u%26title%3DLead%2BOptimization%2Bof%2B4-Acetylamino-2-%25283%252C5-dimethylpyrazol-1-yl%2529-6-pyridylpyrimidines%2Bas%2BA2A%2BAdenosine%2BReceptor%2BAntagonists%2Bfor%2Bthe%2BTreatment%2Bof%2BParkinson%25E2%2580%2599s%2BDisease%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7110%26publicationDate%3DNovember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800851u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2870</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800851u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaohu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;E. Tellew&quot;},{&quot;first_name&quot;:&quot;Zhiyong&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Manisha&quot;,&quot;last_name&quot;:&quot;Moorjani&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Marion&quot;,&quot;last_name&quot;:&quot;C. Lanier&quot;},{&quot;first_name&quot;:&quot;Yongsheng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;P. Williams&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Saunders&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;M. Lechner&quot;},{&quot;first_name&quot;:&quot;Stacy&quot;,&quot;last_name&quot;:&quot;Markison&quot;},{&quot;first_name&quot;:&quot;Tanya&quot;,&quot;last_name&quot;:&quot;Joswig&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Petroski&quot;},{&quot;first_name&quot;:&quot;Jaime&quot;,&quot;last_name&quot;:&quot;Piercey&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;Kargo&quot;},{&quot;first_name&quot;:&quot;Siobhan&quot;,&quot;last_name&quot;:&quot;Malany&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Santos&quot;},{&quot;first_name&quot;:&quot;Raymond&quot;,&quot;last_name&quot;:&quot;S. Gross&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Kayvon&quot;,&quot;last_name&quot;:&quot;Jalali&quot;},{&quot;first_name&quot;:&quot;Zhihong&quot;,&quot;last_name&quot;:&quot;O’Brien&quot;},{&quot;first_name&quot;:&quot;Carol&quot;,&quot;last_name&quot;:&quot;E. Stotz&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;I. Crespo&quot;},{&quot;first_name&quot;:&quot;José-Luis&quot;,&quot;last_name&quot;:&quot;Díaz&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;H. Slee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;7099-7110&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800851u&quot;},&quot;abstract&quot;:&quot;4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-pyrimidines bearing substituted pyridyl groups as C-6 substituents were prepared as selective adenosine hA2A receptor antagonists for the treatment of Parkinson’s disease. The 5-methoxy-3-pyridyl derivative 6g (hA2A Ki 2.3 nM, hA1 Ki 190 nM) was orally active at 3 mg/kg in a rat HIC model but exposure was poor in nonrodent species, presumably due to poor aqueous solubility. Follow-on compound 16a (hA2A Ki 0.83 nM, hA1 Ki 130 nM), bearing a 6-(morpholin-4-yl)-2-pyridyl substituent at C-6, had improved solubility and was orally efficacious (3 mg/kg, HIC) but showed time-dependent cytochrome P450 3A4 inhibition, possibly related to morpholine ring metabolism. Compound 16j (hA2A Ki 0.44 nM, hA1 Ki 80 nM), bearing a 6-(4-methoxypiperidin-1-yl)-2-pyridyl substituent at C-6, was sparingly soluble but had good oral exposure in rodent and nonrodent species, had no cytochrome P450 or human ether-a-go-go related gene channel issues, and was orally efficacious at 1 mg/kg in HIC &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800851u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800851u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800851u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800851u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800851u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800851u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800851u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800851u&amp;href=/doi/10.1021/jm800851u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800851u" /></input><a href="/doi/pdf/10.1021/jm800851u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (271 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800851u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800851u%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DZhang%26date%3D2008%26atitle%3DLead%2BOptimization%2Bof%2B4-Acetylamino-2-%25283%252C5-dimethylpyrazol-1-yl%2529-6-pyridylpyrimidines%2Bas%2BA2A%2BAdenosine%2BReceptor%2BAntagonists%2Bfor%2Bthe%2BTreatment%2Bof%2BParkinson%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D22%26spage%3D7099%26epage%3D7110%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-pyrimidines bearing substituted pyridyl groups as C-6 substituents were prepared as selective adenosine hA<sub>2A</sub> receptor antagonists for the treatment of Parkinson’s disease. The 5-methoxy-3-pyridyl derivative <b>6g</b> (hA<sub>2A</sub><i>K</i><sub>i</sub> 2.3 nM, hA<sub>1</sub><sup></sup><i>K</i><sub>i</sub> 190 nM) was orally active at 3 mg/kg in a rat HIC<sup></sup> model but exposure was poor in nonrodent species, presumably due to poor aqueous solubility. Follow-on compound <b>16a</b> (hA<sub>2A</sub><i>K</i><sub>i</sub> 0.83 nM, hA<sub>1</sub><i>K</i><sub>i</sub> 130 nM), bearing a 6-(morpholin-4-yl)-2-pyridyl substituent at C-6, had improved solubility and was orally efficacious (3 mg/kg, HIC) but showed time-dependent cytochrome P450 3A4 inhibition, possibly related to morpholine ring metabolism. Compound <b>16j</b> (hA<sub>2A</sub><i>K</i><sub>i</sub> 0.44 nM, hA<sub>1</sub><i>K</i><sub>i</sub> 80 nM), bearing a 6-(4-methoxypiperidin-1-yl)-2-pyridyl substituent at C-6, was sparingly soluble but had good oral exposure in rodent and nonrodent species, had no cytochrome P450 or human ether-a-go-go related gene channel issues, and was orally efficacious at 1 mg/kg in HIC and at 3 mg/kg for potentiation of <span class="smallcaps smallerCapital">l</span>-dopa-induced contralateral rotations in 6-hydroxydopamine-lesioned rats.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Extracellular adenosine regulates a wide range of functions in higher organisms, in which the effects are mediated by a family of four class A (rhodopsin-like) GPCRs,<a class="ref internalNav" href="#fn7" aria-label="a">a</a><div class="NLM_fn" id="fn7">a<p class="last">hA<sub>2A</sub>, human adenosine 2A; hA<sub>1</sub>, human adenosine 1; HIC, haloperidol induced catalepsy; GPCR, G-protein coupled receptor; MED, minimal effective dose; hERG, human ether-a-go-go related gene; CYP, cytochrome P450.</p></div><sup>,</sup><a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> adenosine receptors known as A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub>.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Caffeine, a nonselective adenosine receptor antagonist, has been used for millennia for its effects on wakefulness and alertness, and in recent years, epidemiological studies have shown that consumption of caffeine is associated with a decreased risk of developing Parkinson’s disease, although a true neuroprotective effect has not been demonstrated.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The neurological effects of caffeine are due in large part to its activity at human adenosine 2A (hA<sub>2A</sub>) receptors, which are abundant in the nucleus accumbens, olfactory tubercle, and striatum, where they are colocalized with dopamine D<sub>2</sub> receptors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> It has been shown that antagonists of A<sub>2A</sub> receptors in the striatum can potentiate the response of dopamine agonists acting at D<sub>2</sub> receptors in the same location. This has led to the hypotheses that A<sub>2A</sub> antagonists, either alone or in combination with dopamine agonists, can have a role in the treatment of neurodegenerative movement disorders such as Parkinson’s disease and Huntington’s disease, and there is substantial preclinical evidence in support of this hypothesis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Accordingly, the pharmaceutical industry has made a substantial investment in recent years to develop selective, orally available A<sub>2A</sub> antagonists.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> At least three A<sub>2A</sub> antagonists are currently undergoing clinical trials for Parkinson’s symptomology.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Previously we reported work on a series of 4-acylaminopyrimidine A<sub>2A</sub> antagonists based on <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This compound has high affinity for the hA<sub>2A</sub> and rat A<sub>2A</sub> (rA<sub>2A</sub>) receptors but has poor selectivity over the human A<sub>1</sub> (hA<sub>1</sub>) receptor (hA<sub>2A</sub><i>K</i><sub>i</sub> 0.6 nM, hA<sub>1</sub><i>K</i><sub>i</sub> 9.2 nM), blockade of which could lead to diuresis and various cardiovascular effects.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The simple furan substituent in this series of compounds also represents a toxicology risk.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Recently, we reported on a series of active and selective compounds such as <b>2</b> (hA<sub>2A</sub><i>K</i><sub>i</sub> 12 nM, hA<sub>1</sub><i>K</i><sub>i</sub> 850 nM), in which the furyl group has been substituted or replaced entirely. During the course of that work, it became clear that one of the preferred pyrimidine C-6 substituents, 3,5-dimethylpyrazol-1-yl, could also serve well as a C-2 furan replacement, as in <b>3</b> (hA<sub>2A</sub><i>K</i><sub>i</sub> 27 nM, hA<sub>1</sub><i>K</i><sub>i</sub> 1700 nM).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead acylaminopyrimidine hA<sub>2A</sub> antagonists. R = phenyl, substituted phenyl, pyridyl or substituted pyridyl, R<sup>1</sup> = small alkyl or alkoxy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds with amine-bearing substituents on the acyl group such as <b>2</b> tend to be blockers of the hERG channel,<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> blockade of which has been associated with cardiovascular safety risks.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Neutral lipophilic acyl groups yield active and selective compounds<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with reduced hERG liability, but these compounds tend to be poorly soluble and are not generally orally active in rat haloperidol-induced catalepsy (HIC), an in vivo pharmacological model used to assess reversal of the effects of the dopamine D<sub>2</sub> antagonist haloperidol.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Elaborate acyl groups, whether neutral or basic, tend to improve selectivity over hA<sub>1</sub>, but they also tend to decrease activity at the rA<sub>2A</sub> receptor, complicating interpretation of in vivo results. We reasoned that combining the C-2 dimethylpyrazole substituent of <b>3</b> with a simple 4-acylamino group, as in <b>1</b>, might allow us to discover compounds that had a combination of good human and rat A<sub>2A</sub> activity, good selectivity over hA<sub>1</sub>, and low hERG inhibitory activity. We recently reported preliminary results from this approach, in which we explored substituted phenyl substituents at the C-6 position.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> We now report the extension of this work to pyridyl compounds of general structure <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), in which R<sup>1</sup> is a small alkyl or alkoxy group. This work resulted in the discovery of a highly active and selective series of compounds, the best of which (<b>6g</b> and <b>16j</b>) displayed good in vivo oral activity in rat models for Parkinson’s disease and were advanced to preclinical development. The details of this investigation are disclosed herein.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Chemistry</h3><div class="NLM_p">The compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were prepared from <b>5</b><sup></sup><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> according to the methods described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Compounds <b>6a</b>−<b>6h</b> bear simple 6-aryl substituents and were prepared in one step by Suzuki coupling with suitable commercially available boronic acids or esters (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Compound <b>7</b> was prepared by Mitsunobu alkylation of <b>6h</b>. Compound <b>9a</b> was prepared by acylation of <b>8</b> with chloroacetyl chloride, followed by displacement with morpholine. Compound <b>9b</b> was prepared by acylation of <b>8</b> with propionyl chloride. Because direct reaction of <b>8</b> with chloroformates was unsuccessful, we prepared <b>9c</b> and <b>9d</b> by reaction of <b>8</b> with triphosgene, followed by treatment with methanol or ethanol, respectively.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Human A<sub>2A</sub> and A<sub>1</sub> Binding Affinity and Other Data for Compounds <b>6a</b>−<b>6h</b>, <b>7</b>, and <b>9a</b>−<b>9d</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0008.gif" alt="" id="_i4" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="char" valign="middle"> </th><th colspan="2" align="char" valign="middle" char="±"><i>K</i><sub>i</sub> ± SEM (nM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th align="char" valign="middle" char="."> </th><th colspan="2" align="center" valign="middle">Cl<sub>int</sub> (mL/min kg)</th><th align="center" valign="middle"> </th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R</th><th align="center" valign="middle">R<sup>1</sup></th><th align="center" valign="middle" char="±">hA<sub><b>2A</b></sub><a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char="±">hA<sub><b>1</b></sub><a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></th><th align="center" valign="middle" char=".">hA<sub><b>1</b></sub>/hA<sub>2A</sub></th><th align="center" valign="middle">HLM</th><th align="center" valign="middle" char=".">RLM</th><th align="center" valign="middle">CYP-3A4 IC<sub><b>50</b></sub>(μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>6a</b></td><td align="left">Ph</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">87 ± 9</td><td align="char" char="±">290 ± 110</td><td align="char" char=".">3.3</td><td align="left">ND</td><td align="char" char=".">ND</td><td align="left">43</td></tr><tr valign="top"><td align="left"><b>6b</b></td><td align="left">3-pyridyl</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">120 ± 4</td><td align="char" char="±">2100 ± 20</td><td align="char" char=".">18</td><td align="left">ND</td><td align="char" char=".">ND</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>6c</b></td><td align="left">4-pyridyl</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">40 ± 0</td><td align="char" char="±">820 ± 150</td><td align="char" char=".">21</td><td align="left">ND</td><td align="char" char=".">ND</td><td align="left">8.5</td></tr><tr valign="top"><td align="left"><b>6d</b></td><td align="left">3-MeO-Ph</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">0.92 ± 0.13</td><td align="char" char="±">65 ± 8</td><td align="char" char=".">71</td><td align="left">ND</td><td align="char" char=".">ND</td><td align="left">0.74</td></tr><tr valign="top"><td align="left"><b>6e</b></td><td align="left">2-F-3-MeO-Ph</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">0.60 ± 0.04</td><td align="char" char="±">110 ± 9</td><td align="char" char=".">187</td><td align="left">36</td><td align="char" char=".">360</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>6f</b></td><td align="left">3,5-di-MeO-Ph</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">0.19 ± 0.05</td><td align="char" char="±">22 ± 2</td><td align="char" char=".">116</td><td align="left">9.3</td><td align="char" char=".">110</td><td align="left">0.38</td></tr><tr valign="top"><td align="left"><b>6g</b></td><td align="left">5-MeO-3-pyridyl</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">2.3 ± 0.2</td><td align="char" char="±">190 ± 20</td><td align="char" char=".">82</td><td align="left">35</td><td align="char" char=".">120</td><td align="left">18</td></tr><tr valign="top"><td align="left"><b>6h</b></td><td align="left">5-OH-3-pyridyl</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">2.9 ± 0.5</td><td align="char" char="±">195 ± 100</td><td align="char" char=".">67</td><td align="left">41</td><td align="char" char=".">140</td><td align="left">18</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">5-(2-methoxy-ethoxy)-3-pyridyl</td><td align="left">CH<sub>3</sub></td><td align="char" char="±">3.1 ± 0.6</td><td align="char" char="±">110 ± 13</td><td align="char" char=".">36</td><td align="left">3.0</td><td align="char" char=".">43</td><td align="left">14</td></tr><tr valign="top"><td align="left"><b>9a</b></td><td align="left">5-MeO-3-pyridyl</td><td align="left">(morpholin-4-yl)-methyl</td><td align="char" char="±">4.0 ± 0.1</td><td align="char" char="±">940 ± 170</td><td align="char" char=".">235</td><td align="left">3.0</td><td align="char" char=".">150</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>9b</b></td><td align="left">5-MeO-3-pyridyl</td><td align="left">Et</td><td align="char" char="±">1.8 ± 0.4</td><td align="char" char="±">70 ± 22</td><td align="char" char=".">39</td><td align="left">29</td><td align="char" char=".">110</td><td align="left">17</td></tr><tr valign="top"><td align="left"><b>9c</b></td><td align="left">5-MeO-3-pyridyl</td><td align="left">OMe</td><td align="char" char="±">7.4 ± 0.6</td><td align="char" char="±">780 ± 60</td><td align="char" char=".">106</td><td align="left">16</td><td align="char" char=".">93</td><td align="left">16</td></tr><tr valign="top"><td align="left"><b>9d</b></td><td align="left">5-MeO-3-pyridyl</td><td align="left">OEt</td><td align="char" char="±">7.8 ± 1.8</td><td align="char" char="±">620 ± 100</td><td align="char" char=".">79</td><td align="left">38</td><td align="char" char=".">59</td><td align="left">20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Data are expressed as geometric means of at least two runs ± the standard error of measurement (SEM).</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Displacement of specific [<sup>3</sup>H]-<b>27</b> ([<sup>3</sup>H]-ZM241385, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> binding at hA<sub>2A</sub> receptors expressed in HEK293 cells.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">Displacement of specific [<sup>3</sup>H]-<b>28</b> ([<sup>3</sup>H]-DPCPX, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> binding at hA<sub>1</sub> receptors expressed in HEK293 cells; HLM = human liver microsomes; RLM = rat liver microsomes; ND = not determined.</p></div></div></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0005.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RB(OR′)<sub>2</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 90 °C; (b) 2-methoxyethanol, DEAD, Ph<sub>3</sub>P; (c) K<sub>2</sub>CO<sub>3</sub>, MeOH, r.t.; (d) ClCH<sub>2</sub>COCl, pyridine; morpholine; (e) EtCOCl, pyridine, DCM; (f) triphosgene, DCM; methanol or ethanol.</p></p></figure><div class="NLM_p">The aminopyridine-substituted compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were generally prepared from halopyridyl intermediates <b>10</b>, <b>11</b>, and <b>12</b> by either thermal or metal-catalyzed amine displacement reactions (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). In the thermal reaction, under a variety of conditions, the desired acetylamino products were typically accompanied by the corresponding deacetylated primary amine products. The halopyridyl intermediates were obtained by Suzuki reaction of <b>5</b> with commercially available halopyridyl boronate esters. Compound <b>16b</b> was obtained by direct Suzuki reaction of <b>5</b> with 6-aminopyridin-2-ylboronic acid pinacol ester (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Data for Compounds <b>17</b>, <b>14</b>, <b>15</b>, and <b>16a</b>−<b>16k</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0009.gif" alt="" id="_i6" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char="±"><i>K</i><sub>i</sub> ± SEM (nM)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char="."> </th><th colspan="2" align="center" valign="middle">Cl<sub>int</sub> (mL/min kg)</th><th align="left" valign="middle"> </th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">NR<sup>2</sup>R<sup>3</sup></th><th align="center" valign="middle" char="±">hA<sub>2A</sub><a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char="±">hA<sub>1</sub><a class="ref internalNav" href="#tbl4-fn3" aria-label="c">c</a></th><th align="center" valign="middle" char=".">hA<sub>1</sub>/hA<sub>2A</sub></th><th align="center" valign="middle">HLM</th><th align="center" valign="middle">RLM</th><th align="center" valign="middle">CYP-3A4 IC<sub><b>50</b></sub>(μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>17</b></td><td align="left">morpholin-4-yl</td><td align="char" char="±">87 ± 7</td><td align="char" char="±">4600 ± 350</td><td align="char" char=".">53</td><td align="left">ND</td><td align="left">ND</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left">morpholin-4-yl</td><td align="char" char="±">3.0 ± 0.8</td><td align="char" char="±">220 ± 90</td><td align="char" char=".">74</td><td align="left">12</td><td align="left">150</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="left">morpholin-4-yl</td><td align="char" char="±">12 ± 1</td><td align="char" char="±">580 ± 170</td><td align="char" char=".">48</td><td align="left">ND</td><td align="left">ND</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>16a</b></td><td align="left">morpholin-4-yl</td><td align="char" char="±">0.83 ± 0.1</td><td align="char" char="±">130 ± 13</td><td align="char" char=".">155</td><td align="left">3.0</td><td align="left">25</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>16b</b></td><td align="left">amino</td><td align="char" char="±">7.9 ± 0.5</td><td align="char" char="±">440 ± 15</td><td align="char" char=".">57</td><td align="left">ND</td><td align="left">ND</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>16c</b></td><td align="left"><i>N</i>,<i>N</i>-dimethyl-amino</td><td align="char" char="±">0.61 ± 0.07</td><td align="char" char="±">81 ± 12</td><td align="char" char=".">133</td><td align="left">54</td><td align="left">1600</td><td align="left">25</td></tr><tr valign="top"><td align="left"><b>16d</b></td><td align="left">pyrrolidin-1-yl</td><td align="char" char="±">0.26 ± 0.01</td><td align="char" char="±">7.2 ± 4</td><td align="char" char=".">28</td><td align="left">ND</td><td align="left">ND</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>16e</b></td><td align="left">piperidin-1-yl</td><td align="char" char="±">0.56 ± 0.05</td><td align="char" char="±">31 ± 5</td><td align="char" char=".">54</td><td align="left">ND</td><td align="left">ND</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>16f</b></td><td align="left">homomorpholin-4-yl</td><td align="char" char="±">2.3 ± 0.4</td><td align="char" char="±">280 ± 20</td><td align="char" char=".">121</td><td align="left">94</td><td align="left">1000</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>16g</b></td><td align="left">4-methylpiperazin-1-yl</td><td align="char" char="±">0.71 ± 0.11</td><td align="char" char="±">120 ± 10</td><td align="char" char=".">175</td><td align="left">3.0</td><td align="left">25</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>16h</b></td><td align="left">(2-methoxy-ethyl)-methyl-amino</td><td align="char" char="±">0.72 ± 0.13</td><td align="char" char="±">55 ± 17</td><td align="char" char=".">76</td><td align="left">52</td><td align="left">490</td><td align="left">2.5</td></tr><tr valign="top"><td align="left"><b>16i</b></td><td align="left">3-methoxy-azetidin-1-yl</td><td align="char" char="±">0.47 ± 0.06</td><td align="char" char="±">34 ± 15</td><td align="char" char=".">72</td><td align="left">25</td><td align="left">160</td><td align="left">11</td></tr><tr valign="top"><td align="left"><b>16j</b></td><td align="left">4-methoxy-piperidin-1-yl</td><td align="char" char="±">0.44 ± 0.1</td><td align="char" char="±">85 ± 24</td><td align="char" char=".">193</td><td align="left">41</td><td align="left">540</td><td align="left">>20</td></tr><tr valign="top"><td align="left"><b>16k</b></td><td align="left">4-hydroxy-piperidin-1-yl</td><td align="char" char="±">1.9 ± 0.2</td><td align="char" char="±">470 ± 110</td><td align="char" char=".">247</td><td align="left">43</td><td align="left">230</td><td align="left">>20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Data are expressed as geometric means of at least two runs ± the standard error of measurement (SEM);</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Displacement of specific [<sup>3</sup>H]-<b>27</b> binding at human A<sub>2A</sub> receptors expressed in HEK293 cells;</p></div><div class="footnote" id="tbl4-fn3"><sup>c</sup><p class="last">Displacement of specific [<sup>3</sup>H]-<b>28</b> binding at human A<sub>1</sub> receptors expressed in HEK293 cells; HLM = Human liver Microsomes; RLM = Rat liver Microsomes; ND = not determined.</p></div></div></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0006.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RB(OR′)<sub>2</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 90 °C; (b) amine, DMA, 190 °C, microwave; (c) amine, DMSO, 100 °C; (d) amine hydrochloride, NMP, TEA, 160 °C, 80 min, microwave; (e) amine hydrochloride, dioxane, Pd<sub>2</sub>dba<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, ligand <b>13</b>, 100 °C; (f) morpholine, DMSO, CuI, <span class="smallcaps smallerCapital">l</span>-proline, K<sub>2</sub>CO<sub>3</sub>, 100 °C.</p></p></figure><div class="NLM_p">In the case of compound <b>17</b>, the displacement routes of Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> failed, so an alternate route involving de novo synthesis of the pyrimidine nucleus was used (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Potassium <i>tert</i>-butoxide promoted reaction of acetonitrile with cyanopyridine <b>20b</b> provided enaminonitrile <b>21b</b>. Subsequent condensation<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with thiourea, methylation, and oxidation with oxone provided sulfone <b>24b</b>. Displacement of the methanesulfonyl group with 3,5-dimethylpyrazole was problematic; however, displacement with hydrazine, followed by condensation with 2,4-pentanedione, provided the pyrazole <b>26b</b> in acceptable yield. Acetylation furnished final compound <b>17</b>. Variations of the route in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> were used to perform scale-up syntheses of <b>16a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and other compounds in this general series. Depending on the substrate, the oxidation of sulfide <b>23</b> to sulfone <b>24</b> could be accompanied by oxidation of the amine side chain to generate an <i>N</i>-oxide. The parent amine was regenerated via reduction with hydrazine (or another reaction component) during the subsequent sulfone displacement step.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0007.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine, DMA, Et<sub>3</sub>N, 100 °C; (b) NH<sub>3</sub>, MeOH, sealed tube, 75 °C; (c) (CF<sub>3</sub>CO)<sub>2</sub>O, DCM, Et<sub>3</sub>N, 0 °C to r.t.; (d) t-BuOK, MeCN, toluene, r.t.; (e) thiourea, NaOEt, EtOH, sealed tube, 100 °C; (f) NaOH, H<sub>2</sub>O, MeI, r.t.; (g) oxone, MeOH, H<sub>2</sub>O, NaHCO<sub>3;</sub> (h) H<sub>2</sub>NNH<sub>2</sub>, EtOH, reflux; (i) 2,4-pentanedione, EtOH, r.t.; (j) AcCl, pyridine, DCM, r.t.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The prototypical phenyl and pyridyl compounds <b>6a</b>, <b>6b</b>, and <b>6c</b> were found to be moderately potent binders at the hA<sub>2A</sub> receptor but had poor selectivity versus hA<sub>1</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). We performed an extensive survey of substituted phenyl groups at the pyrimidine C-6 position with the goal of improving potency and selectivity against the hA<sub>1</sub> receptor. This survey revealed that a variety of substitution patterns gave compounds with hA<sub>2A</sub> activity in the 10−50 nM range but typically with low to fair selectivity over hA<sub>1</sub> (5−30×). The key finding from this survey was that a hydrogen bond accepting group in the phenyl 3-position, such as fluoro or methoxy, improved both hA<sub>2A</sub> binding activity and selectivity over hA<sub>1</sub>. Thus compounds such as <b>6d</b>, <b>6e</b>, and in particular <b>6f</b> were among the most active and selective compounds in the series (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). As expected for these very weakly basic compounds, little or no hERG inhibition was seen in this series.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">Further profiling of <b>6e</b> and <b>6f</b> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) indicated that both compounds had moderate to good stability in human (HLM) and rat (RLM) liver microsomal assays and had good human functional antagonist activity in a cAMP assay,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> validating the design premise for the series. Compound <b>6f</b> was poorly soluble and had poor permeability in an in vitro Caco-2 cell permeability assay (<i>p</i> = 24 nm/s), while <b>6e</b> had reasonable solubility in a high-throughput solubility assay in pH 7.4 phosphate-buffered saline (PBS). Compound <b>6e</b> also was found to have good Caco-2 cell permeability (<i>p</i> = 260 nm/s). In the rat HIC model, however, orally dosed (PO) <b>6e</b> was inactive, presumably due to lack of exposure (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compound <b>6f</b>, in spite of its in vitro profile, had good oral exposure and was quite efficacious in the HIC model, having a minimal effective dose (MED<sup></sup>) of 1 mg/kg (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Unfortunately, these and other 3-methoxyphenyl compounds interacted with CYP3A4<sup></sup>, either through direct inhibition or in the case of <b>6f</b>, through time-dependent increase of CYP3A4 inhibition, indicating potent inhibition by a metabolite.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Secondary Data for Select Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="middle" char=".">Rat HIC MED (mg/kg)</th><th align="center" valign="middle" char=".">HIC % reversal<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></th><th align="center" valign="middle"><i>C</i><sub>plasma</sub><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a>(ng/mL)</th><th align="center" valign="middle"><i>C</i><sub>brain</sub><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a> (ng/g)</th><th align="center" valign="middle" char=".">rA<sub>2A</sub><a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a><i>K</i><sub>i</sub> (nM)</th><th align="center" valign="bottom" char=".">hcAMP<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a>IC<sub>50</sub> (nM)</th><th align="center" valign="middle">solubility<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a>(mg/mL)</th><th align="center" valign="bottom">measured logD<sub>7.4</sub></th><th align="center" valign="bottom">measured p<i>K</i><sub>a</sub></th></tr></thead><tbody><tr valign="top"><td align="left"><b>6e</b><a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a></td><td align="char" char="."> </td><td align="char" char="."> </td><td align="left">ND</td><td align="left">ND</td><td align="char" char=".">12</td><td align="char" char=".">32</td><td align="left">0.17</td><td align="left">2.0</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>6f</b></td><td align="char" char=".">1<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="char" char=".">49</td><td align="left">1330</td><td align="left">1150</td><td align="char" char=".">3</td><td align="char" char=".">17</td><td align="left"><0.02</td><td align="left">3.2</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>6h</b><a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a></td><td align="char" char="."> </td><td align="char" char="."> </td><td align="left">ND</td><td align="left">ND</td><td align="char" char=".">62</td><td align="char" char=".">57</td><td align="left">ND</td><td align="left">ND</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>6g</b></td><td align="char" char=".">1</td><td align="char" char=".">64</td><td align="left">264</td><td align="left">154</td><td align="char" char=".">32</td><td align="char" char=".">64</td><td align="left">ND</td><td align="left">2.4</td><td align="left">3.5</td></tr><tr valign="top"><td align="left"><b>9a</b><a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a></td><td align="char" char="."> </td><td align="char" char="."> </td><td align="left">ND</td><td align="left">ND</td><td align="char" char=".">30</td><td align="char" char=".">49</td><td align="left">ND</td><td align="left">2.4</td><td align="left">5.3, 3.6</td></tr><tr valign="top"><td align="left"><b>9b</b></td><td align="char" char=".">1</td><td align="char" char=".">69</td><td align="left">860</td><td align="left">1380</td><td align="char" char=".">21</td><td align="char" char=".">31</td><td align="left">ND</td><td align="left">2.8</td><td align="left">3.6</td></tr><tr valign="top"><td align="left"><b>9c</b></td><td align="char" char=".">10</td><td align="char" char=".">46</td><td align="left">ND</td><td align="left">ND</td><td align="char" char=".">68</td><td align="char" char=".">167</td><td align="left">ND</td><td align="left">ND</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>9d</b><a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a></td><td align="char" char="."> </td><td align="char" char="."> </td><td align="left">ND</td><td align="left">ND</td><td align="char" char=".">82</td><td align="char" char=".">196</td><td align="left">ND</td><td align="left">ND</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>16a</b></td><td align="char" char=".">3<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="char" char=".">55</td><td align="left">150</td><td align="left">170</td><td align="char" char=".">10</td><td align="char" char=".">13</td><td align="left">0.14</td><td align="left">ND</td><td align="left">2.9</td></tr><tr valign="top"><td align="left"><b>16g</b><a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a></td><td align="char" char="."> </td><td align="char" char="."> </td><td align="left">53</td><td align="left">91</td><td align="char" char=".">7</td><td align="char" char=".">7</td><td align="left">0.24</td><td align="left">ND</td><td align="left">7.6</td></tr><tr valign="top"><td align="left"><b>16c</b></td><td align="char" char=".">30</td><td align="char" char="."> </td><td align="left">290</td><td align="left">180</td><td align="char" char=".">20</td><td align="char" char=".">156</td><td align="left">ND</td><td align="left">ND</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>16h</b></td><td align="char" char=".">10</td><td align="char" char=".">70</td><td align="left">220</td><td align="left">870</td><td align="char" char=".">14</td><td align="char" char=".">70</td><td align="left">ND</td><td align="left">ND</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>16j</b></td><td align="char" char=".">1<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="char" char=".">88</td><td align="left">150</td><td align="left">560</td><td align="char" char=".">1.5</td><td align="char" char=".">18</td><td align="left">0.03</td><td align="left">3.6</td><td align="left">3.4</td></tr><tr valign="top"><td align="left"><b>16k</b></td><td align="char" char=".">30</td><td align="char" char="."> </td><td align="left">16</td><td align="left">9</td><td align="char" char=".">10</td><td align="char" char=".">22</td><td align="left">0.20</td><td align="left">ND</td><td align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">At time = 2 h after 10 mg/kg oral dose.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Displacement of specific [<sup>3</sup>H]-<b>27</b> binding at rA<sub>2A</sub> receptors expressed in CHO cells.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">hA<sub>2A</sub> receptor antagonism of 3-[4-[2-[[6-amino-9-[(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid (CGS-21680)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> stimulated cAMP.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">Solubility in PBS at pH 7.4.</p></div><div class="footnote" id="tbl2-fn5"><sup>e</sup><p class="last">Inactive at a dose of 30 mg/kg PO.</p></div><div class="footnote" id="tbl2-fn6"><sup>f</sup><p class="last">Lowest dose tested; ND = not determined.</p></div></div></div><div class="NLM_p">Our discovery efforts thus turned to finding a compound with the efficacy and selectivity profile of <b>6f</b> but with a more favorable metabolism profile. Because the simple 3-pyridyl compound <b>6b</b> was similar in activity to phenyl compound <b>6a</b> and appeared to have somewhat less CYP3A4 inhibitory activity, we made methoxypyridine <b>6g</b>. This compound was a potent antagonist of hA<sub>2A</sub> and was reasonably selective versus hA<sub>1</sub> yet was only a weak inhibitor of CYP3A4 and a weak blocker of the hERG channel (IC<sub>50</sub> 24 μM, electrophysiology assay). It had good functional activity and was orally efficacious at 1 mg/kg in HIC. We prepared a series of analogues of <b>6g</b> in which we varied the methoxy group (<b>6h</b>, <b>7</b>) or the acyl group (<b>9a</b>−<b>9d</b>); however, none of these compounds was superior overall to <b>6g</b>, having either lower selectivity (<b>7</b>, <b>9b</b>) or poor in vivo efficacy in the HIC model (<b>6h</b>, <b>9a</b>, <b>9c</b>, <b>9d</b> Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compound <b>6g</b> had poor aqueous solubility (<0.01 mg/mL at pH ≥ 2) but had reasonable oral exposure in the rat (AUC<sub>0−24</sub> 1430 ng h/mL at 10 mg/kg, free base, 25% PEG-400 in D5W).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Exposure at elevated doses (30−300 mg/kg) in rat was sufficient for 14 day toxicological studies in that species (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). However, exposure in nonrodent species (dog, cynomolgus monkey, marmoset) was extremely low using a variety of formulations, precluding further development. The extremely high melting point (283 °C) of <b>6g</b> free base no doubt contributed to the solubility and exposure difficulties.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compound <b>6g</b> (p<i>K</i><sub>a</sub> 3.5) could be formulated as a hydrochloride salt, but this resulted in no overall improvement in pharmacokinetics.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Plasma Exposure of <b>6g</b> in Rats Following Oral Dosing (Vehicle: 25% PEG-400 in D5W)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">dose (mg/kg)</th><th align="center" valign="middle" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th align="center" valign="middle" char=".">AUC<sub>0−24</sub> (ng h/mL)</th></tr></thead><tbody><tr valign="top"><td align="left">10</td><td align="char" char=".">410</td><td align="char" char=".">1430</td></tr><tr valign="top"><td align="left">30</td><td align="char" char=".">2600</td><td align="char" char=".">18700</td></tr><tr valign="top"><td align="left">100</td><td align="char" char=".">3400</td><td align="char" char=".">28900</td></tr><tr valign="top"><td align="left">300</td><td align="char" char=".">4200</td><td align="char" char=".">36800</td></tr></tbody></table></div></div><div class="NLM_p">We sought a followup to <b>6g</b> that would have improved nonrodent exposure, which we hoped to achieve by increasing aqueous solubility and/or decreasing the melting point.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We reasoned that introducing a weakly basic or polar substituent onto the pyridine ring could increase solubility by disrupting crystal packing and/or increasing polarity. To this end, we prepared a series of morpholine-substituted pyridine isomers <b>14</b>, <b>15</b>, <b>16a</b>, and <b>17</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound <b>17</b> had only moderate binding affinity, while <b>14</b> had poor functional activity (cAMP IC<sub>50</sub> 213 nM). Compound <b>15</b> was reasonably active and selective; however, the 3-morphinyl-2-pyridyl isomer <b>16a</b>stood out, having very potent hA<sub>2A</sub> binding affinity, high selectivity over hA<sub>1</sub>, and very good functional activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Solubility of <b>16a</b> (0.14 mg/mL in PBS) was also improved over that of <b>6g</b>.</div><div class="NLM_p">Fixing on the 3-substituted-2-pyridyl isomeric relationship, we then surveyed other amines in place of the morpholine of <b>16a</b>, with illustrative examples shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. A simple amino group (<b>16b</b>) gave weaker binding, while some acyclic amines such as dimethylamine (<b>16c</b>) gave compounds with high binding affinity and selectivity although with relatively poor human functional activity (cAMP IC<sub>50</sub> 156 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Cyclic aliphatic amines such as pyrrolidine (<b>16d</b>) or piperidine (<b>16e</b>) gave potent compounds but with reduced selectivity. Homomorpholine <b>16f</b> was less active and had poor RLM stability. <i>N</i>-Methylpiperazine derivative <b>16g</b> was the most potent compound in the series, both in terms of binding affinity and also in terms of functional activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In addition, it was highly selective over hA<sub>1</sub> (175×) and its weakly basic amino group (measured p<i>K</i><sub>a</sub> 7.6) provided options for formulation, although actual solubility (0.24 mg/mL, PBS) was similar to that of <b>16a</b>. Compound <b>16g</b> was studied in the rat HIC model, where, disappointingly, it showed no inhibition of catalepsy. Exposure was somewhat low (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) in spite of good stability in the RLM assay and reasonable in vitro permeability (MDCK-MDR assay, <i>p</i> = 154 nm/s). However, comparison with <b>6g</b> indicates that the poor efficacy for <b>16g</b> is clearly not due to modest exposure alone and is consistent with a trend we have observed in which basic compounds, in spite of good plasma and gross brain exposure, have generally weak efficacy in the rat HIC model.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Compound <b>16g</b> was also found to be a potent blocker of the hERG channel (IC<sub>50</sub> 540 nM, electrophysiology assay).</div><div class="NLM_p">Returning to the relatively nonbasic morpholine <b>16a</b>, we found that it had a good overall in vitro profile (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and showed good efficacy in the HIC model with a MED of 3 mg/kg. This compound was inactive at the hERG channel and was not a potent inhibitor of CYP3A4 under normal assay conditions. However, <b>16a</b> was found to have time-dependent inhibition of CYP3A4 and was further found to form glutathione adducts when incubated with HLM in the presence of glutathione, implying metabolic generation of a reactive species. Metabolite identification studies (HLM) indicated that a substantial portion of the metabolism took place on the morpholine ring.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">We then set out to replace the morpholine ring with a group that would not be susceptible to the metabolic issues seen with <b>16a</b>. Since we had observed that an oxygen atom (presumably a hydrogen bond acceptor) distal to the amine nitrogen improved selectivity, we incorporated a number of oxygen-bearing cyclic and acyclic amines in place of the morpholine. In particular, we chose methoxyalkyl-substituted amines, reasoning that the metabolically “soft” methoxy group might divert metabolism from the aminopyridine center. Selected compounds are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Acyclic derivative <b>16h</b> was a potent and reasonably selective hA<sub>2A</sub> antagonist and was efficacious in the HIC model at 10 mg/kg. The methoxyazetidine <b>16i</b> was similarly selective and had even more potent binding affinity. However, the 4-methoxypiperidine compound <b>16j</b> had the most interesting in vitro profile and was selected for detailed characterization.</div><div class="NLM_p">Compound <b>16j</b> was a highly potent A<sub>2A</sub> antagonist at both the human and rat receptors with greater than 100× selectivity over hA<sub>1</sub>. Compound <b>16j</b> did not show time-dependent inhibition of CYP3A4 and did not generate glutathione adducts upon incubation with HLM in the presence of glutathione. Metabolic stability in HLM and RLM assays was decreased relative to <b>16a</b> but remained reasonable. As anticipated, the major metabolite observed from incubation with HLM was the <i>O</i>-demethylated compound <b>16k</b>, which turned out to be a potent and selective hA<sub>2A</sub> antagonist as well (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Solubility for <b>16j</b> was still poor (0.03 mg/mL, PBS); however, its melting point was 140 °C, substantially lower than for <b>6g</b>, indicating weaker crystal packing and the potential for more rapid absorption.</div><div class="NLM_p">In spite of its relatively poor solubility, <b>16j</b> demonstrated efficacy in two Parkinson’s related behavioral models. <b>16j</b> was efficacious down to a dose of 1 mg/kg PO in HIC and demonstrated 88% inhibition of catalepsy at 10 mg/kg, a dose at which plasma exposure (150 ng/mL) was moderate but brain exposure (560 ng/g) was relatively high (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). We also examined the ability of <b>16j</b> to potentiate <span class="smallcaps smallerCapital">l</span>-dopa induced rotational behavioral in unilaterally 6-hydroxydopamine-lesioned rats (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). <b>16j</b> dose-dependently potentiated <span class="smallcaps smallerCapital">l</span>-dopa induced rotations with an MED of 3 mg/kg when dosed orally.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Potentiation of <span class="smallcaps smallerCapital">l</span>-dopa induced rotations in unilaterally 6-hydroxydopamine-lesioned rats by orally dosed <b>16j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In escalating dose pharmacokinetic studies in the rat, exposure of <b>16j</b> reached a plateau at moderate doses using a variety of formulations, limiting the scope of safety studies. However, adequate exposure of <b>16j</b>, for safety screening, was achieved in the mouse with 5% TPGS<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> in 0.5% methylcellulose at pH 3.7 as vehicle (AUC<sub>0−24</sub> 25,700 ng h/mL at 300 mg/kg PO). Solubility in this formulation was 1 mg/mL. In dogs, acceptable exposure was also observed (AUC<sub>0−24</sub> 3,400 ng h/mL at 30 mg/kg PO) using 10% PEG400 in 0.25% methylcellulose as vehicle. On the basis of the above data, <b>16j</b> was selected for further preclinical evaluation.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of antagonists used in binding assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Hydroxypiperidine metabolite <b>16k</b> had very low exposure when dosed orally at 10 mg/kg (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and thus had low efficacy in the rat HIC model at this dose. It is interesting to note, however, that <b>16k</b> strongly inhibited catalepsy at a dose of 30 mg/kg PO (90% inhibition, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Exposure at this dose was moderate (plasma and brain levels 180 ng/mL and 91 ng/g, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), suggesting that circulating <b>16k</b> could contribute to the efficacy of <b>16j</b> in vivo.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have prepared a series of potent and selective 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)pyrimidine hA<sub>2A</sub> antagonists with substituted pyridines as the C-6 substituent. Selected compounds had good in vivo activity in the rat HIC model of Parkinson’s symptomology. The advanced compound <b>6g</b> was precluded from further development due to solubility-related low exposure in nonrodent species. Successor compound <b>16a</b>, with a more elaborate morpholine substituent on the pyridine ring, was more soluble and showed promising activity but also showed time-dependent CYP3A4 inhibition and generated glutathione adducts when incubated with HLM in the presence of glutathione. Methoxypiperidine <b>16j</b>, with a readily metabolized methoxy group, was free of the reactive metabolite issues seen with <b>16a</b> and had a superior in vitro and in vivo profile. Although <b>16j</b> still suffered from poor thermodynamic aqueous solubility, its melting point was significantly lower than that of <b>6g</b>, allowing for more rapid absorption with proper formulation. Exposure in mouse and dog was sufficient for <b>16j</b> to be chosen for further preclinical development, which included 14-day safety screening. The results of these studies will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Biology</h3><div class="NLM_p last">Human and rat A<sub>2A</sub> and human A<sub>1</sub> binding assays, metabolism studies, hERG assays, membrane permeability assays, pharmacokinetic assays, and HIC efficacy studies were performed as described previously.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <span class="smallcaps smallerCapital">l</span>-dopa Induced Rotations in 6-Hydroxydopamine Lesioned Rats</h3><div class="NLM_p last">Male Wistar rats (Charles River; 250 g) were pretreated 30 min before surgery with desipramine and pargyline to ensure a maximal effect of the 6-hydroxydopamine (6-OHDA). Then 8 μg of 6-OHDA was injected over 4 min into the medial forebrain bundle (+2.4 mm lateral to the midline, −2.2 mm anterior to bregma (AP), −8.1 mm ventral to the dura surface). After a 3 week recovery, the lesion was verified by measuring rotational behavior in response to apomorphine hydrochloride (0.5 mg/kg sc). Rats that failed to make more than 300 rotations in a 1 h test period were excluded from the study. Rats that passed the apomorphine screen underwent <span class="smallcaps smallerCapital">l</span>-dopa sensitization; they were treated with <span class="smallcaps smallerCapital">l</span>-dopa (10 mg/kg ip) three times separated by 3−5 days. If rats did not respond to <span class="smallcaps smallerCapital">l</span>-dopa by increasing rotations on two of the three sensitization days, they were excluded from the experiment. Each rat underwent each treatment in a randomized design. Test days were separated by 2−3 days. On each test day, rats were habituated to the rotational chambers for 30 min, injected with carbidopa (12 mg/kg ip), 30 min later they were given the treatment, then 30 min later treated with <span class="smallcaps smallerCapital">l</span>-dopa (10 mg/kg ip). Rotational behavioral was then measured over the next 5 h.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> CYP2D6 and CYP3A4 Inhibition Screen</h3><div class="NLM_p">Recombinant CYP2D6 or CYP3A4 were incubated with a selective marker substrate (AMMC (3-[2-(<i>N</i>,<i>N</i>-diethyl-<i>N</i>-methylammonium)-ethyl]-7-methoxy-4-methylcoumarin) for CPY2D6 and BFC (7-benzyloxy-4-trifluoromethylcoumarin) for CYP3A4) in a NADPH generating system in 96-well assay plates with a total incubation volume of 200 μL/well. Incubations were carried out using NCE concentrations of 0.16, 0.8, 4.0, and 200 μM. The NADPH generating system for the CYP2D6 assay consisted of 75 mM potassium phosphate buffer (pH 7.4), 0.5 mM magnesium chloride, 0.01 mM nicotinamide adenine dinucleotide phosphate (NADP), 0.5 mM glucose-6-phosphate (G-6-P), 1 unit/mL glucose-6-phosphate dehydrogenase (G-6-PD). The NADPH generating system for the CYP3A4 assay consisted of 75 mM potassium phosphate buffer (pH 7.4), 3.0 mM magnesium chloride, 1.0 mM NADP, 5.0 mM gluc G-6-P, and 1 unit/mL G-6-PD.</div><div class="NLM_p last">Reactions were initiated with the addition of the enzyme solution and the samples are incubated at 37 °C for 30 min. Reactions were stopped by adding 75 μL of ice-cold 80% acetonitrile/20% 0.5 M Tris Base. The amount of AHMC formed from CYP2D6 catalyzed <i>O</i>-demethylation of AMMC and the amount of 7-HFC formed from CYP3A4 catalyzed dealkylation of BFC were detected using a 96-well microplate fluorescence reader.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Metabolic Stability Screen</h3><div class="NLM_p">Pooled human liver microsomes (0.5 mg/mL; <i>n</i> > 10; mixed gender) were incubated at 37 °C with the NCE in the presence of an NADPH-generating system containing 50 mM, potassium phosphate buffer (pH 7.4), 3 mM magnesium chloride, 1 mM EDTA, 1 mM NADP, 5 mM G-6-P, and 1 unit/mL G-6-PD.</div><div class="NLM_p last">Incubations were conducted in six 1.2 mL titer tube plates using a 1 μM concentration of each NCE (containing up to 0.01% DMSO) with a total volume of 250 μL per incubation. Each plate representing a single time point contains 96 Titertube Micro Tubes allowing for duplicates of 48 compounds at each time point (0, 5, 10, 20, 40, and 60 min). Reactions were stopped by the addition of 0.3 mL of acetonitrile (containing an internal standard for LC-MS). Precipitated proteins were removed by centrifugation for 35 min at 3500 rpm at 5 °C, and the supernatant fluid (∼0.1 mL) was analyzed by LC-MS-MS to determine the amount of parent compound remaining. The in vitro initial rates of metabolism are scaled using constants such as 45 mg microsomal protein/gm liver, 20 g liver/kg body weight, and 20 mL/min/kg liver blood flow to predict systemic clearance and % bioavailability. These calculations from nonlinear regression assume that liver metabolism and not absorption is the determinant of Bioavailability.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Time-Dependent Inhibition of CYP450 Enzymes (1A2, 2C9, 2C19, 2D6, 3A4)</h3><div class="NLM_p last">Pooled human liver microsomes (<i>N</i> = 10) were preincubated with the NCE at 37 °C for 0 and 30 min in mixtures containing potassium phosphate buffer (50 mM, pH 7.4), MgCl<sub>2</sub> (3 mM), and EDTA (1 mM) with an NADPH-generating system (1 mM NADP, 5 mM G-6-P, and 1 unit/mL G-6-PD) at the final concentrations indicated. After the preincubation period, the marker substrates (1A2: phenacetin at 50 μM; 2C9: diclofenac at 4 μM; 2C19: S-mephenytoin at 35 μM; 2D6: dextromethorphan at 5 μM; 3A4: midazolam at 3 μM) were added, and the incubation was continued for 10 min (30 min for 1A2). Several concentrations (e.g., 5−7 concentrations) of the NCE were studied, which normally cover a range that spans at lease 2 orders of magnitude (e.g., 0.5−100 μM). Incubations were stopped by the addition of a stop reagent (e.g., acetonitrile with internal standard). Precipitated proteins were removed by centrifugation (3500 rpm for 35 min at 5 °C). Aliquots of supernatant fractions were analyzed by LC-MS-MS to determine the amounts of the metabolites of the marker substrates (acetaminophen, 4′-hydroxydiclofenac, 4′-hydroxymephenytoin, dextrorphan, 1′-hydroxymidazolam, respectively).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vitro Absorption Studies in Caco-2 Cells</h3><div class="NLM_p">Caco-2 cells (approximately 1.35 × 10<sup>6</sup> cells/mL) were thawed and transferred to a Corning Costar T-75 flask (Cambridge, MA) with 25 mL of DMEM supplemented with 10 mM HEPES buffer, 1 mM sodium pyruvate, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 0.1 mM MEM nonessential amino acids solution, and 10% FBS for subculture. After subculture to a minimum of 69 passages, Caco-2 cells were seeded (∼67000 cells) onto the apical side of microporous polycarbonate membranes in 24-well Costar Transwell plates and cultured for at least 21 days to allow for formation of a confluent monolayer (diffusional barrier) and optimal expression of P-glycoprotein at 37 °C, 95% humidity and 5% CO<sub>2</sub>.</div><div class="NLM_p last">Incubation of Caco-2 cell monolayer with 20 μM of a NCE (containing up to 0.1% DMSO) in a solution containing 99% HBSS, 1% HEPES, 0.1 μM propranolol, and 25 μM PEG 400 (1.0 mL for basolateral chamber and 0.3 mL for apical chamber) was conducted at 37 °C, 95% humidity with gentle rotary shaking for 60 min. After the incubation the contents of the apical and basolateral chambers were collected in a 96-deep well plate and analyzed by LC-MS-MS to determine the amount of parent compound in each chamber. Digoxin was used as a positive control for P-glycoprotein-mediated transport, and propranolol and PEG 400 were used as high permeability internal standard and low permeability internal standard for quantitation, respectively.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p last">Reagents, starting materials, and solvents were purchased from commercial suppliers and used as received. Concentration refers to evaporation under vacuum using a Büchi rotatory evaporator. Reaction products were purified, when necessary, by flash chromatography on silica gel (40−63 μm) with the solvent system indicated. Spectroscopic data were recorded on a Varian Mercury 300 MHz spectrometer or a Bruker Avance 500 MHz spectrometer. Elemental analyses were done by Robertson Microlit Laboratory, Madison, NJ, or Numega Resonance Laboratories, San Diego, CA. High-resolution mass spectrometry was performed by the Scripps Research Institute Mass Spectrometry Facility, La Jolla, CA. Melting points were recorded on a Büchi 535 apparatus. Preparative HPLC-MS: Platform, Dionex equipped with a Gilson 215 autosampler/fraction collector, UV detector, and a Dionex MSQ mass detector; HPLC column, Phenomenex Synergy Max-RP, 21.2 mm × 50 mm. HPLC gradient: 35 mL/min, acetonitrile/water, 8−30 min run times. Both acetonitrile and water have 0.05% TFA.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Suzuki Coupling Method: <i>N</i>-[6-(6-Chloropyridin-2-yl)-2-(3,5-dimethyl-pyrazol-1-yl)-pyrimidin-4-yl]-acetamide (<b>12</b>)</h3><div class="NLM_p last">A mixture of <b>5</b> (1.8 g, 6.8 mmol), 6-chloropyridin-2-boronic acid pinacol ester (2.27 g, 9.5 mmol), potassium carbonate (1.88 g, 13.6 mmol), dioxane (35 mL), and water (3.5 mL) was sparged with nitrogen gas for 5 min. Tetrakis(triphenylphosphine)palladium(0) (785 mg, 0.68 mmol) was added, the mixture was sparged with nitrogen gas for an additional 10 min, then the vessel was sealed and heated with stirring at 90 °C for 16 h. Water (50 mL) was added, and the resulting solid was collected, rinsed with water and ethyl acetate, and then dried under vacuum to provide the title compound (1.53 g, 4.5 mmol, 66%) as a pink solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.94 (s, 1H), 8.87 (s, 1H), 8.26 (d, <i>J</i> = 8, 1H), 7.81 (t, <i>J</i> = 8, 1H), 7.44 (d, <i>J</i> = 8, 1H), 6.14 (s, 1H), 2.83 (s, 3H), 2.43 (s, 3H), 2.28 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 6.39 min. MS: <i>m</i>/<i>z</i> 343, 345 [M + H]<sup>+</sup>, expected 343, 345 [M + H]<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-[6-(2-Chloropyridin-4-yl)-2-(3,5-dimethyl-pyrazol-1-yl)-pyrimidin-4-yl]-acetamide (<b>10</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from 6-chloropyridin-2-boronic acid pinacol ester (40% crude yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.58 (d, <i>J</i> = 5, 1H), 8.55 (s, 1H), 7.99 (s, 1H), 7.87 (dd, <i>J</i> = 1,5, 1H), 6.19 (s, 1H), 6.03 (s, 1H), 2.84 (s, 3H), 2.47 (s, 3H), 2.30 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 5.99 min. MS: <i>m</i>/<i>z</i> 343, 345 [M + H]<sup>+</sup>, expected 343, 345 [M + H]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-[6-(5-Bromopyridin-3-yl)-2-(3,5-dimethyl-pyrazol-1-yl)-pyrimidin-4-yl]-acetamide (<b>11</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b>, from 3-bromopyridine-5-boronic acid. Purification by chromatography (9:1 DCM/methanol eluant) yielded the title compound as a white solid (11% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.26 (d, <i>J</i> = 2, 1H), 8.80 (d, <i>J</i> = 2, 1H), 8.65 (s, 1H), 8.50 (t, <i>J</i> = 2, 1H), 8.47 (s, 1H), 6.09 (s, 1H), 2.78 (s, 3H), 2.35 (s, 3H), 2.26 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 6.04 min. MS: <i>m</i>/<i>z</i> 387, 389 [M + H]<sup>+</sup>, expected 387, 389 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-phenyl-pyrimidin-4-yl]-acetamide (<b>6a</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from phenylboronic acid. Purification by HPLC yielded the title compound (10 mg, 30% yield). A sample was further purified by preparative TLC (1:1 hexanes/acetone eluant). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.26 (br s, 1H), 8.45 (s, 1H), 8.06−8.09 (m, 2H), 7.56−7.59 (m, 3H), 6.16 (s, 1H), 2.68 (s, 3H), 2.19 (s, 3H), 2.18 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 6.68 min. (97%); MS: <i>m</i>/<i>z</i> 308 [M + H]<sup>+</sup>, expected 308 [M + H]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-pyridin-3-yl-pyrimidin-4-yl]-acetamide (<b>6b</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from 3-pyridylboronic acid. Purification by HPLC yielded the title compound (5 mg, 6% yield) as the TFA salt. LCMS-2: <i>t</i><sub>R</sub> = 3.69 min. (95%); MS: <i>m</i>/<i>z</i> 309 [M + H]<sup>+</sup>, expected 309 [M + H]<sup>+</sup>. LCMS-4: <i>t</i><sub>R</sub> = 6.15 min (100%). MS: <i>m</i>/<i>z</i> 309 [M + H]<sup>+</sup>, expected 309 [M + H]<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-pyridin-4-yl-pyrimidin-4-yl]-acetamide (<b>6c</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from 4-pyridylboronic acid. Purification by HPLC yielded the title compound (17 mg, 21%) as the TFA salt. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.85−8.87 (m, 2H), 8.55 (s, 1H), 8.10−8.12 (m, 2H), 6.20 (s, 1H), 2.70 (s, 3H), 2.21 (s, 6H). LCMS-4: <i>t</i><sub>R</sub> = 6.13 min (99%). MS: <i>m</i>/<i>z</i> 309 [M + H]<sup>+</sup>, expected 309 [M + H]<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(3-methoxyphenyl)-pyrimidin-4-yl]-acetamide (<b>6d</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from 3-methoxyphenylboronic acid. Purification by HPLC yielded the title compound (34 mg, 39%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.51 (br s, 1H), 8.46 (s, 1H), 7.69−7.72 (m, 2H), 7.42 (t, <i>J</i> = 8, 1H), 7.05−7.08 (m, 1H), 6.07 (s, 1H), 3.89 (s, 3H), 2.81 (s, 3H), 2.35 (s, 3H), 2.24 (s,3H). LCMS-2: <i>t</i><sub>R</sub> = 6.78 min (99%). MS: <i>m</i>/<i>z</i> 338 [M + H]<sup>+</sup>, expected 338 [M + H]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(2-fluoro-3-methoxy-phenyl)-pyrimidin-4-yl]-acetamide (<b>6e</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from 2-fluoro-3-methoxyphenylboronic acid. The crude product was taken up in 9:1 DCM/methanol, filtered, and then the filtrate was concentrated to yield a solid. This solid was triturated with ether to yield the title compound as a pale-yellow solid (230 mg, 43%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.28 (s, 1H), 8.45 (s, 1H), 7.50 (m, 1H), 7.35 (m, 2H), 6.17 (s, 1H), 3.90 (s, 3H), 2.62 (s, 3H), 2.20 (s, 3H), 2.19 (s, 3H). LCMS-3: <i>t</i><sub>R</sub> = 21.16 min (100%). MS: <i>m</i>/<i>z</i> 356 [M + H]<sup>+</sup>, expected 356 [M + H]<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>18</sub>FN<sub>5</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-[6-(3,5-Dimethoxy-phenyl)-2-(3,5-dimethyl-pyrazol-1-yl)-pyrimidin-4-yl]-acetamide (<b>6f</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from 3,5-dimethoxyphenylboronic acid pinacol ester. Purification as for <b>6e</b> yielded the title compound as a white solid (296 mg, 54%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.42 (s, 1H), 7.18 (m, 2H), 6.75 (m, 1H), 6.17 (s, 1H), 3.86 (s, 6H), 3.35 (s, 3H), 2.68 (s, 3H), 2.19 (s, 3H). LCMS-3: <i>t</i><sub>R</sub> = 22.43 min (100%). MS: <i>m</i>/<i>z</i> 368 [M + H]<sup>+</sup>, expected 368 [M + H]<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(5-methoxy-pyridin-3-yl)-pyrimidin-4-yl]-acetamide (<b>6g</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from 4.8 g (18 mmol) <b>5</b> and 5-methoxypyridyl-3-boronic acid pinacol ester. The crude reaction mixture was concentrated and the residue suspended in a mixture of ethyl acetate and water. The mixture was filtered, and then the resulting solid was slurried in ether. Filtration yielded the title compound (2.93 g, 48%). A portion of this material (1.5 g, 4.4 mmol) was suspended in hexafluoroisopropanol (20 mL) and treated with 2 M hydrogen chloride in ether (2.7 mL, 5.4 mmol) at rt. The sample was concentrated, then twice taken up in 100 mL water and lyophilized to dryness to provide the title compound as the hydrochloride salt dihydrate. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 9.27 (d, <i>J</i> = 1, 1H), 8.85 (m, 1H), 8.70 (d, <i>J</i> = 3, 1H), 8.65 (s, 1H), 6.23 (s, 1H), 4.15 (s, 3H), 2.76 (s, 3H), 2.35 (s, 3H), 2.29 (s, 3H). LCMS-3: <i>t</i><sub>R</sub> = 13.50 min (100%). MS: <i>m</i>/<i>z</i> 339 [M + H]<sup>+</sup>, expected 339 [M + H]<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub>·HCl·2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-[6-(5-Hydroxypyridin-3-yl)-2-(3,5-dimethyl-pyrazol-1-yl)-pyrimidin-4-yl]-acetamide (<b>6h</b>)</h3><div class="NLM_p">A mixture of 3-bromo-5-hydroxypyridine (1.0 g, 5.7 mmol), bis(pinacolato)diboron (1.75 g, 6.9 mmol), potassium acetate (1.7 g, 17 mmol), [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (PdCl<sub>2</sub>·dppf, 380 mg, 0.47 mmol), and anhydrous dioxane (15 mL) was sparged with nitrogen and then heated in a sealed tube for 5 h. Additional bis(pinacolato)diboron (1.75 g, 6.9 mmol) and PdCl<sub>2</sub>·dppf (380 mg, 0.47 mmol) were added and the reaction heated for an additional 24 h. Ethyl acetate was added, and the reaction mixture was poured onto celite and washed with ethyl acetate. The filtrate was discarded. The solid cake was then washed with 1:1 DCM/methanol, and then methanol. The filtrate was concentrated to provide a crude mixture of 5-hydroxypyridyl-3-boronic acid and its pinacol ester (400 mg).</div><div class="NLM_p last">A mixture of the crude boronic acid/ester from above (400 mg), <b>5</b> (765 mg, 2.9 mmol), tris(dibenzylideneacetone)dipalladium(0) (132 mg, 0.14 mmol), cesium carbonate (1.9 g, 5.8 mmol), tri-<i>tert</i>-butylphosphonium tetrafluoroborate salt (84 mg, 0.30 mmol), THF (10 mL), and water (2 mL) was sparged with nitrogen for 10 min and then heated at reflux under nitrogen for 5 h. The cooled reaction mixture was filtered and the solid rinsed with THF and water. The collected solid (200 mg) was taken up in 1:1 DCM/methanol, then filtered and the filtrate concentrated. The residue was taken up in THF (10 mL) and water (2 mL) and stirred with Smopex-110 resin (Alfa-Aesar no. 44724) for 16 h. The mixture was filtered to remove the resin, rinsed with THF/water, methanol, and DCM. The filtrate was concentrated, then azeotroped with ethanol, and then dried under vacuum to provide the product as a yellow solid (158 mg, 27% yield). A sample was purified by preparative HPLC to provide the TFA salt. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.41 (s, 1H), 8.87 (br s, 1H), 8.53 (m, 1H), 8.48 (s, 1H), 8.34 (br s, 1H), 6.20 (s, 1H), 2.69 (s, 3H), 2.21 (s, 6H). LCMS-3: <i>t</i><sub>R</sub> = 10.96 min (100%). MS: <i>m</i>/<i>z</i> 325 [M + H]<sup>+</sup>, expected 325 [M + H]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-[6-(6-Amino-pyridin-2-yl)-2-(3,5-dimethyl-pyrazol-1-yl)-pyrimidin-4-yl]-acetamide (<b>16b</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>12</b> from 6-aminopyridin-2-ylboronic acid pinacol ester. HPLC purification provided the TFA salt (68 mg, 28%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.38 (dd, <i>J</i> = 1,5, 1H), 8.19 (s, 1H), 8.09 (s, 1H), 7.70−7.61 (m, 2H), 7.48 (d, <i>J</i> = 8, 1H), 6.97−7.01 (m, 1H), 6.02 (s, 1H), 2.63 (s, 3H), 2.33 (s, 3H), 2.21 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 3.65 min (100%). MS: <i>m</i>/<i>z</i> 324 [M + H]<sup>+</sup>, expected 324 [M + H]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 6-(5-Methoxypyridin-3-yl)-2-(3,5-dimethyl-pyrazol-1-yl)-pyrimidin-4-ylanine (<b>8</b>)</h3><div class="NLM_p last">A mixture of <b>6g</b> (1.05 g, 3.1 mmol), potassium carbonate (325 mesh, 1.29 g, 9.3 mmol), and methanol (45 mL) was stirred at rt for 16 h and then was filtered and concentrated. The residue was chromatographed (9:1 DCM/methanol eluant) to provide the title compound (845 mg, 92%) as a solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.79 (d, <i>J</i> = 1, 1H), 8.40 (d, <i>J</i> = 3, 1H), 7.87 (dd, <i>J</i> = 1,3, 1H), 6.72 (s, 1H), 6.05 (s, 1H), 5.40 (br s, 2H), 3.92 (s, 3H), 2.76 (s, 3H), 2.35 (s, 3H). LCMS-4: <i>t</i><sub>R</sub> = 3.08. MS: <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>, expected 297 [M + H]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(5-methoxy-pyridin-3-yl)-pyrimidin-4-yl]-2-morpholin-4-yl-acetamide (<b>9a</b>)</h3><div class="NLM_p last">A solution of <b>8</b> (1.0 g, 3.4 mmol) and pyridine (0.32 mL, 4.1 mmol) in dichloromethane (70 mL) was treated at rt with chloroacetyl chloride (0.30 mL, 3.7 mmol). The mixture was stirred at rt for 2 h then partitioned against 10% aqueous sodium hydrogensulfate solution. The aqueous layer was extracted with dichloromethane, and then the combined dichloromethane layers were washed with brine, dried over sodium sulfate, filtered, and concentrated. The crude product was triturated with ethyl acetate to provide a solid, which was dissolved in dichloromethane (30 mL). Morpholine (0.57 g, 6.6 mmol) was added, and the resulting solution was stirred at rt for 16 h. The mixture was concentrated and the residue purified by silica gel chromatography (95/3/0.1 DCM/methanol/aqueous ammonia eluant) to provide the title compound as a beige solid (1.1 g, 76% yield). The free base was dissolved in dichloromethane and treated with an excess of hydrogen chloride in ether. Concentration provided the HCl salt as a beige solid (1.09 g) <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.85 (s, 1H), 8.55 (s, 1H), 8.38 (s, 1H), 7.98 (s, 1H), 6.20 (s, 1H), 4.37 (s, 2H), 3.94 (s, 3H), 3.80−4.00 (m, 4H), 3.20−3.60 (m, 4H), 2.70 (s, 3H), 2.20 (s, 3H). LCMS-4: <i>t</i><sub>R</sub> = 7.00 min (98.4%). MS: <i>m</i>/<i>z</i> 424 [M + H]<sup>+</sup>, expected 424 [M + H]<sup>+</sup>; Anal. (C<sub>21</sub>H<sub>25</sub>N<sub>7</sub>O<sub>3</sub>·HCl·H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(5-methoxy-pyridin-3-yl)-pyrimidin-4-yl]-propionamide (<b>9b</b>)</h3><div class="NLM_p last">A mixture of <b>8</b> (300 mg, 1.0 mmol), pyridine (0.15 mL, 1.8 mmol), and DCM (3 mL) was treated with propionyl chloride (188 mg, 2.0 mmol) at rt and stirred at rt for 68 h. Aqueous sodium bicarbonate was added, and the mixture was extracted with four portions of DCM. The combined organic extracts were washed with aqueous sodium hydrogensulfate and brine, dried over magnesium sulfate, and then a few drops of methanol were added and the mixture was filtered and concentrated. The residue was purified by chromatography (97:3 DCM/MeOH eluant) to provide the title compound as a solid (200 mg, 52%). The free base was dissolved in DCM (30 mL) and then was treated with 2 M hydrogen chloride in ether (0.285 mL, 0.57 mmol). The mixture was concentrated and dried under vacuum to provide the title compound (200 mg) as the HCl salt. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 9.35 (d, <i>J</i> = 2, 1H), 8.96 (m, 1H), 8.78 (d, <i>J</i> = 3, 1H), 8.73 (s, 1H), 6.32 (s, 1H), 4.19 (s, 3H), 2.81 (s, 3H), 2.60 (q, <i>J</i> = 8, 2H), 2.41 (s, 3H), 1.24 (t, <i>J</i> = 8, 3H). LCMS-3: <i>t</i><sub>R</sub> = 15.08 min (98.6%). MS: <i>m</i>/<i>z</i> 353 [M + H]<sup>+</sup>, expected 353 [M + H]<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> [2-(3,5-Dimethyl-pyrazol-1-yl)-6-(5-methoxy-pyridin-3-yl)-pyrimidin-4-yl]-carbamic acid methyl ester (<b>9c</b>)</h3><div class="NLM_p last">A solution of triphosgene (300 mg, 1.0 mmol) in dichloromethane (3 mL) was added to an ice-cold suspension of <b>8</b> (300 mg, 1.0 mmol) and pyridine (0.60 mL, 7.4 mmol) in DCM (3 mL). The mixture was stirred at 0 °C for 90 min, then methanol (0.30 mL, 7.4 mmol) was added and the mixture was stirred at rt for 68 h. The reaction mixture was concentrated and the residue partially purified by preparative HPLC. The product was converted to the free base by extraction with DCM from aqueous sodium bicarbonate, then the residue was purified by preparative TLC (95:5 DCM/MeOH eluant) to provide the title compound as a white solid (52 mg, 15%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.21 (s, 1H), 8.84 (d, <i>J</i> = 1, 1H), 8.50 (d, <i>J</i> = 2, 1H), 8.25 (s, 1H), 7.95 (br s, 1H), 6.17 (s, 1H), 3.95 (s, 3H), 3.76 (s, 3H), 2.67 (s, 3H), 2.21 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 4.49 min (100%). MS: <i>m</i>/<i>z</i> 355 [M + H]<sup>+</sup>, expected 355 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> [2-(3,5-Dimethyl-pyrazol-1-yl)-6-(5-methoxy-pyridin-3-yl)-pyrimidin-4-yl]-carbamic acid ethyl ester (<b>9d</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>9c</b> from <b>8</b> (80 mg, 0.27 mmol) and ethanol. Following HPLC purification, the product was dissolved in DCM and treated with 2 M HCl in ether (0.30 mL, 0.6 mmol). The mixture was concentrated to provide the title compound as the HCl salt (57 mg, 52% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.14 (s, 1H), 8.86 (br s, 1H), 8.54 (d, <i>J</i> = 2, 1H), 8.25 (s, 1H), 8.02 (br s, 1H), 6.16 (s, 1H), 4.21 (q, <i>J</i> = 7, 2H), 3.95 (s, 3H), 2.65 (s, 3H), 2.19 (s, 3H), 1.26 (t, <i>J</i> = 7, 3H). LCMS-4: <i>t</i><sub>R</sub> = 7.62 min (100%). MS: <i>m</i>/<i>z</i> 369 [M + H]<sup>+</sup>, expected 369 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-{2-(3,5-Dimethyl-pyrazol-1-yl)-6-[5-(2-methoxy-ethoxy)-pyridin-3-yl]-pyrimidin-4-yl}-acetamide (<b>7</b>)</h3><div class="NLM_p last">Diethyl azodicarboxylate (DEAD, 61 mg, 0.35 mmol) was added to a solution of <b>6h</b> (75 mg, 0.23 mmol), 2-methoxyethanol (26 mg, 0.74 mmol), and triphenylphosphine (91 mg, 0.34 mmol) in THF (1 mL) at rt. The mixture was stirred at rt for 16 h. Additional DEAD (22 mg), triphenylphosphine (30 mg), and 2-methoxyethanol (10 mg) were added, and the mixture was stirred at rt for an additional 4 h. The mixture was concentrated and purified by preparative HPLC to yield the product as the TFA salt (22 mg, 19%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.41 (s, 1H), 8.82 (d, <i>J</i> = 1, 1H), 8.50 (d, <i>J</i> = 1, 1H), 8.46 (s, 1H), 7.95 (s, 1H), 6.19 (s, 1H), 4.29−4.32 (m, 2H), 3.70−3.73 (m, 2H), 3.33 (s, 3H), 2.69 (s, 3H), 2.21 (s, 3H), 2.20 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 4.35 min (95.9%). MS: <i>m</i>/<i>z</i> 383 [M + H]<sup>+</sup>, expected 383 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(2-morpholin-4-yl-pyridin-4-yl)-pyrimidin-4-yl]-acetamide (<b>15</b>)</h3><div class="NLM_p last">A mixture of <b>10</b> (50 mg, 0.15 mmol), morpholine (26 mg, 0.30 mmol), and DMA (1 mL) was heated in a microwave reactor at 190 °C for 20 min. Direct purification of the reaction mixture by preparative HPLC furnished the title compound as the TFA salt. This material was converted to the free base by extraction with DCM from aqueous sodium bicarbonate to yield the free base as a yellow solid (10 mg, 17% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.62 (s, 1H), 8.49 (s, 1H), 8.38 (d, <i>J</i> = 6, 1H), 7.39−7.31 (m, 2H), 6.11 (s, 1H), 3.87 (t, <i>J</i> = 5, 4H), 3.63 (t, <i>J</i> = 5, 4H), 2.79 (s, 3H), 2.38 (s, 3H), 2.26 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 3.91 min (100%). MS: <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>, expected 394 [M + H]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(2-(3,5-Dimethyl-pyrazol-1-yl)-6-{6-[(2-methoxyethyl)-methylamino]-pyridin-2-yl}-pyrimidin-4-yl)-acetamide (<b>16h</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>15</b> starting from <b>12</b> (500 mg, 1.5 mmol) and <i>N</i>-(2-methoxyethyl)methylamine (1.0 g, 11 mmol). Aqueous sodium bicarbonate was added to the crude reaction mixture, and the mixture was extracted with DCM. The combined organic extracts were dried over sodium sulfate, filtered, and concentrated. The residue was purified by preparative TLC (9:1 DCM/MeOH with 1% NH<sub>4</sub>OH as eluant) to provide the title compound (70 mg 12%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.93 (s, 1H), 8.31 (s, 1H), 7.65−7.57 (m, 2H), 6.68 (d, <i>J</i> = 8, 1H), 6.06 (s, 1H), 3.87 (t, <i>J</i> = 6, 3H), 3.72 (t, <i>J</i> = 5, 3H), 3.39 (s, 3H), 3.19 (s, 3H), 2.81 (s, 3H), 2.35 (s, 3H), 2.22 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 4.96 min (100%). MS: <i>m</i>/<i>z</i> 396 [M + H]<sup>+</sup>, expected 396 [M + H]<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(4-methoxy-3,4,5,6-tetrahydro-2<i>H</i>-[1,2′]bipyridinyl-6′-yl)-pyrimidin-4-yl]-acetamide (<b>16j</b>)</h3><div class="NLM_p last">A mixture of <b>12</b> (300 mg, 0.85 mmol), powdered potassium phosphate (650 mg, 3.1 mmol), tris(dibenzylideneacetone)dipalladium(0) (39 mg, 0.038 mmol), 4-methoxypiperidine hydrochloride (264 mg, 1.74 mmol), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (72 mg, 0.18 mmol), and dioxane (10 mL) was sparged with nitrogen gas for 5 min, and then the reaction vessel was sealed and the mixture heated with stirring at 100 °C for 16 h. Water and ethyl acetate were added to the cooled reaction mixture, and then the mixture was filtered and the aqueous phase extracted twice with ethyl acetate. The combined organic extracts were dried over sodium sulfate, filtered, and concentrated to provide a yellow oil. Preparative HPLC, followed by neutralization of product fractions with solid sodium bicarbonate and extraction with ethyl acetate, provided a brown solid. Trituration with ethyl acetate provide the title compound as a yellow-brown solid (80 mg, 22%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.20 (s, 1H), 8.87 (s, 1H), 7.76−7.62 (m, 2H), 7.06 (d, <i>J</i> = 9, 1H), 6.16 (s, 1H), 4.04−4.08 (m, 2H), 3.44−3.46 (m, 1H), 3.34 (s, 3H), 3.24−3.34 (m, 2H), 2.69 (s, 3H), 2.20 (s, 3H), 2.18 (s, 3H), 1.92−1.96 (m, 2H), 1.47−1.49 (m, 2H). LCMS-3: <i>t</i><sub>R</sub> = 22.07 min (100%). MS: <i>m</i>/<i>z</i> 422 [M + H]<sup>+</sup>, expected 422 [M + H]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>27</sub>N<sub>7</sub>O<sub>2</sub>·<sup>1</sup>/<sub>4</sub>HOAc) C, H, N.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(5-morpholin-4-yl-pyridin-3-yl)-pyrimidin-4-yl]-acetamide (<b>14</b>)</h3><div class="NLM_p last">A mixture of <b>11</b> (150 mg, 0.39 mmol), morpholine (150 mg, 1.7 mmol), potassium carbonate (150 mg, 1.1 mmol), <span class="smallcaps smallerCapital">l</span>-proline (50 mg, 0.43 mmol), copper(I) iodide (50 mg, 0.26 mmol), and DMSO (3 mL) was heated in a sealed tube with stirring at 100 °C for 16 h. The cooled reaction mixture was diluted with methanol, filtered, and purified by prep HPLC. Extraction of product fractions (DCM/aqueous sodium bicarbonate), followed by two preparative TLC purifications (9:1 DCM/methanol eluant, then ethyl acetate eluant) provided the free base (yield 3.4 mg, 2%). LCMS-2: <i>t</i><sub>R</sub> = 3.88 min (95%). MS: <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>, expected 394 [M + H]<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-[6-(6-Dimethylamino-pyridin-2-yl)-2-(3,5-dimethyl-pyrazol-1-yl)-pyrimidin-4-yl]-acetamide (<b>16c</b>)</h3><div class="NLM_p last">A mixture of <b>12</b> (400 mg), dimethylamine hydrochloride (300 mg), and DMF (6 mL) was heated in a microwave reactor at 200 °C for 20 min. The cooled reaction mixture was diluted with methanol, filtered, and partially purified by preparative HPLC. Extraction of product fractions (DCM/aqueous sodium bicarbonate), followed by preparative TLC purification (9:1 CHCl<sub>3</sub>/MeOH eluant) provided the free base as a yellow solid (70 mg, 17% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.99 (s, 1H), 8.32 (s, 1H), 7.57−7.65 (m, 2H), 6.66 (dd, <i>J</i> = 9,1, 1H), 6.06 (s, 1H), 3.19 (s, 6H), 2.81 (s, 3H), 2.36 (s, 3H), 2.23 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 4.57 min (100%). MS: <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>, expected 352 [M + H]<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(6-pyrrolidin-1-yl-pyridin-2-yl)-pyrimidin-4-yl]-acetamide (<b>16d</b>)</h3><div class="NLM_p last">A mixture of <b>12</b> (100 mg, 0.38 mmol), pyrrolidine (0.8 mL), and DMSO (1 mL) was heated in a sealed tube at 90 °C for 64 h. Preparative HPLC purification yielded the deacetylated product (90 mg, 69%) as the TFA salt. The salt was converted to the free base by extraction with DCM from aqueous sodium bicarbonate (yield 65 mg). This material was reacetylated by treatment with pyridine (32 mg) and acetyl chloride (17 mg) in DCM (5 mL) at rt for 1 h. The reaction mix was concentrated and subjected to preparative HPLC purification. Extraction (DCM/aqueous sodium bicarbonate) provided the free base (17 mg, 12% yield) as a yellow solid. LCMS-2: <i>t</i><sub>R</sub> = 4.43 min (100%). MS: <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>, expected 378 [M + H]<sup>+</sup>. ESHRMS <i>m</i>/<i>z</i> 378.2040, [M + H]<sup>+</sup> requires 378.2037.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(3,4,5,6-tetrahydro-2<i>H</i>-[1,2′]bipyridinyl-6′-yl)-pyrimidin-4-yl]-acetamide (<b>16e</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>15</b> from <b>12</b> (50 mg, 0.15 mmol) and piperidine. Direct purification of the reaction mixture by preparative HPLC furnished the title compound (3 mg, 5% yield) as the TFA salt. LCMS-2: <i>t</i><sub>R</sub> = 6.22 min (98%). MS: <i>m</i>/<i>z</i> 392 [M + H]<sup>+</sup>, expected 392 [M + H]<sup>+</sup>. ESHRMS <i>m</i>/<i>z</i> 392.2188, [M + H]<sup>+</sup> requires 392.2193.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(6-[1,4]oxazepan-4-yl-pyridin-2-yl)-pyrimidin-4-yl]-acetamide (<b>16f</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>15</b> from <b>12</b> (50 mg, 0.15 mmol), homomorpholine hydrochloride (42 mg, 0.3 mmol), and triethylamine (0.042 mL, 0.3 mmol). Direct purification of the reaction mixture by preparative HPLC furnished the title compound (17 mg, 28% yield) as the TFA salt. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.92 (s, 1H), 8.44 (s, 1H), 7.59−7.63 (m, 2H), 6.68 (d, <i>J</i> = 8, 1H), 6.06 (s, 1H), 3.84−3.92 (m, 4H), 3.71 (t, <i>J</i> = 6, 2H), 2.80 (s, 3H), 2.35 (s, 3H), 2.23 (s, 3H), 2.10 (t, <i>J</i> = 5, 2H), 0.8−1.2 (m, 2H). LCMS-1: <i>t</i><sub>R</sub> = 2.33 min (100%). MS: <i>m</i>/<i>z</i> 408 [M + H]<sup>+</sup>, expected 408 [M + H]<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-{2-(3,5-Dimethyl-pyrazol-1-yl)-6-[6-(4-methyl-piperazin-1-yl)-pyridin-2-yl]-pyrimidin-4-yl}-acetamide (<b>16g</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>15</b> from <b>12</b> (45 mg, 0.13 mmol) and <i>N</i>-methylpiperazine. Direct purification of the reaction mixture by preparative HPLC furnished the title compound as the TFA salt. This material was converted to the free base by extraction with DCM from aqueous sodium bicarbonate to yield the free base as a yellow solid (12 mg, 23%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.92 (s, 1H), 8.33 (s, 1H), 7.72 (d, <i>J</i> = 8, 1H), 7.64 (d, <i>J</i> = 8, 1H), 6.80 (d, <i>J</i> = 8, 1H), 6.07 (s, 1H), 3.71 (t, <i>J</i> = 5, 4H), 2.80 (s, 3H), 2.55 (t, <i>J</i> = 5, 4H), 2.36 (s, 3H), 2.35 (s, 3H), 2.23 (s, 3H). LCMS-3: <i>t</i><sub>R</sub> = 15.11 min (100%). MS: <i>m</i>/<i>z</i> 407 [M + H]<sup>+</sup>, expected 407 [M + H]<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-{2-(3,5-Dimethyl-pyrazol-1-yl)-6-[6-(3-methoxy-azetidin-1-yl)-pyridin-2-yl]-pyrimidin-4-yl}-acetamide (<b>16i</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>15</b> from <b>12</b> (50 mg, 0.15 mmol), 3-methoxyazetidine hydrochloride (37 mg, 0.30 mmol), and DIPEA (0.053 mL, 0.30 mmol). Direct purification of the reaction mixture by preparative HPLC furnished the title compound (3 mg, 5% yield) as the TFA salt. LCMS-2: <i>t</i><sub>R</sub> = 4.67 min (90%). MS: <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>, expected 394 [M + H]<sup>+</sup>. ESHRMS <i>m</i>/<i>z</i> 394.1995, [M + H]<sup>+</sup> requires 394.1986.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(4-hydroxy-3,4,5,6-tetrahydro-2<i>H</i>-[1,2′]bipyridinyl-6′-yl)-pyrimidin-4-yl]-acetamide (<b>16k</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>15</b> from <b>12</b> (500 mg, 1.5 mmol) and 4-hydroxypiperidine (300 mg, 2.9 mmol). Direct purification of the reaction mixture by preparative HPLC furnished the title compound as the TFA salt. This material was converted to the free base by extraction with DCM from aqueous sodium bicarbonate to yield the free base as a yellow solid (45 mg, 8% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.19 (s, 1H), 8.85 (s, 1H), 7.60−7.73 (m, 2H), 7.04 (d, <i>J</i> = 9, 1H), 6.16 (s, 1H), 4.72 (d, <i>J</i> = 5, 1H), 4.09−4.14 (m, 2H), 3.70−3.75 (m, 1H), 3.15−3.22 (m, 2H), 2.67 (s, 3H), 2.19 (s, 3H), 2.17 (s, 3H), 1.79−1.85 (m, 2H), 1.37−1.44 (m, 2H). LCMS-3: <i>t</i><sub>R</sub> = 16.99 min (100%). MS: <i>m</i>/<i>z</i> 408 [M + H]<sup>+</sup>, expected 408 [M + H]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>25</sub>N<sub>7</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Ethyl 6-(Morpholin-4-yl)pyridine-2-carboxylate (<b>18a</b>)</h3><div class="NLM_p last">Morpholine (4.17 mL, 47.9 mmol, 1.05 equiv) was added to a solution of ethyl 6-bromopyridine-2-carboxylate (10.5 g, 45.6 mmol, 1.0 equiv) and triethylamine (9.5 mL, 68.4 mmol, 1.5 equiv) in <i>N</i>,<i>N</i>-dimethylacetamide (20 mL). The mixture was heated at 100 °C in a sealed tube for 14.5 h. Aqueous sodium bicarbonate was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over sodium sulfate, filtered, and concentrated to a brown oil. Chromatography (3:1 hexanes/EtOAc eluant) gave the product as a yellow solid (6.5 g, 60% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.62 (t, <i>J</i> = 7, 1H), 7.47 (d, <i>J</i> = 7, 1H), 6.85 (d, <i>J = 7,</i> 1H), 4.39 (q, <i>J = 7,</i> 2H) 3.85 (t, <i>J = 5</i>, 4H), 3.59 (t, <i>J = 5</i>, 4H), 1.42 (t, <i>J = 7,</i> 3H). LCMS-1: <i>t</i><sub>R</sub> = 2.35 min. MS: <i>m</i>/<i>z</i> 237 [M + H]<sup>+</sup>, expected 237 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 6-(Morpholin-4-yl)pyridine-2-carboxamide (<b>19a</b>)</h3><div class="NLM_p last"><b>18a</b> (6.3 g, 26.7 mmol) was dissolved in 7N ammonia in methanol (150 mL). The solution was heated with stirring in a sealed tube at 75 °C for 16 h. The mixture was concentrated, and the solid residue was coevaporated with methanol, then ethyl acetate. The solid product was dried under vacuum to provide the title compound (5.46 g) as an off-white solid, which was used without further purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub> + 1 drop CD<sub>3</sub>OD): δ 7.60 (t, <i>J</i> = 8, 1H), 7.59 (d, <i>J</i> = 8, 1H), 6.89 (d, <i>J =</i> 8, 1H), 3.85 (t, <i>J = 5</i>, 4H), 3.54 (t, <i>J = 5</i>, 4H). LCMS-1: <i>t</i><sub>R</sub> = 1.97 min. MS: <i>m</i>/<i>z</i> 208 [M + H]<sup>+</sup>, expected 208 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 6-(Morpholin-4-yl)pyridine-2-carbonitrile (<b>20a</b>)</h3><div class="NLM_p last">A suspension of <b>19a</b> (5.4 g, 26 mmol) and triethylamine (7.3 mL, 52 mmol) in dichloromethane (100 mL) was cooled in an ice bath and treated dropwise with trifluoroacetic anhydride (4.0 mL, 29 mol). The mixture was allowed to stir at 0 °C for 15 min, then was allowed to warm to rt. After 30 min, additional trifluoroacetic anhydride (0.5 mL, 3.6 mmol) was added, and the mixture was stirred for another 30 min. Aqueous sodium bicarbonate solution was added, and the mixture was extracted with dichloromethane. The organic layer was dried over sodium sulfate, filtered, and concentrated to a solid, which was triturated with 3:1 hexanes/ethyl acetate to provide the title compound (3.69 g) as a white solid. A second crop (0.66 g, slightly yellow solid) was obtained from the mother liquor. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.56 (dd, <i>J</i> = 7,9, 1H), 7.02 (d, <i>J</i> = 7, 1H), 6.83 (d, <i>J =</i> 9, 1H), 3.82 (t, <i>J = 5</i>, 4H), 3.56 (t, <i>J = 5</i>, 4H). LCMS-1: <i>t</i><sub>R</sub> = 2.38 min. MS: <i>m</i>/<i>z</i> 190 [M + H]<sup>+</sup>, expected 190 [M + H]<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3-Amino-3-(6-morpholin-4-yl-pyridin-2-yl)-acrylonitrile (<b>21a</b>)</h3><div class="NLM_p last">A mixture of <b>20a</b> (7.43 g, 39 mmol, 1.0 equiv), anhydrous toluene (100 mL), and potassium <i>t</i>-butoxide (13.2 g, 118 mmol, 3.0 equiv) was stirred without external heating or cooling while anhydrous acetonitrile (4.1 mL, 79 mmol, 2.0 equiv) was added dropwise over 10 min. The thick yellow mixture was stirred for an additional 2 h. Aqueous sodium bicarbonate solution was added (exothermic), and then the mixture was extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and concentrated to provide the title compound as a brown oil (9.6 g), which was used without purification. LCMS-1: <i>t</i><sub>R</sub> = 2.38 min. MS: <i>m</i>/<i>z</i> 231 [M + H]<sup>+</sup>, expected 231 [M + H]<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-Amino-6-(6-morpholin-4-yl-pyridin-2-yl)-1H-pyrimidine-2-thione (<b>22a</b>)</h3><div class="NLM_p last">A suspension of <b>21a</b> (9.5 g, est 35 mmol) and thiourea (5.6 g, 74 mmol) in absolute ethanol (100 mL) was treated with sodium ethoxide solution (21 wt %, Aldrich, 27.5 mL, 74 mmol). The brown mixture was heated in a sealed tube at 100 °C for 49.5 h. The cooled reaction mixture was poured onto 10% aqueous sodium dihydrogen phosphate solution (200 mL) chilled in an ice bath. The mixture was filtered. The filter cake was washed with water and then air-dried briefly to provide the title compound (34.6 g) as a tan gummy solid. This material was used without further purification. A sample was dried further for analysis. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.9 (br s, 1H), 7.7−7.8 (m, 3H), 7.37 (d, <i>J</i> = 8, 1H), 7.05 (d, <i>J</i> = 8, 1H), 6.62 (s, 1H), 3.72 (m, 4H), 3.52 (m, 4H). LCMS-1: <i>t</i><sub>R</sub> = 1.97 min. MS: <i>m</i>/<i>z</i> 290 [M + H]<sup>+</sup>, expected 290 [M + H]<sup>+</sup>.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-Methylsulfanyl-6-(6-morpholin-4-yl-pyridin-2-yl)-pyrimidin-4-ylamine (<b>23a</b>)</h3><div class="NLM_p last">A suspension of <b>22a</b> (34.5 g, est 30 mmol) in 5% aqueous sodium hydroxide (100 mL, 125 mmol) was stirred at rt while iodomethane (1.86 mL, 30 mmol) was added in one portion. A light-tan precipitate formed. After 45 min, the mixture was treated with 10% aqueous sodium dihydrogen phosphate solution (final pH 9), and then the solid was collected, washed with water, and air-dried to provide the title compound (9.95 g) as a tan solid, still wet with water. A sample was dried further for analysis. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.59−7.72 (m, 2H), 7.08 (s, 1H), 6.99 (brs, 2H), 6.92 (d, <i>J</i> = 8, 1H), 3.75 (m, 4H), 3.52 (m, 4H), 2.48 (s, 3H). LCMS-1: <i>t</i><sub>R</sub> = 2.06 min. MS: <i>m</i>/<i>z</i> 304 [M + H]<sup>+</sup>, expected 304 [M + H]<sup>+</sup>.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-Methanesulfonyl-6-[6-(4-oxy-morpholin-4-yl)-pyridin-2-yl]-pyrimidin-4-ylamine (<b>24a</b>)</h3><div class="NLM_p last">A suspension of <b>23a</b> (9.9 g, est 25 mmol) in methanol (200 mL) and water (50 mL) was cooled in an ice bath and treated dropwise with a solution of oxone (20.7 g) in water (100 mL) over 10 min. The temperature was kept below 20 °C during the addition. Saturated sodium bicarbonate solution (75 mL) was then added dropwise over 5 min (effervescence), and the ice bath was removed. After 1 h, an additional portion of solid oxone (5.5 g) was added. After an additional 2 h, dichloromethane (200 mL) was added and the mixture was filtered. The filter cake was washed with water and air-dried to provide the first product fraction as a tan solid (7.0 g). The two phases of the filtrate were separated. The aqueous phase was adjusted to pH > 8 and was extracted with dichloromethane and ethyl acetate. The combined organic extracts were dried over sodium sulfate, filtered, and concentrated to provide the second product fraction (1.3 g) as a yellow solid. A slurry of product fractions one (6.8 g) and two (1.3 g) in ethanol was concentrated to dryness to provide the title compound (7.3 g) as a tan solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) major species: δ 8.58 (d, <i>J</i> = 8, 1H), 8.41 (d, <i>J</i> = 8, 1H), 8.27 (t, <i>J</i> = 8, 1H), 7.98 (br s, 2H), 7.60 (s, 1H), 4.41 (t, <i>J</i> = 11, 2H), 4.19 (t, <i>J</i> = 11, 2H), 3.82 (d, <i>J</i> = 11, 2H), 3.38 (s, 3H), 2.95 (d, <i>J</i> = 11, 2H). LCMS-1: <i>t</i><sub>R</sub> = 1.60 min. MS: <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>, expected 352 [M + H]<sup>+</sup>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-(3,5-Dimethyl-pyrazol-1-yl)-6-(6-morpholin-4-yl-pyridin-2-yl)-pyrimidin-4-ylamine (<b>26a</b>)</h3><div class="NLM_p last">A suspension of <b>24a</b> (7.3 g, 19.4 mmol) in ethanol (200 mL) was treated with anhydrous hydrazine (6 mL, 189 mmol). The mixture was refluxed for 16 h. The mixture (containing crude arylhydrazine <b>25a</b>) was allowed to cool to rt, and then pentane-2,4-dione (20.5 mL, 200 mmol) was added dropwise over 30 min without external cooling. The mixture was heated at 70 °C for 1 h and then was allowed to cool and the solvent was removed. The resulting tan solid (30.5 g) was slurried with water (150 mL) at 40 °C for 15 min and then was allowed to cool. The cooled mixture was filtered, and the filter cake was rinsed with water. The resulting filter cake was slurried with ethyl acetate and then concentrated to dryness to provide the product <b>26a</b> (5.9 g) as a tan solid, which contained the desired product in addition to 3,5-dimethylpyrazole (LCMS analysis). A sample was further purified for analysis as follows: The crude product was dissolved in 1 M hydrochloric acid and then the solution was washed three times with EtOAc. 1N Sodium hydroxide solution was added until a white precipitate formed and then the mixture was extracted with DCM. The DCM extract was dried over sodium sulfate, filtered, and then concentrated to provide <b>26a</b> as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) major species: δ 7.72 (t, <i>J</i> = 8, 1H), 7.60 (d, <i>J</i> = 8, 1H), 7.28 (br s, 2H), 7.25 (s, 1H), 6.97 (d, <i>J</i> = 8, 2H), 6.05 (s, 1H), 3.74 (m, 4H), 3.54 (m, 4H), 2.60 (s, 3H), 2.16 (s, 3H). LCMS-1: <i>t</i><sub>R</sub> = 2.27 min. MS: <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>, expected 352 [M + H]<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(6-morpholin-4-yl-pyridin-2-yl)-pyrimidin-4-yl]-acetamide (<b>16a</b>)</h3><div class="NLM_p last">Acetyl chloride (0.035 mL, 0.45 mmol) was added at rt to a stirred mixture of the amine (115 mg, 0.33 mmol) and pyridine (0.053 mL, 0.66 mmol) in DCM (3 mL). The mixture was stirred at rt for 2.5 h, and then brine was added and the mixture was extracted with dichloromethane. The combined extracts were dried over sodium sulfate, filtered, and concentrated. The residue was purified by chromatography (1:1 hexanes/THF eluant) to provide the title compound (110 mg, 85% yield) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.21 (s, 1H), 8.85 (s, 1H), 7.79−7.68 (m, 2H), 7.05 (d, <i>J</i> = 8.3, 1H), 6.15 (s, 1H), 3.75 (t, <i>J</i> = 45.7, 4H), 3.55 (t, <i>J</i> = 4.9, 4H), 3.31 (s, 3H), 2.22 (s, 3H), 2.16 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 6.07 min (100%). MS: <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>, expected 394 [M + H]<sup>+</sup>.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Methyl 2-(morpholin-4-yl)pyridine-4-carboxylate (<b>18b</b>)</h3><div class="NLM_p last">Prepared from methyl 4-chloropyridin-2-carboxylate (4.5 g, 26 mmol) and morpholine according to the procedure of <b>18a</b>, except that the reaction product was not purified by chromatography. Brown solid (yield 3.3 g, 54%), LCMS-1: <i>t</i><sub>R</sub> = 0.43 min. MS: <i>m</i>/<i>z</i> 223 [M + H]<sup>+</sup>, expected 223 [M + H]<sup>+</sup>.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-(Morpholin-4-yl)pyridine-4-carboxamide (<b>19b</b>)</h3><div class="NLM_p last">Prepared from <b>18b</b> (3.3 g, 15 mmol) according to the procedure of <b>19a</b>. The crude solid product was washed with methanol and then ether to provide the title compound as an off-white solid (yield 2.0 g, 65%). LCMS-1: <i>t</i><sub>R</sub> = 0.33 min. MS: <i>m</i>/<i>z</i> 208 [M + H]<sup>+</sup>, expected 208 [M + H]<sup>+</sup><sub></sub>.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-(Morpholin-4-yl)pyridine-4-carbonitrile (<b>20b</b>)</h3><div class="NLM_p last">Prepared from <b>19b</b> (2.0 g, 9.6 mmol) according to the procedure of <b>20a</b>, except that the crude solid was triturated with EtOAc/ether. White solid (1.45 g, 79%). LCMS-1: <i>t</i><sub>R</sub> = 0.98 min. MS: <i>m</i>/<i>z</i> 190 [M + H]<sup>+</sup>, expected 190 [M + H]<sup>+</sup>.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3-Amino-3-(4-morpholin-4-yl-pyridin-2-yl)-acrylonitrile (<b>21b</b>)</h3><div class="NLM_p last">Prepared from <b>20b</b> (1.45 g, 7.6 mmol) according to the procedure of <b>21a</b>. The crude product was triturated with ether to provide the title compound as a yellow solid (1.77 g, 100%). LCMS-1: <i>t</i><sub>R</sub> = 0.91 min. MS: <i>m</i>/<i>z</i> 231 [M + H]<sup>+</sup>, expected 231 [M + H]<sup>+</sup>.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-Amino-6-(4-morpholin-4-yl-pyridin-2-yl)-1<i>H</i>-pyrimidine-2-thione (<b>22b</b>)</h3><div class="NLM_p last">Prepared from <b>21b</b> (1.5 g, 6.5 mmol) according to the procedure of <b>22a</b>, except that the reaction time was 24 h. White solid (1.1 g, 58%). LCMS-1: <i>t</i><sub>R</sub> = 0.64 min. MS: <i>m</i>/<i>z</i> 290 [M + H]<sup>+</sup>, expected 290 [M + H]<sup>+</sup>.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-Methylsulfanyl-6-(4-morpholin-4-yl-pyridin-2-yl)-pyrimidin-4-ylamine (<b>23b</b>)</h3><div class="NLM_p last">Prepared from <b>22b</b> (1.0 g, 3.5 mmol) according to the procedure for <b>23a</b>. Off-white solid (690 mg, 66%). LCMS-1: <i>t</i><sub>R</sub> = 1.91 min. MS: <i>m</i>/<i>z</i> 304 [M + H]<sup>+</sup>, expected 304 [M + H]<sup>+</sup>.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2-Methanesulfonyl-6-[4-(4-morpholin-4-yl)-pyridin-2-yl]-pyrimidin-4-ylamine (<b>24b</b>)</h3><div class="NLM_p last">Prepared from <b>23b</b> (330 mg, 1.1 mmol) according to the procedure for <b>24a</b>. The reaction mixture was filtered and washed with methanol, and then the filtrate was concentrated to provide a yellow foam (370 mg, 100%). The major species present was tertiary amine title compound; the <i>N</i>-oxide was minor. LCMS-1: <i>t</i><sub>R</sub> = 1.71 min. MS: <i>m</i>/<i>z</i> 336 [M + H]<sup>+</sup>, expected 336 [M + H]<sup>+</sup>.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-(3,5-Dimethyl-pyrazol-1-yl)-6-(4-morpholin-4-yl-pyridin-2-yl)-pyrimidin-4-ylamine (<b>26b</b>)</h3><div class="NLM_p last">Prepared from <b>24b</b> (370 mg, 1.1 mmol) according to the procedure for <b>26a</b>, with modifications. Following treatment with hydrazine, the reaction mixture was filtered and the solid washed with methanol. The combined filtrate was concentrated to provide the intermediate hydrazinopyrimidine <b>25b</b> as a yellow foam. This was then treated with pentane-2,4-dione in ethanol according to the procedure of <b>26a</b>. Final purification by chromatography (9:1 DCM/methanol eluant) provided the title compound <b>26b</b> (110 mg, 29% from <b>21b</b>) as a yellow solid. LCMS-1: <i>t</i><sub>R</sub> = 2.05 min. MS: <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>, expected 352 [M + H]<sup>+</sup>.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>N</i>-[2-(3,5-Dimethyl-pyrazol-1-yl)-6-(4-morpholin-4-yl-pyridin-2-yl)-pyrimidin-4-yl]-acetamide (<b>17</b>)</h3><div class="NLM_p last">Prepared according to the procedure for <b>16a</b> from <b>26b</b> (110 mg, 0.31 mmol). Purification of the crude material by preparative HPLC, followed by conversion to the free base (DCM/aqueous sodium bicarbonate extraction) yielded the title compound (15 mg, 12% yield) as a yellow solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.94 (s, 1H), 8.44 (d, <i>J</i> = 6.0, 1H), 8.31 (s, 1H), 7.85 (d, <i>J</i> = 2.4, 1H), 6.77 (dd, <i>J</i> = 6.0, 2.4, 1H), 6.08 (s, 1H), 3.87 (t, <i>J</i> = 4.8, 4H), 3.37 (t, <i>J</i> = 4.8, 4H), 2.79 (s, 3H), 2.36 (s, 3H), 2.23 (s, 3H). LCMS-2: <i>t</i><sub>R</sub> = 3.99 min (100%). MS: <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>, expected 394 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/jm800851u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Copies of NMR and LCMS data are available for key final compounds, along with detailed descriptions of HPLC conditions for compound analysis. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800851u/suppl_file/jm800851u_si_001.pdf">jm800851u_si_001.pdf (2.82 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800851u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John E. Tellew</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e387908f8686a38d8696918c80918a8d86cd808c8ec38997868f8f8694a3848d85cd8c9184"><span class="__cf_email__" data-cfemail="1074637c7575507e7565627f7362797e753e737f7d">[email protected]</span> <span class="__cf_email__" data-cfemail="89e3fdece5e5ecfec9eee7efa7e6fbee">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah H. Slee</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6602150a030326080313140905140f08034805090b460c12030a0a03112601080048091401"><span class="__cf_email__" data-cfemail="e783948b8282a7898292958884958e8982c984888a">[email protected]</span> <span class="__cf_email__" data-cfemail="056f71606969607245626b632b6a7762">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaohu Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiyong Luo</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manisha Moorjani</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily Lin</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marion C. Lanier</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongsheng Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John P. Williams</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Saunders</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra M. Lechner</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stacy Markison</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tanya Joswig</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Petroski</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaime Piercey</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William Kargo</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Siobhan Malany</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Santos</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raymond S. Gross</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny Wen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kayvon Jalali</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihong O’Brien</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carol E. Stotz</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María I. Crespo</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José-Luis Díaz</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, Chemical Development, Preclinical Development, and Pharmaceutical Development, Neurocrine Biosciences, 12780 El Camino Real, San Diego, California 92130, Almirall Research Center, Almirall, Ctra. Laureà Miró, E-08980 St. Feliu de Llobregat, 408-410 Barcelona, Spain</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Shawn Ayube, Paddi Ekhlassi, Jamie Rueter, and John Harman for analytical support.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptor and its modulators: overview on a druggable GPCR and on structure−activity relationship analysis and binding requirements of agonists and antagonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.2174%2F138161208784480081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=18537675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1525-1552&author=G.+Cristalliauthor=C.+Lambertucciauthor=G.+Marucciauthor=R.+Volpiniauthor=D.+Dal+Ben&title=A2A+adenosine+receptor+and+its+modulators%3A+overview+on+a+druggable+GPCR+and+on+structure%E2%88%92activity+relationship+analysis+and+binding+requirements+of+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists</span></div><div class="casAuthors">Cristalli, G.; Lambertucci, C.; Marucci, G.; Volpini, R.; Dal Ben, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1525-1552</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the biol. effects of adenosine, the development of potent and selective agonists and antagonists of adenosine receptors has been the subject of medicinal chem. research for several decades, even if their clin. evaluation has been discontinued.  Main problems include side effects due to the ubiquity of the receptors and the possibility of side effects, or to low brain penetration (in particular for the targeting of CNS diseases), short half-life of compds., lack of effects.  Furthermore, species differences in the affinity of ligands make difficult preclin. testing in animal models.  Nevertheless, adenosine receptors continue to represent promising drug targets.  A2A receptor has proved to be a promising pharmacol. target for small synthetic ligands, and while A2A agonists are undergoing clin. trials for myocardial perfusion imaging and as anti-inflammatory agents, A2A antagonists represent an attractive field of research to discover new drugs for the treatment of neurodegenerative disorders, such as Parkinson's disease.  Furthermore, the information coming from bioinformatics and mol. modeling studies for the A2A receptor has made easier the understanding of ligand-target interaction and the rational design of agonists and antagonists for this subtype.  The aim of this review is to show an overview of the most significant steps and progresses in developing A2A adenosine receptor agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLD7b3gsaCZrVg90H21EOLACvtfcHk0lieRHupy_dKnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D&md5=3b8c004d9a1fbff02c0a0ee1b476fcea</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161208784480081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208784480081%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DDal%2BBen%26aufirst%3DD.%26atitle%3DA2A%2520adenosine%2520receptor%2520and%2520its%2520modulators%253A%2520overview%2520on%2520a%2520druggable%2520GPCR%2520and%2520on%2520structure%25E2%2588%2592activity%2520relationship%2520analysis%2520and%2520binding%2520requirements%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D1525%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors</span> <span class="citation_source-journal">Pharmacol. Rev</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1211%2F0022357011775631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=11734617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=527-52&author=B.+B.+Fredholmauthor=A.+P.+Uzermanauthor=K.+A.+Jacobsonauthor=K.+N.+Klotzauthor=J.+Linden&title=International+Union+of+Pharmacology.+XXV.+Nomenclature+and+Classification+of+Adenosine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Klotz, Karl-Norbert; Linden, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-552</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Four adenosine receptors have been cloned and characterized from several mammalian species.  The receptors are named adenosine A1, A2A, A2B, and A3.  The A2A and A2B receptors preferably interact with members of the Gs family of G proteins and the A1 and A3 receptors with Gi/o proteins.  However, other G protein interactions have also been described.  Adenosine is the preferred endogenous agonist at all these receptors, but inosine can also activate the A3 receptor.  The levels of adenosine seen under basal conditions are sufficient to cause some activation of all the receptors, at least where they are abundantly expressed.  Adenosine levels during, e.g., ischemia can activate all receptors even when expressed in low abundance.  Accordingly, expts. with receptor antagonists and mice with targeted disruption of adenosine A1, A2A, and A3 expression reveal roles for these receptors under physiol. and particularly pathophysiol. conditions.  There are pharmacol. tools that can be used to classify A1, A2A, and A3 receptors but few drugs that interact selectively with A2B receptors.  Testable models of the interaction of these drugs with their receptors have been generated by site-directed mutagenesis and homol.-based modeling.  Both agonists and antagonists are being developed as potential drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJOCrJphTwDrVg90H21EOLACvtfcHk0lguZl4UnBddsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOltQ%253D%253D&md5=060ea8a3d7b07fdc4b2c8acc3b4d4745</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1211%2F0022357011775631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357011775631%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DUzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXV.%2520Nomenclature%2520and%2520Classification%2520of%2520Adenosine%2520Receptors%26jtitle%3DPharmacol.%2520Rev%26date%3D2001%26volume%3D53%26spage%3D527%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.-G.</span><span> </span><span class="NLM_article-title">Adenosine Receptors as Therapeutic Targets</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1038%2Fnrd1983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=16518376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=247-264&author=K.+A.+Jacobsonauthor=Z.-G.+Gao&title=Adenosine+Receptors+as+Therapeutic+Targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as therapeutic targets</span></div><div class="casAuthors">Jacobson, Kenneth A.; Gao, Zhan-Guo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-264</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world.  There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischemic diseases, sleep disorders, immune and inflammatory disorders and cancer.  After more than three decades of medicinal chem. research, a considerable no. of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clin. evaluated, although none has yet received regulatory approval.  However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoG29EyQFoSbVg90H21EOLACvtfcHk0lguZl4UnBddsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr4%253D&md5=85ad553154bd61f24a6bb594f960f9bc</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fnrd1983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1983%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.-G.%26atitle%3DAdenosine%2520Receptors%2520as%2520Therapeutic%2520Targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D247%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascherio, A.</span><span> </span><span class="NLM_article-title">Caffeinated Clues and the Promise of Adenosine A<sub>2A</sub> Antagonists in PD</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1154-1160&author=M.+A.+Schwarzschildauthor=J.-F.+Chenauthor=A.+Ascherio&title=Caffeinated+Clues+and+the+Promise+of+Adenosine+A2A+Antagonists+in+PD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DAscherio%26aufirst%3DA.%26atitle%3DCaffeinated%2520Clues%2520and%2520the%2520Promise%2520of%2520Adenosine%2520A2A%2520Antagonists%2520in%2520PD%26jtitle%3DNeurology%26date%3D2002%26volume%3D58%26spage%3D1154%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Moine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Distribution, Biochemistry and Function of Striatal Adenosine A<sub>2A</sub> Receptors</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1016%2FS0301-0082%2899%2900011-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=10501634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlCgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=355-396&author=P.+Svenningssonauthor=C.+Le+Moineauthor=G.+Fisoneauthor=B.+B.+Fredholm&title=Distribution%2C+Biochemistry+and+Function+of+Striatal+Adenosine+A2A+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution, biochemistry and function of striatal adenosine A2A receptors</span></div><div class="casAuthors">Svenningsson, Per; Le Moine, Catherine; Fisone, Gilberto; Fredholm, Bertil B.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-396</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with >400 refs.  It is well known that the nucleoside adenosine exerts a modulatory influence in the central nervous system by activating G protein coupled receptors.  Adenosine A2A receptors, the subject of the present review, are predominantly expressed in striatum, the major area of the basal ganglia.  Activation of A2A receptors interferes with effects mediated by most of the principal neurotransmitters in striatum.  In particular, the inhibitory interactions between adenosine acting on A2A receptors and dopamine acting on D2 receptors have been well examd. and there is much evidence that A2A receptors may be a possible target for future development of drugs for treatment of Parkinson's disease, schizophrenia and affective disorders.  The authors' understanding of the role of striatal A2A receptors has increased dramatically over the last few years.  New selective antibodies, antagonist radioligands and optimized in situ hybridization protocols have provided detailed information on the distribution of A2A receptors in rodent as well as primate striatum.  Studies on the involvement of A2A receptors in the regulation of DARPP-32 and the expression of immediate early genes, such as nerve growth factor-induced clone A and c-fos, have pointed out an important role for these receptors in regulating striatopallidal neurotransmission.  Moreover, by using novel selective antagonists for A2A receptors and transgenic mice lacking functional A2A receptors, crucial information on the behavioral role of striatal A2A receptors has been provided, esp. concerning their involvement in the stimulatory action of caffeine and the anti-Parkinsonian properties of A2A receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqANBDJTs7Mn7Vg90H21EOLACvtfcHk0lguZl4UnBddsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlCgsbo%253D&md5=84888e21d742a721f43e0332a4d86be8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2899%2900011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252899%252900011-8%26sid%3Dliteratum%253Aachs%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DLe%2BMoine%26aufirst%3DC.%26aulast%3DFisone%26aufirst%3DG.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DDistribution%252C%2520Biochemistry%2520and%2520Function%2520of%2520Striatal%2520Adenosine%2520A2A%2520Receptors%26jtitle%3DProg.%2520Neurobiol.%26date%3D1999%26volume%3D59%26spage%3D355%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tuite, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riss, J.</span><span> </span><span class="NLM_article-title">Recent Developments in the Pharmacological Treatment of Parkinson’s Disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=1335-1352&author=P.+Tuiteauthor=J.+Riss&title=Recent+Developments+in+the+Pharmacological+Treatment+of+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTuite%26aufirst%3DP.%26aulast%3DRiss%26aufirst%3DJ.%26atitle%3DRecent%2520Developments%2520in%2520the%2520Pharmacological%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D8%26spage%3D1335%26epage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceruti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbracchio, M. P.</span><span> </span><span class="NLM_article-title">Functions, Dysfunctions and Possible Therapeutic Relevance of Adenosine A<sub>2A</sub> Receptors in Huntington’s Disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1016%2Fj.pneurobio.2006.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=17303312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=331-348&author=P.+Popoliauthor=D.+Blumauthor=A.+Martireauthor=C.+Ledentauthor=S.+Cerutiauthor=M.+P.+Abbracchio&title=Functions%2C+Dysfunctions+and+Possible+Therapeutic+Relevance+of+Adenosine+A2A+Receptors+in+Huntington%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease</span></div><div class="casAuthors">Popoli, Patrizia; Blum, David; Martire, Alberto; Ledent, Catherine; Ceruti, Stefania; Abbracchio, Maria P.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">331-348</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The aim of this review is to summarize and critically discuss the complex role played by adenosine A2A receptors (A2ARs) in Huntington's disease (HD).  Since A2ARs are mainly localized on the neurons, which degenerate early in HD, and given their ability to stimulate glutamate outflow and inflammatory gliosis, it was hypothesized that they could be involved in the pathogenesis of HD, and that A2AR antagonists could be neuroprotective.  This was further sustained by the demonstration that A2ARs and underlying signaling systems undergo profound changes in cellular and animal models of HD.  More recently, however, the equation A2A receptor blockade = neuroprotection has appeared too simplistic.  First, it is now definitely clear that, besides mediating bad' responses (for example, stimulation of glutamate outflow and excessive glial activation), A2ARs also promote good' responses (such as trophic and anti-inflammatory effects).  This implies that A2AR blockade results either in pro-toxic or neuroprotective effects according to the mechanisms involved in a given exptl. model.  Second, since HD is a chronically progressive disease, the multiple mechanisms involving A2ARs may play different relative roles along the degenerative process.  Such different mechanisms can be influenced by A2AR activation or blockade in different ways, even leading to opposite outcomes depending on the time of agonist/antagonist administration.  The no., and the complexity, of the possible scenarios is further increased by the influence of mutant Huntingtin on both the expression and functions of A2ARs, and by the strikingly different effects mediated by A2ARs expressed by different cell populations within the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6cwj0loKaMrVg90H21EOLACvtfcHk0ljbixFoMinETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLo%253D&md5=21d5036cfe261f44869776d1485dcdf1</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DMartire%26aufirst%3DA.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DCeruti%26aufirst%3DS.%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26atitle%3DFunctions%252C%2520Dysfunctions%2520and%2520Possible%2520Therapeutic%2520Relevance%2520of%2520Adenosine%2520A2A%2520Receptors%2520in%2520Huntington%25E2%2580%2599s%2520Disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2007%26volume%3D81%26spage%3D331%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Vu, C. B.</span><span> </span><span class="NLM_article-title">Recent Advances in the Design and Optimization of Adenosine A<sub>2A</sub> Receptor Antagonists</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=16022182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFCgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=458-468&author=C.+B.+Vu&title=Recent+Advances+in+the+Design+and+Optimization+of+Adenosine+A2A+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the design and optimization of adenosine A2A receptor antagonists</span></div><div class="casAuthors">Vu, Chi B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-468</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  In recent years, the adenosine A2A receptor has gained interest as a potential therapeutic target for alleviating the symptoms of Parkinson's disease.  Adenosine A2A receptor antagonists are orally effective in a variety of rodent models of Parkinson's disease.  Traditionally, adenosine A2A receptor antagonists are divided into 2 general classes, xanthine or non-xanthine derivs.  Extensive optimization among the xanthine derivs. has already led to the clin. candidate KW-6002 (Kyowa Hakko Kogyo Co Ltd).  However, there is increasing interest among researchers in this field to explore other classes of compds. as potential antagonists for this particular receptor.  This review highlights the more recent developments in the design and optimization of non-xanthine derivs. as adenosine A2A receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFVWEy9JKDtbVg90H21EOLACvtfcHk0ljbixFoMinETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFCgt7c%253D&md5=3d081bf399a0984379c193565a58d337</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Design%2520and%2520Optimization%2520of%2520Adenosine%2520A2A%2520Receptor%2520Antagonists%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2005%26volume%3D8%26spage%3D458%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><div class="note"><p class="first last">Thomson Scientific Investigational Drugs Database, <a href="http://www.iddb3.com" class="extLink">www.iddb3.com</a>.</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Scientific+Investigational+Drugs+Database%2C+www.iddb3.com.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">Identification of Novel, Water Soluble 2-Amino-<i>N</i>-pyrimidin-4-yl Acetamides as A<sub>2A</sub> Antagonists with In Vivo Efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070623o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=400-406&author=D.+H.+Sleeauthor=X.+Zhangauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+K.+Rueterauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=T.+Joswigauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+P.+Williamsauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=J.+Saunders&title=Identification+of+Novel%2C+Water+Soluble+2-Amino-N-pyrimidin-4-yl+Acetamides+as+A2A+Antagonists+with+In+Vivo+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm070623o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070623o%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520Novel%252C%2520Water%2520Soluble%25202-Amino-N-pyrimidin-4-yl%2520Acetamides%2520as%2520A2A%2520Antagonists%2520with%2520In%2520Vivo%2520Efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D400%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wolff, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skettino, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span> </span><span class="NLM_article-title">Renal Effects of BG9719, a Specific A<sub>1</sub> Adenosine Receptor Antagonist, in Congestive Heart Failure</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1998&pages=166-171&author=A.+A.+Wolffauthor=S.+L.+Skettinoauthor=E.+Beckmanauthor=L.+Belardinelli&title=Renal+Effects+of+BG9719%2C+a+Specific+A1+Adenosine+Receptor+Antagonist%2C+in+Congestive+Heart+Failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolff%26aufirst%3DA.%2BA.%26aulast%3DSkettino%26aufirst%3DS.%2BL.%26aulast%3DBeckman%26aufirst%3DE.%26aulast%3DBelardinelli%26aufirst%3DL.%26atitle%3DRenal%2520Effects%2520of%2520BG9719%252C%2520a%2520Specific%2520A1%2520Adenosine%2520Receptor%2520Antagonist%252C%2520in%2520Congestive%2520Heart%2520Failure%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1998%26volume%3D45%26spage%3D166%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Givertz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditrich, H.</span><span> </span><span class="NLM_article-title">The Effects of KW-3902, an Adenosine A<sub>1</sub>-Receptor Antagonist, on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1016%2Fj.jacc.2007.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=17936154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKisLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1551-1560&author=M.+Givertzauthor=B.+Massieauthor=T.+Fieldsauthor=L.+Pearsonauthor=H.+Ditrich&title=The+Effects+of+KW-3902%2C+an+Adenosine+A1-Receptor+Antagonist%2C+on+Diuresis+and+Renal+Function+in+Patients+with+Acute+Decompensated+Heart+Failure+and+Renal+Impairment+or+Diuretic+Resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The Effects of KW-3902, an Adenosine A1-Receptor Antagonist,on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance</span></div><div class="casAuthors">Givertz, Michael M.; Massie, Barry M.; Fields, Tara K.; Pearson, Leeanne L.; Dittrich, Howard C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1551-1560</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: This study sought to evaluate the dose-dependent effects of adenosine A1-receptor blockade on diuresis and renal function in patients with acute decompensated heart failure (ADHF) and renal impairment or diuretic resistance.  Background: I.v. loop diuretics are the mainstay of therapy for patients with ADHF.  Treatment, however, may be complicated by diuretic resistance and/or worsening renal function.  Methods: We carried out a pair of randomized, double-blind, placebo-controlled, proof-of-concept studies in 2 clin. challenging ADHF populations.  Results: In the ADHF protocol, 146 patients with vol. overload and an estd. creatinine clearance (CrCl) of 20 to 80 mL/min were randomized to placebo or 1 of 4 doses of KW-3902 (rolofylline) infused over 2 h daily for up to 3 days.  On day 1, KW-3902 monotherapy increased urine output during the first 6 h (445, 531, 631, and 570 mL in the 2.5-, 15-, 30-, and 60-mg groups, resp.) compared with placebo (374 mL; p = 0.02).  On day 2, serum creatinine decreased in all KW-3902 groups and increased with placebo (p = 0.04).  By day 4 or day of discharge if earlier, i.v. furosemide administration tended to be lower in the KW-3902 groups compared with placebo (p = 0.10).  In the diuretic-resistant protocol, 35 patients with an av. CrCl of 34 mL/min were randomized to a single infusion of placebo, 10, 30, or 60 mg of KW-3902.  Compared with placebo, KW-3902 increased hourly urine vol. and estd. CrCl with peak effects occurring at 2 to 3 h and at 24 h, resp.  Adverse events were not different between placebo and KW-3902.  Conclusions: In patients with ADHF and vol. overload, KW-3902, an adenosine A1-receptor antagonist, enhances the response to loop diuretics and may have a renal protective effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXzGv-pgMH97Vg90H21EOLACvtfcHk0ljF6Kt282xY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKisLnE&md5=814fcbce42c24cd088db9e9cc4ac1ec1</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2007.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2007.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DGivertz%26aufirst%3DM.%26aulast%3DMassie%26aufirst%3DB.%26aulast%3DFields%26aufirst%3DT.%26aulast%3DPearson%26aufirst%3DL.%26aulast%3DDitrich%26aufirst%3DH.%26atitle%3DThe%2520Effects%2520of%2520KW-3902%252C%2520an%2520Adenosine%2520A1-Receptor%2520Antagonist%252C%2520on%2520Diuresis%2520and%2520Renal%2520Function%2520in%2520Patients%2520with%2520Acute%2520Decompensated%2520Heart%2520Failure%2520and%2520Renal%2520Impairment%2520or%2520Diuretic%2520Resistance%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2007%26volume%3D50%26spage%3D1551%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span> </span><span class="NLM_article-title">Minimising the Potential for Metabolic Activation in Drug Discovery</span> <span class="citation_source-journal">Exp. Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1517%2F17425255.1.1.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=16922655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=91-142&author=A.+S.+Kalgutkarauthor=J.+R.+Soglia&title=Minimising+the+Potential+for+Metabolic+Activation+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Minimising the potential for metabolic activation in drug discovery</span></div><div class="casAuthors">Kalgutkar, Amit S.; Soglia, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-142</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Investigations into the role of bioactivation in the pathogenesis of xeno-biotic-induced toxicity have been a major area of research since the link between reactive metabolites and carcinogenesis was first reported in the 1930s.  Circumstantial evidence suggests that bioactivation of relatively inert functional groups to reactive metabolites may contribute towards certain drug-induced adverse reactions.  Reactive metabolites, if not detoxified, can covalently modify essential cellular targets.  The identity of the susceptible biomacromol.(s), and the physiol. consequence of its covalent modification, will dictate the resulting toxicol. response (e.g., covalent modification of DNA by reactive intermediates derived from procarcinogens that potentially leads to carcinogenesis).  The formation of drug-protein adducts often carries a potential risk of clin. toxicities that may not be predicted from preclin. safety studies.  Animal models used to reliably predict idio-syncratic drug toxicity are unavailable at present.  Furthermore, considering that the frequency of occurrence of idiosyncratic adverse drug reactions (IADRs) is fairly rare (1 in 1000 to 1 in 10,000), it is impossible to detect such phenomena in early clin. trials.  Thus, the occurrence of IADRs during late clin. trials or after a drug has been released can lead to an unanticipated restriction in its use and even in its withdrawal.  Major themes explored in this review include a comprehensive cataloguing of bioactivation pathways of functional groups commonly utilized in drug design efforts with appropriate strategies towards detection of corresponding reactive intermediates.  Several instances wherein replacement of putative structural alerts in drugs assocd. with IADRs with a latent functionality eliminates the underlying liability are also presented.  Examples of where bioactivation phenomenon in drug candidates can be successfully abrogated via iterative chem. interventions are also discussed.  Finally, appropriate strategies that aid in potentially mitigating the risk of IADRs are explored, esp. in circumstances in which the structural alert is also responsible for the primary pharmacol. of the drug candidate and cannot be replaced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryrPwGKBtP3rVg90H21EOLACvtfcHk0ljF6Kt282xY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVGhs7s%253D&md5=15a3312335273663b6ef1222534f5428</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.1.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.1.91%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26atitle%3DMinimising%2520the%2520Potential%2520for%2520Metabolic%2520Activation%2520in%2520Drug%2520Discovery%26jtitle%3DExp.%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D91%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+Reactions+of+Five-Membered+Aromatic+Heterocyclic+Rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0ljF6Kt282xY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520Reactions%2520of%2520Five-Membered%2520Aromatic%2520Heterocyclic%2520Rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub> Receptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1729</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1719-1729&author=D.+H.+Sleeauthor=Y.+Chenauthor=X.+Zhangauthor=M.+Moorjaniauthor=M.+C.+Lanierauthor=E.+Linauthor=J.+K.+Rueterauthor=J.+P.+Williamsauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=K.+Jalaliauthor=Y.+Saiauthor=Z.+Zuoauthor=C.+Yangauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saunders&title=2-Amino-N-pyrimidin-4-ylacetamides+as+A2A+Receptor+Antagonists%3A+1.+Structure%E2%88%92Activity+Relationships+and+Optimization+of+Heterocyclic+Substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm701185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701185v%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3D2-Amino-N-pyrimidin-4-ylacetamides%2520as%2520A2A%2520Receptor%2520Antagonists%253A%25201.%2520Structure%25E2%2588%2592Activity%2520Relationships%2520and%2520Optimization%2520of%2520Heterocyclic%2520Substituents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1719%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><div class="note"><p class="first last">hERG activity was routinely assessed using a dofetolide competition binding assay. Key compounds were further assayed in a patch clamp electrophysiology assay; see reference <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a> for experimental details.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=hERG+activity+was+routinely+assessed+using+a+dofetolide+competition+binding+assay.+Key+compounds+were+further+assayed+in+a+patch+clamp+electrophysiology+assay%3B+see+reference+14+for+experimental+details."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><div class="note"><p class="first last">In the hERG electrophysiology assay, <b>2</b> had an IC<sub>50</sub> of 950 nM.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+the+hERG+electrophysiology+assay%2C+2+had+an+IC50+of+950+nM."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub> Receptor Antagonists: 2. Reduction of hERG Activity, Observed Species Selectivity, and Structure−Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1730</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701187w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1730-1739&author=D.+H.+Sleeauthor=M.+Moorjaniauthor=X.+Zhangauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+K.+Rueterauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=T.+Joswigauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+P.+Williamsauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=K.+Jalaliauthor=Y.+Saiauthor=Z.+Zuoauthor=C.+Yangauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=R.+Petroskiauthor=J.+Saunders&title=2-Amino-N-pyrimidin-4-ylacetamides+as+A2A+Receptor+Antagonists%3A+2.+Reduction+of+hERG+Activity%2C+Observed+Species+Selectivity%2C+and+Structure%E2%88%92Activity+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm701187w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701187w%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3D2-Amino-N-pyrimidin-4-ylacetamides%2520as%2520A2A%2520Receptor%2520Antagonists%253A%25202.%2520Reduction%2520of%2520hERG%2520Activity%252C%2520Observed%2520Species%2520Selectivity%252C%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1730%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+Chemistry+of+hERG+Optimizations%3A+Highlights+and+Hang-Ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lgkxJ9E2hsKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520Chemistry%2520of%2520hERG%2520Optimizations%253A%2520Highlights%2520and%2520Hang-Ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekhlassi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">2,6-Diaryl-4-phenacylaminopyrimidines as Potent and Selective Adenosine A<sub>2A</sub> Antagonists with Reduced hERG Liability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1269-1273&author=M.+Moorjaniauthor=X.+Zhangauthor=Y.+Chenauthor=E.+Linauthor=J.+K.+Rueterauthor=R.+S.+Grossauthor=M.+C.+Lanierauthor=J.+E.+Tellewauthor=J.+P.+Williamsauthor=S.+M.+Lechnerauthor=S.+Malanyauthor=M.+Santosauthor=P.+Ekhlassiauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saundersauthor=D.+H.+Slee&title=2%2C6-Diaryl-4-phenacylaminopyrimidines+as+Potent+and+Selective+Adenosine+A2A+Antagonists+with+Reduced+hERG+Liability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DEkhlassi%26aufirst%3DP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3D2%252C6-Diaryl-4-phenacylaminopyrimidines%2520as%2520Potent%2520and%2520Selective%2520Adenosine%2520A2A%2520Antagonists%2520with%2520Reduced%2520hERG%2520Liability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1269%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-Pyrimidinyl-2-phenoxyacetamides as Adenosine A<sub>2A</sub> Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1778</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1778-1783&author=X.+Zhangauthor=J.+K.+Rueterauthor=Y.+Chenauthor=M.+Moorjaniauthor=M.+C.+Lanierauthor=E.+Linauthor=R.+S.+Grossauthor=J.+E.+Tellewauthor=J.+P.+Williamsauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=T.+Joswigauthor=S.+Malanyauthor=M.+Santosauthor=J.-C.+Castro-Palominoauthor=M.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saundersauthor=D.+H.+Slee&title=Synthesis+of+N-Pyrimidinyl-2-phenoxyacetamides+as+Adenosine+A2A+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DCastro-Palomino%26aufirst%3DJ.-C.%26aulast%3DCrespo%26aufirst%3DM.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DSynthesis%2520of%2520N-Pyrimidinyl-2-phenoxyacetamides%2520as%2520Adenosine%2520A2A%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1778%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">See reference <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a> for experimental details.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+reference+14+for+experimental+details."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Moorjani, M.; Luo, Z.; Lin, E.; Vong, B. G.; Chen, Y.; Zhang, X.; Rueter, J. K.; Gross, R. S.; Lanier, M. C.; Tellew, J. E.; Williams, J. P.; Lechner, S. M.; Malany, S.; Santos, M.; Crespo, M. I.; Diaz, J.-L.; Saunders, J.; Slee, D. H.</span><span> </span><span class="NLM_article-title">2,6-Diaryl-4-acylaminopyrimidines as potent and selective Adenosine A<sub>2A</sub> Antagonists with improved solubility and metabolic stability</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><i>18</i>,  <span class="NLM_fpage">5402</span><span class="NLM_x">–</span> <span class="NLM_lpage">5405</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=5402-5405&author=M.+Moorjani&author=Z.+Luo&author=E.+Lin&author=B.+G.+Vong&author=Y.+Chen&author=X.+Zhang&author=J.+K.+Rueter&author=R.+S.+Gross&author=M.+C.+Lanier&author=J.+E.+Tellew&author=J.+P.+Williams&author=S.+M.+Lechner&author=S.+Malany&author=M.+Santos&author=M.+I.+Crespo&author=J.-L.+Diaz&author=J.+Saunders&author=D.+H.+Slee&title=2%2C6-Diaryl-4-acylaminopyrimidines+as+potent+and+selective+Adenosine+A2A+Antagonists+with+improved+solubility+and+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoorjani%26aufirst%3DM.%26atitle%3D2%252C6-Diaryl-4-acylaminopyrimidines%2520as%2520potent%2520and%2520selective%2520Adenosine%2520A2A%2520Antagonists%2520with%2520improved%2520solubility%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26spage%3D5402%26epage%3D5405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Crespo, M. I.; Prat, M.; Gual, S.; Castro-Palomini, J. C.; Slee, D. H.</span> PCT Patent Application WO2005/058883,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Crespo%2C+M.+I.%3B+Prat%2C+M.%3B+Gual%2C+S.%3B+Castro-Palomini%2C+J.+C.%3B+Slee%2C+D.+H.+PCT+Patent+Application+WO2005%2F058883%2C+2005%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Polonovski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, H.</span> <span class="citation_source-journal">Bull. Soc Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1948</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Polonovski%2C+M.%3B+Pesson%2C+M.%3B+Schmitt%2C+H.Bull.+Soc+Chim.+Fr.+1948%2C+392"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolonovski%26aufirst%3DM.%26aulast%3DPesson%26aufirst%3DM.%26aulast%3DSchmitt%26aufirst%3DH.%26jtitle%3DBull.%2520Soc%2520Chim.%2520Fr.%26date%3D1948%26spage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">In the hERG electrophysiology assay at a concentration of 10 μM, the following % inhibition values were observed: <b>6e</b> (9%), <b>6f</b> (2%)..</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+the+hERG+electrophysiology+assay+at+a+concentration+of+10+%CE%BCM%2C+the+following+%25+inhibition+values+were+observed%3A+6e+%289%25%29%2C+6f+%282%25%29.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><div class="note"><p class="first last">4-[2-(7-Amino-2-furan-2-yl-[1,2,4]triazolo[1,5-<i>a</i>][1,3,5]triazin-5-ylamino)-ethyl]-phenol (ZM241385).</p></div><span class="NLM_contrib-group">Cacciari, B.; Pastorin, G.; Spalluto, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of A<sub>2A</sub> adenosine receptor antagonists</span>.  <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span>− <span class="NLM_lpage">411</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.2174%2F1568026033392183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=12570758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=403-411&author=B.+Cacciari&author=G.+Pastorin&author=G.+Spalluto&title=Medicinal+chemistry+of+A2A+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of A2A adenosine receptor antagonists</span></div><div class="casAuthors">Cacciari, Barbara; Pastorin, Giorgia; Spalluto, Giampiero</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-411</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Due to the clearly demonstrated receptor-receptor interaction between adenosine A2A and dopamine D2 receptors in the basal ganglia, the discovery and development of potent and selective A2A adenosine receptor antagonists became, in the last ten years, an attractive field of research to discovery new drugs for the treatment of neurodegenerative disorders, such as Parkinsons disease.  Different compds. have been deeply investigated as A2A adenosine receptor antagonists, which could be classified in two great families: xanthine derivs. and nitrogen polyheterocyclic systems.  These studies led to the discovery of some highly potent and selective A2A adenosine receptor antagonists such as ZM241385, SCH58261 and some xanthine derivs. (KW6002), which have been used as pharmacol. tools for studying this receptor subtype.  However, those compds. showed some problems that do not permit their use in clin. studies, such as poor water soly. (SCH58261, and xanthine derivs.) or good affinity for A2B adenosine receptor subtype (ZM241385).  In the last few years great efforts have been made to overcome these problems, trying to optimize not only the pharmacol. profile but also the pharmacokinetic character of this class of compds.  The aim of this report is to briefly summarize the recent progress made in this attractive field of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Js9jSgCJ7LVg90H21EOLACvtfcHk0lifG5ZvONNOfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGisg%253D%253D&md5=28a5cf572c5400ec56ab33b2120e717f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1568026033392183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392183%26sid%3Dliteratum%253Aachs%26aulast%3DCacciari%26aufirst%3DB.%26atitle%3DMedicinal%2520chemistry%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D403%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><div class="note"><p class="first last">8-Cyclopentyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (DPCPX).</p></div><span class="NLM_contrib-group">Coates, J.; Sheehan, M. J.; Strong, P.</span><span> </span><span class="NLM_article-title">1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): a useful tool for pharmacologists and physiologists?</span> <span class="citation_source-journal">Gen. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span>− <span class="NLM_lpage">394</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=7926579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADyaK2cXksV2nu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=387-394&author=J.+Coates&author=M.+J.+Sheehan&author=P.+Strong&title=1%2C3-Dipropyl-8-cyclopentyl+xanthine+%28DPCPX%29%3A+a+useful+tool+for+pharmacologists+and+physiologists%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Dipropyl-8-cyclopentylxanthine (DPCPX): a useful tool for pharmacologists and physiologists?</span></div><div class="casAuthors">Coates, Jill; Sheehan, Michael J.; Strong, Peter</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">387-94</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    </div><div class="casAbstract">A review, with 58 refs., describing the in vitro and in vivo pharmacol. of DPCPX and discussing its use as a tool in studying the pharmacol. and potential (patho)physiol. significance of adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9b3KnGedYQbVg90H21EOLACvtfcHk0lgUII62_BNd7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksV2nu7o%253D&md5=3089ceb0ab1deb0679b7f38c3411dc41</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoates%26aufirst%3DJ.%26atitle%3D1%252C3-Dipropyl-8-cyclopentyl%2520xanthine%2520%2528DPCPX%2529%253A%2520a%2520useful%2520tool%2520for%2520pharmacologists%2520and%2520physiologists%253F%26jtitle%3DGen.%2520Pharmacol.%26date%3D1994%26volume%3D25%26spage%3D387%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">Assessed by inhibition of agonist-induced cAMP production in CHO cells expressin human A<sub>2A</sub>; see reference <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a> for experimental details..</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Assessed+by+inhibition+of+agonist-induced+cAMP+production+in+CHO+cells+expressin+human+A2A%3B+see+reference+13+for+experimental+details.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><div class="note"><p class="first last">3-[4-[2-[[6-amino-9-[(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid (CGS-21680).</p></div><span class="NLM_contrib-group">Cristalli, G.; Lambertucci, C.; Taffi, S.; Vittori, S.; Volpini, R.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of adenosine A<sub>2A</sub> receptor agonists</span>.  <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span>− <span class="NLM_lpage">401</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.2174%2F1568026033392282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=12570757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=387-401&author=G.+Cristalli&author=C.+Lambertucci&author=S.+Taffi&author=S.+Vittori&author=R.+Volpini&title=Medicinal+chemistry+of+adenosine+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine A2A receptor agonists</span></div><div class="casAuthors">Cristalli, Gloria; Lambertucci, Catia; Taffi, Sara; Vittori, Sauro; Volpini, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The search for potent and selective A2A adenosine receptor agonists has been particularly fruitful in the early nineties.  A series of 2-amino, 2-alkoxy, 2-alkythio-, 2-alkynyl-, and 2-alkenyl-derivs. of adenosine (Ado, 1) and N-ethylcarboxamidoadenosine (NECA, 30) have been synthesized and tested mainly on different model of rat A1 and A2A receptor subtypes.  From these studies some ligands, such as CGS 21680 (33), HENECA (42), and (S)-PHPNECA (46b), showed to possess high A2A affinity combined with good A2A vs A1 selectivity.  More detailed characterization of these ligands at the four cloned human adenosine receptor subtypes revealed that none of the prototypical adenosine receptor agonists exhibits at the same time high affinity and selectivity for the human A2AAR subtype.  Both NECA and CGS 21680, which are available as radioligands for this subtype, have lower affinity at human than at rat receptor.  The 2-alkynylNECA derivs. HENECA an PHPNECA showed high affinity also at human A3 receptors.  In particular, (S)-PHPNECA displayed Kis in the low nanomolar range at A1, A2A, and A3 subtypes and an EC50 of 220 nM at human A2B receptor.  It is now well known that the coronary vasodilation induced by Ado in different species is mediated by activation of A2AAR and a compd. capable of producing coronary vasodilation through activation of A2AAR, but that is devoid of A1-and A3-agonist activity would have advantage over Ado for use in myocardial perfusion imaging studies.  Other potential therapeutic applications of selective A2AAR agonists are as anti-aggregatory, anti-inflammatory, anti-psychotic, and anti-Huntington's disease agents.  This review is aimed at presenting a complete overview of the medicinal chem. development of A2A adenosine receptor agonists and at stressing the strong need for more selective ligands at A2A human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZ9WytCwyQLVg90H21EOLACvtfcHk0lgUII62_BNd7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D&md5=4d2aef4b8cb3f1f30efe8d4f839e01d1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F1568026033392282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392282%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520adenosine%2520A2A%2520receptor%2520agonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><div class="note"><p class="first last">D5W: 5% dextrose in water.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=D5W%3A+5%25+dextrose+in+water."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bergström, C. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassvik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubatsch, I.</span><span> </span><span class="NLM_article-title">Poorly Soluble Marketed Drugs Display Solvation Limited Solubility</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5858</span><span class="NLM_x">–</span> <span class="NLM_lpage">5862</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0706416" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5858-5862&author=C.+A.+S.+Bergstr%C3%B6mauthor=C.+M.+Wassvikauthor=K.+Johanssonauthor=I.+Hubatsch&title=Poorly+Soluble+Marketed+Drugs+Display+Solvation+Limited+Solubility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0706416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0706416%26sid%3Dliteratum%253Aachs%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DC.%2BA.%2BS.%26aulast%3DWassvik%26aufirst%3DC.%2BM.%26aulast%3DJohansson%26aufirst%3DK.%26aulast%3DHubatsch%26aufirst%3DI.%26atitle%3DPoorly%2520Soluble%2520Marketed%2520Drugs%2520Display%2520Solvation%2520Limited%2520Solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5858%26epage%3D5862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Rasenack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, B. W.</span><span> </span><span class="NLM_article-title">Poorly Water-Soluble Drugs for Oral Delivery: A Challenge for Pharmaceuctical Development. Part I: Physicochemical and Biopharmaceutical Background/Strategies in Pharmaceutical Development</span> <span class="citation_source-journal">Pharm. Ind.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVWrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=323-326&author=N.+Rasenackauthor=B.+W.+Mueller&title=Poorly+Water-Soluble+Drugs+for+Oral+Delivery%3A+A+Challenge+for+Pharmaceuctical+Development.+Part+I%3A+Physicochemical+and+Biopharmaceutical+Background%2FStrategies+in+Pharmaceutical+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Poorly water-soluble drugs for oral delivery - A challenge for pharmaceutical development: Part I: Physicochemical and biopharmaceutical background / strategies in pharmaceutical development</span></div><div class="casAuthors">Rasenack, Norbert; Mueller, Bernd W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmazeutische Industrie</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-326</span>CODEN:
                <span class="NLM_cas:coden">PHINAN</span>;
        ISSN:<span class="NLM_cas:issn">0031-711X</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">A review.  Several New Chem. Entities (NCEs) in pharmaceutical research are poorly water-sol. which often results in an insufficient bioavailability from common oral dosage forms.  This presents a challenge to develop suitable drug delivery systems for oral use which ensure that the drug has sufficient bioavailability.  Several technologies exist for increasing the dissoln. rate and/or the soly.  This review series in three parts presents pharmaceutical technologies and points out advantages and disadvantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoOdXxQTbtHbVg90H21EOLACvtfcHk0ljnFOOqRUk4hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVWrsrw%253D&md5=4a413110ec42b92e21a3424ce832915e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRasenack%26aufirst%3DN.%26aulast%3DMueller%26aufirst%3DB.%2BW.%26atitle%3DPoorly%2520Water-Soluble%2520Drugs%2520for%2520Oral%2520Delivery%253A%2520A%2520Challenge%2520for%2520Pharmaceuctical%2520Development.%2520Part%2520I%253A%2520Physicochemical%2520and%2520Biopharmaceutical%2520Background%252FStrategies%2520in%2520Pharmaceutical%2520Development%26jtitle%3DPharm.%2520Ind.%26date%3D2005%26volume%3D67%26spage%3D323%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><div class="note"><p class="first last">Metabolic oxidation of <i>N</i>-arylmorpholines to form reactive metabolites has been described:</p></div><span class="NLM_contrib-group">Wu, Y.-J.; Davis, C. D.; Dworetzky, S.; Fitzpatrick, W. C.; Harden, D.; He, H.; Knox, R. J.; Newton, A. E.; Philip, T.; Polson, C.; Sivarao, D. V.; Sun, L.-Q.; Tertyshnikova, S.; Weaver, D.; Yeola, S.; Zoeckler, M.; Sinz, M. W.</span>, <span> </span><span class="NLM_article-title">Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition: Identification of (<i>S</i>)-<i>N</i>-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3-(4-fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent Inhibition</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3778</span>− <span class="NLM_lpage">3781</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm034111v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3778-3781&author=Y.-J.+Wu&author=C.+D.+Davis&author=S.+Dworetzky&author=W.+C.+Fitzpatrick&author=D.+Harden&author=H.+He&author=R.+J.+Knox&author=A.+E.+Newton&author=T.+Philip&author=C.+Polson&author=D.+V.+Sivarao&author=L.-Q.+Sun&author=S.+Tertyshnikova&author=D.+Weaver&author=S.+Yeola&author=M.+Zoeckler&author=M.+W.+Sinz&title=Fluorine+Substitution+Can+Block+CYP3A4+Metabolism-Dependent+Inhibition%3A+Identification+of+%28S%29-N-%5B1-%284-Fluoro-3-+morpholin-4-ylphenyl%29ethyl%5D-3-%284-fluorophenyl%29acrylamide+as+an+Orally+Bioavailable+KCNQ2+Opener+Devoid+of+CYP3A4+Metabolism-Dependent+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm034111v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034111v%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26atitle%3DFluorine%2520Substitution%2520Can%2520Block%2520CYP3A4%2520Metabolism-Dependent%2520Inhibition%253A%2520Identification%2520of%2520%2528S%2529-N-%255B1-%25284-Fluoro-3-%2520morpholin-4-ylphenyl%2529ethyl%255D-3-%25284-fluorophenyl%2529acrylamide%2520as%2520an%2520Orally%2520Bioavailable%2520KCNQ2%2520Opener%2520Devoid%2520of%2520CYP3A4%2520Metabolism-Dependent%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3778%26epage%3D3781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><div class="note"><p class="first last">TPGS: <span class="smallcaps smallerCapital">d</span>-alpha-tocopheryl polyethylene glycol 1000 succinate, a water soluble derivative of Vitamin E.</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TPGS%3A+d-alpha-tocopheryl+polyethylene+glycol+1000+succinate%2C+a+water+soluble+derivative+of+Vitamin+E.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenfeng  Lu</span>, <span class="hlFld-ContribAuthor ">Yongqiang  Liu</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Jiyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Zhijian  Sun</span>, <span class="hlFld-ContribAuthor ">Lusong  Luo</span>, <span class="hlFld-ContribAuthor ">Jiajun  Li</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Zeng-Jie  Yang</span>, and <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structure–Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 1980-1994. <a href="https://doi.org/10.1021/acschemneuro.7b00153" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00153%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BTetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidine%252BDerivatives%252Bas%252BPotent%252BSmoothened%252BAntagonists%252Bwith%252Bin%252BVivo%252BActivity%26aulast%3DLu%26aufirst%3DWenfeng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25042017%26date%3D15062017%26date%3D30062017%26date%3D20092017%26date%3D15062017%26volume%3D8%26issue%3D9%26spage%3D1980%26epage%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Xu  Wang</span>, <span class="hlFld-ContribAuthor ">Linlang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>, <span class="hlFld-ContribAuthor ">Youyong  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>, and <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel and Selective Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease through Comparative Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (6)
                                     , 1474-1487. <a href="https://doi.org/10.1021/acs.jcim.7b00188" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00188%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BNovel%252Band%252BSelective%252BAdenosine%252BA2A%252BReceptor%252BAntagonists%252Bfor%252BTreating%252BParkinson%2525E2%252580%252599s%252BDisease%252Bthrough%252BComparative%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DTian%26aufirst%3DSheng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04042017%26date%3D15052017%26date%3D26062017%26date%3D02052017%26volume%3D57%26issue%3D6%26spage%3D1474%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaohui  Yang</span>, <span class="hlFld-ContribAuthor ">Linlang  Li</span>, <span class="hlFld-ContribAuthor ">Jiyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Jiajun  Li</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>, and <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a New Series of Potent Adenosine A2A Receptor Antagonists Based on 4-Amino-5-carbonitrile Pyrimidine Template for the Treatment of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (11)
                                     , 1575-1584. <a href="https://doi.org/10.1021/acschemneuro.6b00218" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00218%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Bof%252Ba%252BNew%252BSeries%252Bof%252BPotent%252BAdenosine%252BA2A%252BReceptor%252BAntagonists%252BBased%252Bon%252B4-Amino-5-carbonitrile%252BPyrimidine%252BTemplate%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DYang%26aufirst%3DZhaohui%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26072016%26date%3D28082016%26date%3D09092016%26date%3D16112016%26date%3D28082016%26volume%3D7%26issue%3D11%26spage%3D1575%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhaohui  Yang</span>, <span class="hlFld-ContribAuthor ">Xuan  Li</span>, <span class="hlFld-ContribAuthor ">Linlang  Li</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Meiyu  Wang</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>, and <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of 6-Heterocyclic-2-(1H-pyrazol-1-yl)-N-(pyridin-2-yl)pyrimidin-4-amine as Potent Adenosine A2A Receptor Antagonists for the Treatment of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (8)
                                     , 674-682. <a href="https://doi.org/10.1021/cn5000716" title="DOI URL">https://doi.org/10.1021/cn5000716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn5000716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn5000716%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DOptimization%252Bof%252B6-Heterocyclic-2-%2525281H-pyrazol-1-yl%252529-N-%252528pyridin-2-yl%252529pyrimidin-4-amine%252Bas%252BPotent%252BAdenosine%252BA2A%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DZheng%26aufirst%3DJiyue%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05042014%26date%3D11062014%26date%3D23062014%26date%3D20082014%26date%3D12062014%26volume%3D5%26issue%3D8%26spage%3D674%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  de Lera Ruiz</span>, <span class="hlFld-ContribAuthor ">Yeon-Hee  Lim</span>, and <span class="hlFld-ContribAuthor ">Junying  Zheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor as a Drug Discovery Target. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (9)
                                     , 3623-3650. <a href="https://doi.org/10.1021/jm4011669" title="DOI URL">https://doi.org/10.1021/jm4011669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4011669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4011669%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdenosine%252BA2A%252BReceptor%252Bas%252Ba%252BDrug%252BDiscovery%252BTarget%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DManuel%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D31072013%26date%3D15112013%26date%3D08052014%26date%3D28102013%26volume%3D57%26issue%3D9%26spage%3D3623%26epage%3D3650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Bacilieri</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Silvia  Paoletta</span>, <span class="hlFld-ContribAuthor ">Stephanie  Federico</span>, <span class="hlFld-ContribAuthor ">Sandro  Cosconati</span>, <span class="hlFld-ContribAuthor ">Barbara  Cacciari</span>, <span class="hlFld-ContribAuthor ">Sabrina  Taliani</span>, <span class="hlFld-ContribAuthor ">Federico  Da Settimo</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Karl Norbert  Klotz</span>, <span class="hlFld-ContribAuthor ">Giampiero  Spalluto</span>, and <span class="hlFld-ContribAuthor ">Stefano  Moro</span>  . </span><span class="cited-content_cbyCitation_article-title">Revisiting a Receptor-Based Pharmacophore Hypothesis for Human A2A Adenosine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (7)
                                     , 1620-1637. <a href="https://doi.org/10.1021/ci300615u" title="DOI URL">https://doi.org/10.1021/ci300615u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci300615u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci300615u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DRevisiting%252Ba%252BReceptor-Based%252BPharmacophore%252BHypothesis%252Bfor%252BHuman%252BA2A%252BAdenosine%252BReceptor%252BAntagonists%26aulast%3DBacilieri%26aufirst%3DMagdalena%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D08102012%26date%3D20062013%26date%3D22072013%26date%3D25052013%26volume%3D53%26issue%3D7%26spage%3D1620%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  St. Jean,Jr.</span> and <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>  . </span><span class="cited-content_cbyCitation_article-title">Mitigating Heterocycle Metabolism in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (13)
                                     , 6002-6020. <a href="https://doi.org/10.1021/jm300343m" title="DOI URL">https://doi.org/10.1021/jm300343m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300343m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMitigating%252BHeterocycle%252BMetabolism%252Bin%252BDrug%252BDiscovery%26aulast%3DSt.%2BJean%26aufirst%3DDavid%2BJ.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D12032012%26date%3D07052012%26date%3D12072012%26date%3D25042012%26volume%3D55%26issue%3D13%26spage%3D6002%26epage%3D6020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anette G.  Sams</span>, <span class="hlFld-ContribAuthor ">Gitte K.  Mikkelsen</span>, <span class="hlFld-ContribAuthor ">Mogens  Larsen</span>, <span class="hlFld-ContribAuthor ">Morten  Langgård</span>, <span class="hlFld-ContribAuthor ">Mark E.  Howells</span>, <span class="hlFld-ContribAuthor ">Tenna J.  Schrøder</span>, <span class="hlFld-ContribAuthor ">Lise T.  Brennum</span>, <span class="hlFld-ContribAuthor ">Lars  Torup</span>, <span class="hlFld-ContribAuthor ">Erling B.  Jørgensen</span>, <span class="hlFld-ContribAuthor ">Christoffer  Bundgaard</span>, <span class="hlFld-ContribAuthor ">Mads  Kreilgård</span>, and <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Phosphoric Acid Mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} Ester (Lu AA47070): A Phosphonooxymethylene Prodrug of a Potent and Selective hA2A Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (3)
                                     , 751-764. <a href="https://doi.org/10.1021/jm1008659" title="DOI URL">https://doi.org/10.1021/jm1008659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1008659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1008659%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPhosphoric%252BAcid%252BMono-%25257B2-%25255B%252528E%25252FZ%252529-4-%2525283%25252C3-dimethyl-butyrylamino%252529-3%25252C5-difluoro-benzoylimino%25255D-thiazol-3-ylmethyl%25257D%252BEster%252B%252528Lu%252BAA47070%252529%25253A%252BA%252BPhosphonooxymethylene%252BProdrug%252Bof%252Ba%252BPotent%252Band%252BSelective%252BhA2A%252BReceptor%252BAntagonist%26aulast%3DSams%26aufirst%3DAnette%2BG.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D12072010%26date%3D06012011%26date%3D10022011%26volume%3D54%26issue%3D3%26spage%3D751%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vicente  Yaziji</span>, <span class="hlFld-ContribAuthor ">David  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Hugo  Gutiérrez-de-Terán</span>, <span class="hlFld-ContribAuthor ">Alberto  Coelho</span>, <span class="hlFld-ContribAuthor ">Olga  Caamaño</span>, <span class="hlFld-ContribAuthor ">Xerardo  García-Mera</span>, <span class="hlFld-ContribAuthor ">José  Brea</span>, <span class="hlFld-ContribAuthor ">María Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">María Isabel  Cadavid</span>, and <span class="hlFld-ContribAuthor ">Eddy  Sotelo</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrimidine Derivatives as Potent and Selective A3 Adenosine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (2)
                                     , 457-471. <a href="https://doi.org/10.1021/jm100843z" title="DOI URL">https://doi.org/10.1021/jm100843z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100843z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100843z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrimidine%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252BA3%252BAdenosine%252BReceptor%252BAntagonists%26aulast%3DYaziji%26aufirst%3DVicente%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D11062010%26date%3D27122010%26date%3D27012011%26volume%3D54%26issue%3D2%26spage%3D457%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vicente  Yaziji</span>, <span class="hlFld-ContribAuthor ">Alberto  Coelho</span>, <span class="hlFld-ContribAuthor ">Abdelaziz  El Maatougui</span>, <span class="hlFld-ContribAuthor ">José  Brea</span>, <span class="hlFld-ContribAuthor ">M. Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">Xerardo  Garcia-Mera</span> and <span class="hlFld-ContribAuthor ">Eddy  Sotelo</span>  . </span><span class="cited-content_cbyCitation_article-title">Divergent Solution-Phase Synthesis of Diarylpyrimidine Libraries as Selective A3 Adenosine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Combinatorial Chemistry</span><span> <strong>2009,</strong> <em>11 </em>
                                    (4)
                                     , 519-522. <a href="https://doi.org/10.1021/cc900044k" title="DOI URL">https://doi.org/10.1021/cc900044k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cc900044k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcc900044k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Combinatorial%2520Chemistry%26atitle%3DDivergent%252BSolution-Phase%252BSynthesis%252Bof%252BDiarylpyrimidine%252BLibraries%252Bas%252BSelective%252BA3%252BAdenosine%252BReceptor%252BAntagonists%26aulast%3DYaziji%26aufirst%3DVicente%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D18%252003%25202009%26date%3D27052009%26date%3D13072009%26volume%3D11%26issue%3D4%26spage%3D519%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marion C.  Lanier</span>, <span class="hlFld-ContribAuthor ">Manisha  Moorjani</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Luo</span>, <span class="hlFld-ContribAuthor ">Yongsheng  Chen</span>, <span class="hlFld-ContribAuthor ">Emily  Lin</span>, <span class="hlFld-ContribAuthor ">John E.  Tellew</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>, <span class="hlFld-ContribAuthor ">John P.  Williams</span>, <span class="hlFld-ContribAuthor ">Raymond S.  Gross</span>, <span class="hlFld-ContribAuthor ">Sandra M.  Lechner</span>, <span class="hlFld-ContribAuthor ">Stacy  Markison</span>, <span class="hlFld-ContribAuthor ">Tanya  Joswig</span>, <span class="hlFld-ContribAuthor ">William  Kargo</span>, <span class="hlFld-ContribAuthor ">Jaime  Piercey</span>, <span class="hlFld-ContribAuthor ">Mark  Santos</span>, <span class="hlFld-ContribAuthor ">Siobhan  Malany</span>, <span class="hlFld-ContribAuthor ">Marilyn  Zhao</span>, <span class="hlFld-ContribAuthor ">Robert  Petroski</span>, <span class="hlFld-ContribAuthor ">María I.  Crespo</span>, <span class="hlFld-ContribAuthor ">José-Luis  Díaz</span>, <span class="hlFld-ContribAuthor ">John  Saunders</span>, <span class="hlFld-ContribAuthor ">Jenny  Wen</span>, <span class="hlFld-ContribAuthor ">Zhihong  O’Brien</span>, <span class="hlFld-ContribAuthor ">Kayvon  Jalali</span>, <span class="hlFld-ContribAuthor ">Ajay  Madan</span> and <span class="hlFld-ContribAuthor ">Deborah H.  Slee</span>. </span><span class="cited-content_cbyCitation_article-title">N-[6-Amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A Receptor Antagonists with Improved Drug Like Properties and in Vivo Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (3)
                                     , 709-717. <a href="https://doi.org/10.1021/jm800908d" title="DOI URL">https://doi.org/10.1021/jm800908d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800908d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800908d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-%25255B6-Amino-2-%252528heteroaryl%252529pyrimidin-4-yl%25255Dacetamides%252Bas%252BA2A%252BReceptor%252BAntagonists%252Bwith%252BImproved%252BDrug%252BLike%252BProperties%252Band%252Bin%252BVivo%252BEfficacy%26aulast%3DLanier%26aufirst%3DMarion%2BC.%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D12%252002%25202009%26date%3D13%252001%25202009%26date%3D21%252007%25202008%26volume%3D52%26issue%3D3%26spage%3D709%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">2-Aminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 237-283. <a href="https://doi.org/10.1002/9781118686263.ch7" title="DOI URL">https://doi.org/10.1002/9781118686263.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch7%26sid%3Dliteratum%253Aachs%26atitle%3D2-Aminopyrimidines%26date%3D2018%26date%3D2018%26spage%3D237%26epage%3D283%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefania  Baraldi</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Paola  Oliva</span>, <span class="hlFld-ContribAuthor ">Kiran S.  Toti</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">A2A Adenosine Receptor: Structures, Modeling, and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 91-136. <a href="https://doi.org/10.1007/978-3-319-90808-3_5" title="DOI URL">https://doi.org/10.1007/978-3-319-90808-3_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-90808-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-90808-3_5%26sid%3Dliteratum%253Aachs%26atitle%3DA2A%252BAdenosine%252BReceptor%25253A%252BStructures%25252C%252BModeling%25252C%252Band%252BMedicinal%252BChemistry%26aulast%3DBaraldi%26aufirst%3DStefania%26date%3D2018%26date%3D2018%26spage%3D91%26epage%3D136%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BAdenosine%252BReceptors%26aulast%3DBorea%26aufirst%3DPier%2BAndrea%26date%3D2018%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olena  Vakuliuk</span>, <span class="hlFld-ContribAuthor ">Anna  Purc</span>, <span class="hlFld-ContribAuthor ">Guillaume  Clermont</span>, <span class="hlFld-ContribAuthor ">Mireille  Blanchard-Desce</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gryko</span>. </span><span class="cited-content_cbyCitation_article-title">The Impact of the Interplay between Steric and Electronic Effects on the Synthesis and Optical Properties of Diketopyrrolopyrroles Bearing Pyridine Moieties. </span><span class="cited-content_cbyCitation_journal-name">ChemPhotoChem</span><span> <strong>2017,</strong> <em>1 </em>
                                    (5)
                                     , 243-252. <a href="https://doi.org/10.1002/cptc.201600047" title="DOI URL">https://doi.org/10.1002/cptc.201600047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cptc.201600047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcptc.201600047%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPhotoChem%26atitle%3DThe%252BImpact%252Bof%252Bthe%252BInterplay%252Bbetween%252BSteric%252Band%252BElectronic%252BEffects%252Bon%252Bthe%252BSynthesis%252Band%252BOptical%252BProperties%252Bof%252BDiketopyrrolopyrroles%252BBearing%252BPyridine%252BMoieties%26aulast%3DVakuliuk%26aufirst%3DOlena%26date%3D2017%26date%3D2017%26volume%3D1%26issue%3D5%26spage%3D243%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad A.  Khanfar</span>, <span class="hlFld-ContribAuthor ">Saja  Al-Qtaishat</span>, <span class="hlFld-ContribAuthor ">Maha  Habash</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent adenosine A2a antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2016,</strong> <em>254 </em>, 93-101. <a href="https://doi.org/10.1016/j.cbi.2016.05.023" title="DOI URL">https://doi.org/10.1016/j.cbi.2016.05.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2016.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2016.05.023%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DDiscovery%252Bof%252Bpotent%252Badenosine%252BA2a%252Bantagonists%252Bas%252Bpotential%252Banti-Parkinson%252Bdisease%252Bagents.%252BNon-linear%252BQSAR%252Banalyses%252Bintegrated%252Bwith%252Bpharmacophore%252Bmodeling%26aulast%3DKhanfar%26aufirst%3DMohammad%2BA.%26date%3D2016%26volume%3D254%26spage%3D93%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delia  Preti</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Allan R.  Moorman</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>. </span><span class="cited-content_cbyCitation_article-title">History and Perspectives of A
              2A
              Adenosine Receptor Antagonists as Potential Therapeutic Agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (4)
                                     , 790-848. <a href="https://doi.org/10.1002/med.21344" title="DOI URL">https://doi.org/10.1002/med.21344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21344%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHistory%252Band%252BPerspectives%252Bof%252BA%252B2A%252BAdenosine%252BReceptor%252BAntagonists%252Bas%252BPotential%252BTherapeutic%252BAgents%26aulast%3DPreti%26aufirst%3DDelia%26date%3D2015%26date%3D2015%26volume%3D35%26issue%3D4%26spage%3D790%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepak  Dalvie</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Weichao  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Practical approaches to resolving reactive metabolite liabilities in early discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2015,</strong> <em>47 </em>
                                    (1)
                                     , 56-70. <a href="https://doi.org/10.3109/03602532.2014.984813" title="DOI URL">https://doi.org/10.3109/03602532.2014.984813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/03602532.2014.984813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F03602532.2014.984813%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DPractical%252Bapproaches%252Bto%252Bresolving%252Breactive%252Bmetabolite%252Bliabilities%252Bin%252Bearly%252Bdiscovery%26aulast%3DDalvie%26aufirst%3DDeepak%26date%3D2015%26date%3D2014%26volume%3D47%26issue%3D1%26spage%3D56%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christa E.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor Antagonists in Drug Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 39-56. <a href="https://doi.org/10.1007/978-3-319-20273-0_3" title="DOI URL">https://doi.org/10.1007/978-3-319-20273-0_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-20273-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-20273-0_3%26sid%3Dliteratum%253Aachs%26atitle%3DAdenosine%252BA2A%252BReceptor%252BAntagonists%252Bin%252BDrug%252BDevelopment%26aulast%3DM%25C3%25BCller%26aufirst%3DChrista%2BE.%26date%3D2015%26date%3D2015%26spage%3D39%26epage%3D56%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BAdenosinergic%252BSystem%26aulast%3DMorelli%26aufirst%3DMicaela%26date%3D2015%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Lu</span>, <span class="hlFld-ContribAuthor ">Zhijian  Sun</span>, <span class="hlFld-ContribAuthor ">Lusong  Luo</span>, <span class="hlFld-ContribAuthor ">Delong  Geng</span>, <span class="hlFld-ContribAuthor ">Zhaohui  Yang</span>, <span class="hlFld-ContribAuthor ">Enqin  Li</span>, <span class="hlFld-ContribAuthor ">Jiyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Meiyu  Wang</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Shilin  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and structure–activity-relationship of tetrahydrothiazolopyridine derivatives as potent smoothened antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>89 </em>, 721-732. <a href="https://doi.org/10.1016/j.ejmech.2014.11.006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bstructure%2525E2%252580%252593activity-relationship%252Bof%252Btetrahydrothiazolopyridine%252Bderivatives%252Bas%252Bpotent%252Bsmoothened%252Bantagonists%26aulast%3DMa%26aufirst%3DHaikuo%26date%3D2015%26volume%3D89%26spage%3D721%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Morales-Bayuelo</span>, <span class="hlFld-ContribAuthor ">Verónica  Valdiris</span>, <span class="hlFld-ContribAuthor ">Ricardo  Vivas-Reyes</span>. </span><span class="cited-content_cbyCitation_article-title">Mathematical Analysis of a Series of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines: A Simple Way to Relate Quantum Similarity to Local Chemical Reactivity Using the Gaussian Orbitals Localized Theory. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>, 1-13. <a href="https://doi.org/10.1155/2014/624891" title="DOI URL">https://doi.org/10.1155/2014/624891</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/624891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F624891%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520Chemistry%26atitle%3DMathematical%252BAnalysis%252Bof%252Ba%252BSeries%252Bof%252B4-Acetylamino-2-%2525283%25252C5-dimethylpyrazol-1-yl%252529-6-pyridylpyrimidines%25253A%252BA%252BSimple%252BWay%252Bto%252BRelate%252BQuantum%252BSimilarity%252Bto%252BLocal%252BChemical%252BReactivity%252BUsing%252Bthe%252BGaussian%252BOrbitals%252BLocalized%252BTheory%26aulast%3DMorales-Bayuelo%26aufirst%3DAlejandro%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Shook</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 1-42. <a href="https://doi.org/10.1007/7355_2014_67" title="DOI URL">https://doi.org/10.1007/7355_2014_67</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_67%26sid%3Dliteratum%253Aachs%26atitle%3DAdenosine%252BA2A%252BReceptor%252BAntagonists%26aulast%3DShook%26aufirst%3DBrian%2BC.%26date%3D2014%26date%3D2014%26spage%3D1%26epage%3D42%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNovel%252BTherapeutic%252BApproaches%252Bto%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DHopkins%26aufirst%3DCorey%2BR.%26date%3D2016%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaohui  Yang</span>, <span class="hlFld-ContribAuthor ">Xuan  Li</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Jiyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 152-155. <a href="https://doi.org/10.1016/j.bmcl.2013.11.051" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.11.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.11.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DReplacement%252Bof%252Bamide%252Bwith%252Bbioisosteres%252Bled%252Bto%252Ba%252Bnew%252Bseries%252Bof%252Bpotent%252Badenosine%252BA2A%252Breceptor%252Bantagonists%26aulast%3DYang%26aufirst%3DZhaohui%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D152%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hans  Matter</span>, <span class="hlFld-ContribAuthor ">Stefan  Güssregen</span>, <span class="hlFld-ContribAuthor ">Friedemann  Schmidt</span>, <span class="hlFld-ContribAuthor ">Gerhard  Hessler</span>, <span class="hlFld-ContribAuthor ">Thorsten  Naumann</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Baringhaus</span>. </span><span class="cited-content_cbyCitation_article-title">EXPLORATION OF STRUCTURE-ACTIVITY RELATIONSHIPS (SARs) AND TRANSFER OF KEY ELEMENTS IN LEAD OPTIMIZATION. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 205-243. <a href="https://doi.org/10.1002/9781118742785.ch10" title="DOI URL">https://doi.org/10.1002/9781118742785.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118742785.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118742785.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DEXPLORATION%252BOF%252BSTRUCTURE-ACTIVITY%252BRELATIONSHIPS%252B%252528SARs%252529%252BAND%252BTRANSFER%252BOF%252BKEY%252BELEMENTS%252BIN%252BLEAD%252BOPTIMIZATION%26aulast%3DMatter%26aufirst%3DHans%26date%3D2013%26date%3D2013%26spage%3D205%26epage%3D243%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DChemoinformatics%252Bfor%252BDrug%252BDiscovery%26aulast%3DBajorath%26aufirst%3DJ%25C3%25BCrgen%26date%3D2013%26volume%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Tactics to Avoid Inhibition of Cytochrome P450s. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 107-158. <a href="https://doi.org/10.1007/7355_2013_25" title="DOI URL">https://doi.org/10.1007/7355_2013_25</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_25%26sid%3Dliteratum%253Aachs%26atitle%3DTactics%252Bto%252BAvoid%252BInhibition%252Bof%252BCytochrome%252BP450s%26aulast%3DLeach%26aufirst%3DAndrew%2BG.%26date%3D2013%26date%3D2013%26spage%3D107%26epage%3D158%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran Kumar  Mustyala</span>, <span class="hlFld-ContribAuthor ">Annapurna Renee  Chitturi</span>, <span class="hlFld-ContribAuthor ">Prameela Subhashini  Naikal James</span>, <span class="hlFld-ContribAuthor ">Uma  Vuruputuri</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore mapping and in silico screening to identify new potent leads for A
              2A
              adenosine receptor as antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2012,</strong> <em>32 </em>
                                    (2)
                                     , 102-113. <a href="https://doi.org/10.3109/10799893.2012.660532" title="DOI URL">https://doi.org/10.3109/10799893.2012.660532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/10799893.2012.660532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F10799893.2012.660532%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DPharmacophore%252Bmapping%252Band%252Bin%252Bsilico%252Bscreening%252Bto%252Bidentify%252Bnew%252Bpotent%252Bleads%252Bfor%252BA%252B2A%252Badenosine%252Breceptor%252Bas%252Bantagonists%26aulast%3DMustyala%26aufirst%3DKiran%2BKumar%26date%3D2012%26date%3D2012%26volume%3D32%26issue%3D2%26spage%3D102%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerhard  Hessler</span>, <span class="hlFld-ContribAuthor ">Hans  Matter</span>, <span class="hlFld-ContribAuthor ">Friedemann  Schmidt</span>, <span class="hlFld-ContribAuthor ">Clemens  Giegerich</span>, <span class="hlFld-ContribAuthor ">Li-hsing  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan  Güssregen</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Baringhaus</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Application of Antitarget Activity Hotspots to Guide Compound Optimization. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2011,</strong> <em>30 </em>
                                    (11-12)
                                     , 996-1008. <a href="https://doi.org/10.1002/minf.201100116" title="DOI URL">https://doi.org/10.1002/minf.201100116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201100116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201100116%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DIdentification%252Band%252BApplication%252Bof%252BAntitarget%252BActivity%252BHotspots%252Bto%252BGuide%252BCompound%252BOptimization%26aulast%3DHessler%26aufirst%3DGerhard%26date%3D2011%26date%3D2011%26volume%3D30%26issue%3D11-12%26spage%3D996%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonino  Lauria</span>, <span class="hlFld-ContribAuthor ">Marco  Tutone</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Almerico</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual lock-and-key approach: The in silico revival of Fischer model by means of molecular descriptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (9)
                                     , 4274-4280. <a href="https://doi.org/10.1016/j.ejmech.2011.06.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.06.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.06.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVirtual%252Block-and-key%252Bapproach%25253A%252BThe%252Bin%252Bsilico%252Brevival%252Bof%252BFischer%252Bmodel%252Bby%252Bmeans%252Bof%252Bmolecular%252Bdescriptors%26aulast%3DLauria%26aufirst%3DAntonino%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D4274%26epage%3D4280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joel M.  Harris</span>, <span class="hlFld-ContribAuthor ">Bernard R.  Neustadt</span>, <span class="hlFld-ContribAuthor ">Hongtao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jean  Lachowicz</span>, <span class="hlFld-ContribAuthor ">Mary  Cohen-Williams</span>, <span class="hlFld-ContribAuthor ">Geoff  Varty</span>, <span class="hlFld-ContribAuthor ">Jinsong  Hao</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and selective adenosine A2A receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (8)
                                     , 2497-2501. <a href="https://doi.org/10.1016/j.bmcl.2011.02.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.02.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.02.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Band%252Bselective%252Badenosine%252BA2A%252Breceptor%252Bantagonists%25253A%252B%25255B1%25252C2%25252C4%25255D-triazolo%25255B4%25252C3-c%25255Dpyrimidin-3-ones%26aulast%3DHarris%26aufirst%3DJoel%2BM.%26date%3D2011%26volume%3D21%26issue%3D8%26spage%3D2497%26epage%3D2501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard  Barlaam</span>, <span class="hlFld-ContribAuthor ">Richard  Ducray</span>, <span class="hlFld-ContribAuthor ">Christine Lambert-van der  Brempt</span>, <span class="hlFld-ContribAuthor ">Patrick  Plé</span>, <span class="hlFld-ContribAuthor ">Catherine  Bardelle</span>, <span class="hlFld-ContribAuthor ">Nigel  Brooks</span>, <span class="hlFld-ContribAuthor ">Tanya  Coleman</span>, <span class="hlFld-ContribAuthor ">Darren  Cross</span>, <span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Jon  Read</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (8)
                                     , 2207-2211. <a href="https://doi.org/10.1016/j.bmcl.2011.03.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.03.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.03.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhibitors%252Bof%252Bthe%252Btyrosine%252Bkinase%252BEphB4.%252BPart%252B4%25253A%252BDiscovery%252Band%252Boptimization%252Bof%252Ba%252Bbenzylic%252Balcohol%252Bseries%26aulast%3DBarlaam%26aufirst%3DBernard%26date%3D2011%26volume%3D21%26issue%3D8%26spage%3D2207%26epage%3D2211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Wen  Huang</span>, <span class="hlFld-ContribAuthor ">Jin-Sheng  Cheng</span>, <span class="hlFld-ContribAuthor ">Li  Qian</span>, <span class="hlFld-ContribAuthor ">Suo-Yi  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Facile microwave-assisted synthesis of bis-pyrazol pyrimidine derivatives via an N-alkylation reaction. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2011,</strong> <em>37 </em>
                                    (1)
                                     , 1-9. <a href="https://doi.org/10.1007/s11164-010-0217-3" title="DOI URL">https://doi.org/10.1007/s11164-010-0217-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-010-0217-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-010-0217-3%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DFacile%252Bmicrowave-assisted%252Bsynthesis%252Bof%252Bbis-pyrazol%252Bpyrimidine%252Bderivatives%252Bvia%252Ban%252BN-alkylation%252Breaction%26aulast%3DHuang%26aufirst%3DShi-Wen%26date%3D2011%26date%3D2010%26volume%3D37%26issue%3D1%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Osamu  Saku</span>, <span class="hlFld-ContribAuthor ">Mayumi  Saki</span>, <span class="hlFld-ContribAuthor ">Masako  Kurokawa</span>, <span class="hlFld-ContribAuthor ">Ken  Ikeda</span>, <span class="hlFld-ContribAuthor ">Takuya  Takizawa</span>, <span class="hlFld-ContribAuthor ">Noriaki  Uesaka</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic studies on selective adenosine A2A receptor antagonists: Synthesis and structure–activity relationships of novel benzofuran derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (3)
                                     , 1090-1093. <a href="https://doi.org/10.1016/j.bmcl.2009.12.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.12.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.12.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthetic%252Bstudies%252Bon%252Bselective%252Badenosine%252BA2A%252Breceptor%252Bantagonists%25253A%252BSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnovel%252Bbenzofuran%252Bderivatives%26aulast%3DSaku%26aufirst%3DOsamu%26date%3D2010%26volume%3D20%26issue%3D3%26spage%3D1090%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Shin  Cho</span>, <span class="hlFld-ContribAuthor ">Ying  Hou</span>, <span class="hlFld-ContribAuthor ">Christine H.-T.  Chen</span>, <span class="hlFld-ContribAuthor ">Moo Je  Sung</span>. </span><span class="cited-content_cbyCitation_article-title">Chemo- and regioselective halogenation of 4-(pyrazol-4-yl)-pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2009,</strong> <em>50 </em>
                                    (41)
                                     , 5762-5764. <a href="https://doi.org/10.1016/j.tetlet.2009.07.151" title="DOI URL">https://doi.org/10.1016/j.tetlet.2009.07.151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2009.07.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2009.07.151%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DChemo-%252Band%252Bregioselective%252Bhalogenation%252Bof%252B4-%252528pyrazol-4-yl%252529-pyrimidines%26aulast%3DCho%26aufirst%3DYoung%2BShin%26date%3D2009%26volume%3D50%26issue%3D41%26spage%3D5762%26epage%3D5764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy  Coon</span>, <span class="hlFld-ContribAuthor ">Wilna J.  Moree</span>, <span class="hlFld-ContribAuthor ">Binfeng  Li</span>, <span class="hlFld-ContribAuthor ">Jinghua  Yu</span>, <span class="hlFld-ContribAuthor ">Said  Zamani-Kord</span>, <span class="hlFld-ContribAuthor ">Siobhan  Malany</span>, <span class="hlFld-ContribAuthor ">Mark A.  Santos</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Hernandez</span>, <span class="hlFld-ContribAuthor ">Robert E.  Petroski</span>, <span class="hlFld-ContribAuthor ">Aixia  Sun</span>, <span class="hlFld-ContribAuthor ">Jenny  Wen</span>, <span class="hlFld-ContribAuthor ">Sue  Sullivan</span>, <span class="hlFld-ContribAuthor ">Jason  Haelewyn</span>, <span class="hlFld-ContribAuthor ">Michael  Hedrick</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Hoare</span>, <span class="hlFld-ContribAuthor ">Margaret J.  Bradbury</span>, <span class="hlFld-ContribAuthor ">Paul D.  Crowe</span>, <span class="hlFld-ContribAuthor ">Graham  Beaton</span>. </span><span class="cited-content_cbyCitation_article-title">Brain-penetrating 2-aminobenzimidazole H1-antihistamines for the treatment of insomnia. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (15)
                                     , 4380-4384. <a href="https://doi.org/10.1016/j.bmcl.2009.05.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.05.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.05.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.05.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain-penetrating%252B2-aminobenzimidazole%252BH1-antihistamines%252Bfor%252Bthe%252Btreatment%252Bof%252Binsomnia%26aulast%3DCoon%26aufirst%3DTimothy%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4380%26epage%3D4384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead acylaminopyrimidine hA<sub>2A</sub> antagonists. R = phenyl, substituted phenyl, pyridyl or substituted pyridyl, R<sup>1</sup> = small alkyl or alkoxy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0005.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RB(OR′)<sub>2</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 90 °C; (b) 2-methoxyethanol, DEAD, Ph<sub>3</sub>P; (c) K<sub>2</sub>CO<sub>3</sub>, MeOH, r.t.; (d) ClCH<sub>2</sub>COCl, pyridine; morpholine; (e) EtCOCl, pyridine, DCM; (f) triphosgene, DCM; methanol or ethanol.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0006.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RB(OR′)<sub>2</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 90 °C; (b) amine, DMA, 190 °C, microwave; (c) amine, DMSO, 100 °C; (d) amine hydrochloride, NMP, TEA, 160 °C, 80 min, microwave; (e) amine hydrochloride, dioxane, Pd<sub>2</sub>dba<sub>3</sub>, K<sub>3</sub>PO<sub>4</sub>, ligand <b>13</b>, 100 °C; (f) morpholine, DMSO, CuI, <span class="smallcaps smallerCapital">l</span>-proline, K<sub>2</sub>CO<sub>3</sub>, 100 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0007.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine, DMA, Et<sub>3</sub>N, 100 °C; (b) NH<sub>3</sub>, MeOH, sealed tube, 75 °C; (c) (CF<sub>3</sub>CO)<sub>2</sub>O, DCM, Et<sub>3</sub>N, 0 °C to r.t.; (d) t-BuOK, MeCN, toluene, r.t.; (e) thiourea, NaOEt, EtOH, sealed tube, 100 °C; (f) NaOH, H<sub>2</sub>O, MeI, r.t.; (g) oxone, MeOH, H<sub>2</sub>O, NaHCO<sub>3;</sub> (h) H<sub>2</sub>NNH<sub>2</sub>, EtOH, reflux; (i) 2,4-pentanedione, EtOH, r.t.; (j) AcCl, pyridine, DCM, r.t.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Potentiation of <span class="smallcaps smallerCapital">l</span>-dopa induced rotations in unilaterally 6-hydroxydopamine-lesioned rats by orally dosed <b>16j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/medium/jm-2008-00851u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of antagonists used in binding assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm800851u/production/images/large/jm-2008-00851u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800851u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptor and its modulators: overview on a druggable GPCR and on structure−activity relationship analysis and binding requirements of agonists and antagonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.2174%2F138161208784480081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=18537675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1525-1552&author=G.+Cristalliauthor=C.+Lambertucciauthor=G.+Marucciauthor=R.+Volpiniauthor=D.+Dal+Ben&title=A2A+adenosine+receptor+and+its+modulators%3A+overview+on+a+druggable+GPCR+and+on+structure%E2%88%92activity+relationship+analysis+and+binding+requirements+of+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists</span></div><div class="casAuthors">Cristalli, G.; Lambertucci, C.; Marucci, G.; Volpini, R.; Dal Ben, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1525-1552</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the biol. effects of adenosine, the development of potent and selective agonists and antagonists of adenosine receptors has been the subject of medicinal chem. research for several decades, even if their clin. evaluation has been discontinued.  Main problems include side effects due to the ubiquity of the receptors and the possibility of side effects, or to low brain penetration (in particular for the targeting of CNS diseases), short half-life of compds., lack of effects.  Furthermore, species differences in the affinity of ligands make difficult preclin. testing in animal models.  Nevertheless, adenosine receptors continue to represent promising drug targets.  A2A receptor has proved to be a promising pharmacol. target for small synthetic ligands, and while A2A agonists are undergoing clin. trials for myocardial perfusion imaging and as anti-inflammatory agents, A2A antagonists represent an attractive field of research to discover new drugs for the treatment of neurodegenerative disorders, such as Parkinson's disease.  Furthermore, the information coming from bioinformatics and mol. modeling studies for the A2A receptor has made easier the understanding of ligand-target interaction and the rational design of agonists and antagonists for this subtype.  The aim of this review is to show an overview of the most significant steps and progresses in developing A2A adenosine receptor agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLD7b3gsaCZrVg90H21EOLACvtfcHk0liDGmY-ZTQWvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D&md5=3b8c004d9a1fbff02c0a0ee1b476fcea</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161208784480081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208784480081%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DDal%2BBen%26aufirst%3DD.%26atitle%3DA2A%2520adenosine%2520receptor%2520and%2520its%2520modulators%253A%2520overview%2520on%2520a%2520druggable%2520GPCR%2520and%2520on%2520structure%25E2%2588%2592activity%2520relationship%2520analysis%2520and%2520binding%2520requirements%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D1525%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors</span> <span class="citation_source-journal">Pharmacol. Rev</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1211%2F0022357011775631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=11734617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=527-52&author=B.+B.+Fredholmauthor=A.+P.+Uzermanauthor=K.+A.+Jacobsonauthor=K.+N.+Klotzauthor=J.+Linden&title=International+Union+of+Pharmacology.+XXV.+Nomenclature+and+Classification+of+Adenosine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Klotz, Karl-Norbert; Linden, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-552</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Four adenosine receptors have been cloned and characterized from several mammalian species.  The receptors are named adenosine A1, A2A, A2B, and A3.  The A2A and A2B receptors preferably interact with members of the Gs family of G proteins and the A1 and A3 receptors with Gi/o proteins.  However, other G protein interactions have also been described.  Adenosine is the preferred endogenous agonist at all these receptors, but inosine can also activate the A3 receptor.  The levels of adenosine seen under basal conditions are sufficient to cause some activation of all the receptors, at least where they are abundantly expressed.  Adenosine levels during, e.g., ischemia can activate all receptors even when expressed in low abundance.  Accordingly, expts. with receptor antagonists and mice with targeted disruption of adenosine A1, A2A, and A3 expression reveal roles for these receptors under physiol. and particularly pathophysiol. conditions.  There are pharmacol. tools that can be used to classify A1, A2A, and A3 receptors but few drugs that interact selectively with A2B receptors.  Testable models of the interaction of these drugs with their receptors have been generated by site-directed mutagenesis and homol.-based modeling.  Both agonists and antagonists are being developed as potential drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJOCrJphTwDrVg90H21EOLACvtfcHk0ljvrK7VzaY7aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOltQ%253D%253D&md5=060ea8a3d7b07fdc4b2c8acc3b4d4745</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1211%2F0022357011775631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357011775631%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DUzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXV.%2520Nomenclature%2520and%2520Classification%2520of%2520Adenosine%2520Receptors%26jtitle%3DPharmacol.%2520Rev%26date%3D2001%26volume%3D53%26spage%3D527%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.-G.</span><span> </span><span class="NLM_article-title">Adenosine Receptors as Therapeutic Targets</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1038%2Fnrd1983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=16518376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=247-264&author=K.+A.+Jacobsonauthor=Z.-G.+Gao&title=Adenosine+Receptors+as+Therapeutic+Targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as therapeutic targets</span></div><div class="casAuthors">Jacobson, Kenneth A.; Gao, Zhan-Guo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-264</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world.  There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischemic diseases, sleep disorders, immune and inflammatory disorders and cancer.  After more than three decades of medicinal chem. research, a considerable no. of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clin. evaluated, although none has yet received regulatory approval.  However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoG29EyQFoSbVg90H21EOLACvtfcHk0ljvrK7VzaY7aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr4%253D&md5=85ad553154bd61f24a6bb594f960f9bc</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fnrd1983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1983%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.-G.%26atitle%3DAdenosine%2520Receptors%2520as%2520Therapeutic%2520Targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D247%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascherio, A.</span><span> </span><span class="NLM_article-title">Caffeinated Clues and the Promise of Adenosine A<sub>2A</sub> Antagonists in PD</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1154-1160&author=M.+A.+Schwarzschildauthor=J.-F.+Chenauthor=A.+Ascherio&title=Caffeinated+Clues+and+the+Promise+of+Adenosine+A2A+Antagonists+in+PD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DAscherio%26aufirst%3DA.%26atitle%3DCaffeinated%2520Clues%2520and%2520the%2520Promise%2520of%2520Adenosine%2520A2A%2520Antagonists%2520in%2520PD%26jtitle%3DNeurology%26date%3D2002%26volume%3D58%26spage%3D1154%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Moine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Distribution, Biochemistry and Function of Striatal Adenosine A<sub>2A</sub> Receptors</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1016%2FS0301-0082%2899%2900011-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=10501634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlCgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=355-396&author=P.+Svenningssonauthor=C.+Le+Moineauthor=G.+Fisoneauthor=B.+B.+Fredholm&title=Distribution%2C+Biochemistry+and+Function+of+Striatal+Adenosine+A2A+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution, biochemistry and function of striatal adenosine A2A receptors</span></div><div class="casAuthors">Svenningsson, Per; Le Moine, Catherine; Fisone, Gilberto; Fredholm, Bertil B.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-396</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with >400 refs.  It is well known that the nucleoside adenosine exerts a modulatory influence in the central nervous system by activating G protein coupled receptors.  Adenosine A2A receptors, the subject of the present review, are predominantly expressed in striatum, the major area of the basal ganglia.  Activation of A2A receptors interferes with effects mediated by most of the principal neurotransmitters in striatum.  In particular, the inhibitory interactions between adenosine acting on A2A receptors and dopamine acting on D2 receptors have been well examd. and there is much evidence that A2A receptors may be a possible target for future development of drugs for treatment of Parkinson's disease, schizophrenia and affective disorders.  The authors' understanding of the role of striatal A2A receptors has increased dramatically over the last few years.  New selective antibodies, antagonist radioligands and optimized in situ hybridization protocols have provided detailed information on the distribution of A2A receptors in rodent as well as primate striatum.  Studies on the involvement of A2A receptors in the regulation of DARPP-32 and the expression of immediate early genes, such as nerve growth factor-induced clone A and c-fos, have pointed out an important role for these receptors in regulating striatopallidal neurotransmission.  Moreover, by using novel selective antagonists for A2A receptors and transgenic mice lacking functional A2A receptors, crucial information on the behavioral role of striatal A2A receptors has been provided, esp. concerning their involvement in the stimulatory action of caffeine and the anti-Parkinsonian properties of A2A receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqANBDJTs7Mn7Vg90H21EOLACvtfcHk0ljvrK7VzaY7aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlCgsbo%253D&md5=84888e21d742a721f43e0332a4d86be8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2899%2900011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252899%252900011-8%26sid%3Dliteratum%253Aachs%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DLe%2BMoine%26aufirst%3DC.%26aulast%3DFisone%26aufirst%3DG.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DDistribution%252C%2520Biochemistry%2520and%2520Function%2520of%2520Striatal%2520Adenosine%2520A2A%2520Receptors%26jtitle%3DProg.%2520Neurobiol.%26date%3D1999%26volume%3D59%26spage%3D355%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tuite, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riss, J.</span><span> </span><span class="NLM_article-title">Recent Developments in the Pharmacological Treatment of Parkinson’s Disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=1335-1352&author=P.+Tuiteauthor=J.+Riss&title=Recent+Developments+in+the+Pharmacological+Treatment+of+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTuite%26aufirst%3DP.%26aulast%3DRiss%26aufirst%3DJ.%26atitle%3DRecent%2520Developments%2520in%2520the%2520Pharmacological%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D8%26spage%3D1335%26epage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceruti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbracchio, M. P.</span><span> </span><span class="NLM_article-title">Functions, Dysfunctions and Possible Therapeutic Relevance of Adenosine A<sub>2A</sub> Receptors in Huntington’s Disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1016%2Fj.pneurobio.2006.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=17303312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=331-348&author=P.+Popoliauthor=D.+Blumauthor=A.+Martireauthor=C.+Ledentauthor=S.+Cerutiauthor=M.+P.+Abbracchio&title=Functions%2C+Dysfunctions+and+Possible+Therapeutic+Relevance+of+Adenosine+A2A+Receptors+in+Huntington%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease</span></div><div class="casAuthors">Popoli, Patrizia; Blum, David; Martire, Alberto; Ledent, Catherine; Ceruti, Stefania; Abbracchio, Maria P.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">331-348</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The aim of this review is to summarize and critically discuss the complex role played by adenosine A2A receptors (A2ARs) in Huntington's disease (HD).  Since A2ARs are mainly localized on the neurons, which degenerate early in HD, and given their ability to stimulate glutamate outflow and inflammatory gliosis, it was hypothesized that they could be involved in the pathogenesis of HD, and that A2AR antagonists could be neuroprotective.  This was further sustained by the demonstration that A2ARs and underlying signaling systems undergo profound changes in cellular and animal models of HD.  More recently, however, the equation A2A receptor blockade = neuroprotection has appeared too simplistic.  First, it is now definitely clear that, besides mediating bad' responses (for example, stimulation of glutamate outflow and excessive glial activation), A2ARs also promote good' responses (such as trophic and anti-inflammatory effects).  This implies that A2AR blockade results either in pro-toxic or neuroprotective effects according to the mechanisms involved in a given exptl. model.  Second, since HD is a chronically progressive disease, the multiple mechanisms involving A2ARs may play different relative roles along the degenerative process.  Such different mechanisms can be influenced by A2AR activation or blockade in different ways, even leading to opposite outcomes depending on the time of agonist/antagonist administration.  The no., and the complexity, of the possible scenarios is further increased by the influence of mutant Huntingtin on both the expression and functions of A2ARs, and by the strikingly different effects mediated by A2ARs expressed by different cell populations within the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6cwj0loKaMrVg90H21EOLACvtfcHk0ljlDyEhnxKPxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLo%253D&md5=21d5036cfe261f44869776d1485dcdf1</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DMartire%26aufirst%3DA.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DCeruti%26aufirst%3DS.%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26atitle%3DFunctions%252C%2520Dysfunctions%2520and%2520Possible%2520Therapeutic%2520Relevance%2520of%2520Adenosine%2520A2A%2520Receptors%2520in%2520Huntington%25E2%2580%2599s%2520Disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2007%26volume%3D81%26spage%3D331%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Vu, C. B.</span><span> </span><span class="NLM_article-title">Recent Advances in the Design and Optimization of Adenosine A<sub>2A</sub> Receptor Antagonists</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=16022182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFCgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=458-468&author=C.+B.+Vu&title=Recent+Advances+in+the+Design+and+Optimization+of+Adenosine+A2A+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the design and optimization of adenosine A2A receptor antagonists</span></div><div class="casAuthors">Vu, Chi B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-468</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  In recent years, the adenosine A2A receptor has gained interest as a potential therapeutic target for alleviating the symptoms of Parkinson's disease.  Adenosine A2A receptor antagonists are orally effective in a variety of rodent models of Parkinson's disease.  Traditionally, adenosine A2A receptor antagonists are divided into 2 general classes, xanthine or non-xanthine derivs.  Extensive optimization among the xanthine derivs. has already led to the clin. candidate KW-6002 (Kyowa Hakko Kogyo Co Ltd).  However, there is increasing interest among researchers in this field to explore other classes of compds. as potential antagonists for this particular receptor.  This review highlights the more recent developments in the design and optimization of non-xanthine derivs. as adenosine A2A receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFVWEy9JKDtbVg90H21EOLACvtfcHk0ljlDyEhnxKPxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFCgt7c%253D&md5=3d081bf399a0984379c193565a58d337</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Design%2520and%2520Optimization%2520of%2520Adenosine%2520A2A%2520Receptor%2520Antagonists%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2005%26volume%3D8%26spage%3D458%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><div class="note"><p class="first last">Thomson Scientific Investigational Drugs Database, <a href="http://www.iddb3.com" class="extLink">www.iddb3.com</a>.</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Scientific+Investigational+Drugs+Database%2C+www.iddb3.com.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">Identification of Novel, Water Soluble 2-Amino-<i>N</i>-pyrimidin-4-yl Acetamides as A<sub>2A</sub> Antagonists with In Vivo Efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070623o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=400-406&author=D.+H.+Sleeauthor=X.+Zhangauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+K.+Rueterauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=T.+Joswigauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+P.+Williamsauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=J.+Saunders&title=Identification+of+Novel%2C+Water+Soluble+2-Amino-N-pyrimidin-4-yl+Acetamides+as+A2A+Antagonists+with+In+Vivo+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm070623o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070623o%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520Novel%252C%2520Water%2520Soluble%25202-Amino-N-pyrimidin-4-yl%2520Acetamides%2520as%2520A2A%2520Antagonists%2520with%2520In%2520Vivo%2520Efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D400%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wolff, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skettino, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span> </span><span class="NLM_article-title">Renal Effects of BG9719, a Specific A<sub>1</sub> Adenosine Receptor Antagonist, in Congestive Heart Failure</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1998&pages=166-171&author=A.+A.+Wolffauthor=S.+L.+Skettinoauthor=E.+Beckmanauthor=L.+Belardinelli&title=Renal+Effects+of+BG9719%2C+a+Specific+A1+Adenosine+Receptor+Antagonist%2C+in+Congestive+Heart+Failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolff%26aufirst%3DA.%2BA.%26aulast%3DSkettino%26aufirst%3DS.%2BL.%26aulast%3DBeckman%26aufirst%3DE.%26aulast%3DBelardinelli%26aufirst%3DL.%26atitle%3DRenal%2520Effects%2520of%2520BG9719%252C%2520a%2520Specific%2520A1%2520Adenosine%2520Receptor%2520Antagonist%252C%2520in%2520Congestive%2520Heart%2520Failure%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1998%26volume%3D45%26spage%3D166%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Givertz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditrich, H.</span><span> </span><span class="NLM_article-title">The Effects of KW-3902, an Adenosine A<sub>1</sub>-Receptor Antagonist, on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1016%2Fj.jacc.2007.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=17936154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKisLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1551-1560&author=M.+Givertzauthor=B.+Massieauthor=T.+Fieldsauthor=L.+Pearsonauthor=H.+Ditrich&title=The+Effects+of+KW-3902%2C+an+Adenosine+A1-Receptor+Antagonist%2C+on+Diuresis+and+Renal+Function+in+Patients+with+Acute+Decompensated+Heart+Failure+and+Renal+Impairment+or+Diuretic+Resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The Effects of KW-3902, an Adenosine A1-Receptor Antagonist,on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance</span></div><div class="casAuthors">Givertz, Michael M.; Massie, Barry M.; Fields, Tara K.; Pearson, Leeanne L.; Dittrich, Howard C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1551-1560</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: This study sought to evaluate the dose-dependent effects of adenosine A1-receptor blockade on diuresis and renal function in patients with acute decompensated heart failure (ADHF) and renal impairment or diuretic resistance.  Background: I.v. loop diuretics are the mainstay of therapy for patients with ADHF.  Treatment, however, may be complicated by diuretic resistance and/or worsening renal function.  Methods: We carried out a pair of randomized, double-blind, placebo-controlled, proof-of-concept studies in 2 clin. challenging ADHF populations.  Results: In the ADHF protocol, 146 patients with vol. overload and an estd. creatinine clearance (CrCl) of 20 to 80 mL/min were randomized to placebo or 1 of 4 doses of KW-3902 (rolofylline) infused over 2 h daily for up to 3 days.  On day 1, KW-3902 monotherapy increased urine output during the first 6 h (445, 531, 631, and 570 mL in the 2.5-, 15-, 30-, and 60-mg groups, resp.) compared with placebo (374 mL; p = 0.02).  On day 2, serum creatinine decreased in all KW-3902 groups and increased with placebo (p = 0.04).  By day 4 or day of discharge if earlier, i.v. furosemide administration tended to be lower in the KW-3902 groups compared with placebo (p = 0.10).  In the diuretic-resistant protocol, 35 patients with an av. CrCl of 34 mL/min were randomized to a single infusion of placebo, 10, 30, or 60 mg of KW-3902.  Compared with placebo, KW-3902 increased hourly urine vol. and estd. CrCl with peak effects occurring at 2 to 3 h and at 24 h, resp.  Adverse events were not different between placebo and KW-3902.  Conclusions: In patients with ADHF and vol. overload, KW-3902, an adenosine A1-receptor antagonist, enhances the response to loop diuretics and may have a renal protective effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXzGv-pgMH97Vg90H21EOLACvtfcHk0ljOzSmj63ukPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKisLnE&md5=814fcbce42c24cd088db9e9cc4ac1ec1</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2007.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2007.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DGivertz%26aufirst%3DM.%26aulast%3DMassie%26aufirst%3DB.%26aulast%3DFields%26aufirst%3DT.%26aulast%3DPearson%26aufirst%3DL.%26aulast%3DDitrich%26aufirst%3DH.%26atitle%3DThe%2520Effects%2520of%2520KW-3902%252C%2520an%2520Adenosine%2520A1-Receptor%2520Antagonist%252C%2520on%2520Diuresis%2520and%2520Renal%2520Function%2520in%2520Patients%2520with%2520Acute%2520Decompensated%2520Heart%2520Failure%2520and%2520Renal%2520Impairment%2520or%2520Diuretic%2520Resistance%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2007%26volume%3D50%26spage%3D1551%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span> </span><span class="NLM_article-title">Minimising the Potential for Metabolic Activation in Drug Discovery</span> <span class="citation_source-journal">Exp. Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.1517%2F17425255.1.1.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=16922655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=91-142&author=A.+S.+Kalgutkarauthor=J.+R.+Soglia&title=Minimising+the+Potential+for+Metabolic+Activation+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Minimising the potential for metabolic activation in drug discovery</span></div><div class="casAuthors">Kalgutkar, Amit S.; Soglia, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-142</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Investigations into the role of bioactivation in the pathogenesis of xeno-biotic-induced toxicity have been a major area of research since the link between reactive metabolites and carcinogenesis was first reported in the 1930s.  Circumstantial evidence suggests that bioactivation of relatively inert functional groups to reactive metabolites may contribute towards certain drug-induced adverse reactions.  Reactive metabolites, if not detoxified, can covalently modify essential cellular targets.  The identity of the susceptible biomacromol.(s), and the physiol. consequence of its covalent modification, will dictate the resulting toxicol. response (e.g., covalent modification of DNA by reactive intermediates derived from procarcinogens that potentially leads to carcinogenesis).  The formation of drug-protein adducts often carries a potential risk of clin. toxicities that may not be predicted from preclin. safety studies.  Animal models used to reliably predict idio-syncratic drug toxicity are unavailable at present.  Furthermore, considering that the frequency of occurrence of idiosyncratic adverse drug reactions (IADRs) is fairly rare (1 in 1000 to 1 in 10,000), it is impossible to detect such phenomena in early clin. trials.  Thus, the occurrence of IADRs during late clin. trials or after a drug has been released can lead to an unanticipated restriction in its use and even in its withdrawal.  Major themes explored in this review include a comprehensive cataloguing of bioactivation pathways of functional groups commonly utilized in drug design efforts with appropriate strategies towards detection of corresponding reactive intermediates.  Several instances wherein replacement of putative structural alerts in drugs assocd. with IADRs with a latent functionality eliminates the underlying liability are also presented.  Examples of where bioactivation phenomenon in drug candidates can be successfully abrogated via iterative chem. interventions are also discussed.  Finally, appropriate strategies that aid in potentially mitigating the risk of IADRs are explored, esp. in circumstances in which the structural alert is also responsible for the primary pharmacol. of the drug candidate and cannot be replaced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryrPwGKBtP3rVg90H21EOLACvtfcHk0lhSw3uc1-nS-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVGhs7s%253D&md5=15a3312335273663b6ef1222534f5428</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.1.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.1.91%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26atitle%3DMinimising%2520the%2520Potential%2520for%2520Metabolic%2520Activation%2520in%2520Drug%2520Discovery%26jtitle%3DExp.%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D91%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+Reactions+of+Five-Membered+Aromatic+Heterocyclic+Rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0lhSw3uc1-nS-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520Reactions%2520of%2520Five-Membered%2520Aromatic%2520Heterocyclic%2520Rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub> Receptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1729</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1719-1729&author=D.+H.+Sleeauthor=Y.+Chenauthor=X.+Zhangauthor=M.+Moorjaniauthor=M.+C.+Lanierauthor=E.+Linauthor=J.+K.+Rueterauthor=J.+P.+Williamsauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=K.+Jalaliauthor=Y.+Saiauthor=Z.+Zuoauthor=C.+Yangauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saunders&title=2-Amino-N-pyrimidin-4-ylacetamides+as+A2A+Receptor+Antagonists%3A+1.+Structure%E2%88%92Activity+Relationships+and+Optimization+of+Heterocyclic+Substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm701185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701185v%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3D2-Amino-N-pyrimidin-4-ylacetamides%2520as%2520A2A%2520Receptor%2520Antagonists%253A%25201.%2520Structure%25E2%2588%2592Activity%2520Relationships%2520and%2520Optimization%2520of%2520Heterocyclic%2520Substituents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1719%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><div class="note"><p class="first last">hERG activity was routinely assessed using a dofetolide competition binding assay. Key compounds were further assayed in a patch clamp electrophysiology assay; see reference <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a> for experimental details.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=hERG+activity+was+routinely+assessed+using+a+dofetolide+competition+binding+assay.+Key+compounds+were+further+assayed+in+a+patch+clamp+electrophysiology+assay%3B+see+reference+14+for+experimental+details."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><div class="note"><p class="first last">In the hERG electrophysiology assay, <b>2</b> had an IC<sub>50</sub> of 950 nM.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+the+hERG+electrophysiology+assay%2C+2+had+an+IC50+of+950+nM."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub> Receptor Antagonists: 2. Reduction of hERG Activity, Observed Species Selectivity, and Structure−Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1730</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701187w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1730-1739&author=D.+H.+Sleeauthor=M.+Moorjaniauthor=X.+Zhangauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+K.+Rueterauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=T.+Joswigauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+P.+Williamsauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=K.+Jalaliauthor=Y.+Saiauthor=Z.+Zuoauthor=C.+Yangauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=R.+Petroskiauthor=J.+Saunders&title=2-Amino-N-pyrimidin-4-ylacetamides+as+A2A+Receptor+Antagonists%3A+2.+Reduction+of+hERG+Activity%2C+Observed+Species+Selectivity%2C+and+Structure%E2%88%92Activity+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm701187w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701187w%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3D2-Amino-N-pyrimidin-4-ylacetamides%2520as%2520A2A%2520Receptor%2520Antagonists%253A%25202.%2520Reduction%2520of%2520hERG%2520Activity%252C%2520Observed%2520Species%2520Selectivity%252C%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1730%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+Chemistry+of+hERG+Optimizations%3A+Highlights+and+Hang-Ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lgYnezyOkKrUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520Chemistry%2520of%2520hERG%2520Optimizations%253A%2520Highlights%2520and%2520Hang-Ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekhlassi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">2,6-Diaryl-4-phenacylaminopyrimidines as Potent and Selective Adenosine A<sub>2A</sub> Antagonists with Reduced hERG Liability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1269-1273&author=M.+Moorjaniauthor=X.+Zhangauthor=Y.+Chenauthor=E.+Linauthor=J.+K.+Rueterauthor=R.+S.+Grossauthor=M.+C.+Lanierauthor=J.+E.+Tellewauthor=J.+P.+Williamsauthor=S.+M.+Lechnerauthor=S.+Malanyauthor=M.+Santosauthor=P.+Ekhlassiauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saundersauthor=D.+H.+Slee&title=2%2C6-Diaryl-4-phenacylaminopyrimidines+as+Potent+and+Selective+Adenosine+A2A+Antagonists+with+Reduced+hERG+Liability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DEkhlassi%26aufirst%3DP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3D2%252C6-Diaryl-4-phenacylaminopyrimidines%2520as%2520Potent%2520and%2520Selective%2520Adenosine%2520A2A%2520Antagonists%2520with%2520Reduced%2520hERG%2520Liability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1269%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-Pyrimidinyl-2-phenoxyacetamides as Adenosine A<sub>2A</sub> Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1778</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1778-1783&author=X.+Zhangauthor=J.+K.+Rueterauthor=Y.+Chenauthor=M.+Moorjaniauthor=M.+C.+Lanierauthor=E.+Linauthor=R.+S.+Grossauthor=J.+E.+Tellewauthor=J.+P.+Williamsauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=T.+Joswigauthor=S.+Malanyauthor=M.+Santosauthor=J.-C.+Castro-Palominoauthor=M.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saundersauthor=D.+H.+Slee&title=Synthesis+of+N-Pyrimidinyl-2-phenoxyacetamides+as+Adenosine+A2A+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DCastro-Palomino%26aufirst%3DJ.-C.%26aulast%3DCrespo%26aufirst%3DM.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DSynthesis%2520of%2520N-Pyrimidinyl-2-phenoxyacetamides%2520as%2520Adenosine%2520A2A%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1778%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">See reference <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a> for experimental details.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+reference+14+for+experimental+details."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Moorjani, M.; Luo, Z.; Lin, E.; Vong, B. G.; Chen, Y.; Zhang, X.; Rueter, J. K.; Gross, R. S.; Lanier, M. C.; Tellew, J. E.; Williams, J. P.; Lechner, S. M.; Malany, S.; Santos, M.; Crespo, M. I.; Diaz, J.-L.; Saunders, J.; Slee, D. H.</span><span> </span><span class="NLM_article-title">2,6-Diaryl-4-acylaminopyrimidines as potent and selective Adenosine A<sub>2A</sub> Antagonists with improved solubility and metabolic stability</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><i>18</i>,  <span class="NLM_fpage">5402</span><span class="NLM_x">–</span> <span class="NLM_lpage">5405</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=5402-5405&author=M.+Moorjani&author=Z.+Luo&author=E.+Lin&author=B.+G.+Vong&author=Y.+Chen&author=X.+Zhang&author=J.+K.+Rueter&author=R.+S.+Gross&author=M.+C.+Lanier&author=J.+E.+Tellew&author=J.+P.+Williams&author=S.+M.+Lechner&author=S.+Malany&author=M.+Santos&author=M.+I.+Crespo&author=J.-L.+Diaz&author=J.+Saunders&author=D.+H.+Slee&title=2%2C6-Diaryl-4-acylaminopyrimidines+as+potent+and+selective+Adenosine+A2A+Antagonists+with+improved+solubility+and+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoorjani%26aufirst%3DM.%26atitle%3D2%252C6-Diaryl-4-acylaminopyrimidines%2520as%2520potent%2520and%2520selective%2520Adenosine%2520A2A%2520Antagonists%2520with%2520improved%2520solubility%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26spage%3D5402%26epage%3D5405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Crespo, M. I.; Prat, M.; Gual, S.; Castro-Palomini, J. C.; Slee, D. H.</span> PCT Patent Application WO2005/058883,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Crespo%2C+M.+I.%3B+Prat%2C+M.%3B+Gual%2C+S.%3B+Castro-Palomini%2C+J.+C.%3B+Slee%2C+D.+H.+PCT+Patent+Application+WO2005%2F058883%2C+2005%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Polonovski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, H.</span> <span class="citation_source-journal">Bull. Soc Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1948</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Polonovski%2C+M.%3B+Pesson%2C+M.%3B+Schmitt%2C+H.Bull.+Soc+Chim.+Fr.+1948%2C+392"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolonovski%26aufirst%3DM.%26aulast%3DPesson%26aufirst%3DM.%26aulast%3DSchmitt%26aufirst%3DH.%26jtitle%3DBull.%2520Soc%2520Chim.%2520Fr.%26date%3D1948%26spage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">In the hERG electrophysiology assay at a concentration of 10 μM, the following % inhibition values were observed: <b>6e</b> (9%), <b>6f</b> (2%)..</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+the+hERG+electrophysiology+assay+at+a+concentration+of+10+%CE%BCM%2C+the+following+%25+inhibition+values+were+observed%3A+6e+%289%25%29%2C+6f+%282%25%29.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><div class="note"><p class="first last">4-[2-(7-Amino-2-furan-2-yl-[1,2,4]triazolo[1,5-<i>a</i>][1,3,5]triazin-5-ylamino)-ethyl]-phenol (ZM241385).</p></div><span class="NLM_contrib-group">Cacciari, B.; Pastorin, G.; Spalluto, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of A<sub>2A</sub> adenosine receptor antagonists</span>.  <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span>− <span class="NLM_lpage">411</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.2174%2F1568026033392183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=12570758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=403-411&author=B.+Cacciari&author=G.+Pastorin&author=G.+Spalluto&title=Medicinal+chemistry+of+A2A+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of A2A adenosine receptor antagonists</span></div><div class="casAuthors">Cacciari, Barbara; Pastorin, Giorgia; Spalluto, Giampiero</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-411</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Due to the clearly demonstrated receptor-receptor interaction between adenosine A2A and dopamine D2 receptors in the basal ganglia, the discovery and development of potent and selective A2A adenosine receptor antagonists became, in the last ten years, an attractive field of research to discovery new drugs for the treatment of neurodegenerative disorders, such as Parkinsons disease.  Different compds. have been deeply investigated as A2A adenosine receptor antagonists, which could be classified in two great families: xanthine derivs. and nitrogen polyheterocyclic systems.  These studies led to the discovery of some highly potent and selective A2A adenosine receptor antagonists such as ZM241385, SCH58261 and some xanthine derivs. (KW6002), which have been used as pharmacol. tools for studying this receptor subtype.  However, those compds. showed some problems that do not permit their use in clin. studies, such as poor water soly. (SCH58261, and xanthine derivs.) or good affinity for A2B adenosine receptor subtype (ZM241385).  In the last few years great efforts have been made to overcome these problems, trying to optimize not only the pharmacol. profile but also the pharmacokinetic character of this class of compds.  The aim of this report is to briefly summarize the recent progress made in this attractive field of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Js9jSgCJ7LVg90H21EOLACvtfcHk0lgfwlXo7WWU8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGisg%253D%253D&md5=28a5cf572c5400ec56ab33b2120e717f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1568026033392183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392183%26sid%3Dliteratum%253Aachs%26aulast%3DCacciari%26aufirst%3DB.%26atitle%3DMedicinal%2520chemistry%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D403%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><div class="note"><p class="first last">8-Cyclopentyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (DPCPX).</p></div><span class="NLM_contrib-group">Coates, J.; Sheehan, M. J.; Strong, P.</span><span> </span><span class="NLM_article-title">1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): a useful tool for pharmacologists and physiologists?</span> <span class="citation_source-journal">Gen. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span>− <span class="NLM_lpage">394</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=7926579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADyaK2cXksV2nu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=387-394&author=J.+Coates&author=M.+J.+Sheehan&author=P.+Strong&title=1%2C3-Dipropyl-8-cyclopentyl+xanthine+%28DPCPX%29%3A+a+useful+tool+for+pharmacologists+and+physiologists%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Dipropyl-8-cyclopentylxanthine (DPCPX): a useful tool for pharmacologists and physiologists?</span></div><div class="casAuthors">Coates, Jill; Sheehan, Michael J.; Strong, Peter</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">387-94</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    </div><div class="casAbstract">A review, with 58 refs., describing the in vitro and in vivo pharmacol. of DPCPX and discussing its use as a tool in studying the pharmacol. and potential (patho)physiol. significance of adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9b3KnGedYQbVg90H21EOLACvtfcHk0lgfwlXo7WWU8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksV2nu7o%253D&md5=3089ceb0ab1deb0679b7f38c3411dc41</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoates%26aufirst%3DJ.%26atitle%3D1%252C3-Dipropyl-8-cyclopentyl%2520xanthine%2520%2528DPCPX%2529%253A%2520a%2520useful%2520tool%2520for%2520pharmacologists%2520and%2520physiologists%253F%26jtitle%3DGen.%2520Pharmacol.%26date%3D1994%26volume%3D25%26spage%3D387%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">Assessed by inhibition of agonist-induced cAMP production in CHO cells expressin human A<sub>2A</sub>; see reference <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a> for experimental details..</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Assessed+by+inhibition+of+agonist-induced+cAMP+production+in+CHO+cells+expressin+human+A2A%3B+see+reference+13+for+experimental+details.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><div class="note"><p class="first last">3-[4-[2-[[6-amino-9-[(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid (CGS-21680).</p></div><span class="NLM_contrib-group">Cristalli, G.; Lambertucci, C.; Taffi, S.; Vittori, S.; Volpini, R.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of adenosine A<sub>2A</sub> receptor agonists</span>.  <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span>− <span class="NLM_lpage">401</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800851u&amp;key=10.2174%2F1568026033392282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800851u&amp;key=12570757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=387-401&author=G.+Cristalli&author=C.+Lambertucci&author=S.+Taffi&author=S.+Vittori&author=R.+Volpini&title=Medicinal+chemistry+of+adenosine+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine A2A receptor agonists</span></div><div class="casAuthors">Cristalli, Gloria; Lambertucci, Catia; Taffi, Sara; Vittori, Sauro; Volpini, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The search for potent and selective A2A adenosine receptor agonists has been particularly fruitful in the early nineties.  A series of 2-amino, 2-alkoxy, 2-alkythio-, 2-alkynyl-, and 2-alkenyl-derivs. of adenosine (Ado, 1) and N-ethylcarboxamidoadenosine (NECA, 30) have been synthesized and tested mainly on different model of rat A1 and A2A receptor subtypes.  From these studies some ligands, such as CGS 21680 (33), HENECA (42), and (S)-PHPNECA (46b), showed to possess high A2A affinity combined with good A2A vs A1 selectivity.  More detailed characterization of these ligands at the four cloned human adenosine receptor subtypes revealed that none of the prototypical adenosine receptor agonists exhibits at the same time high affinity and selectivity for the human A2AAR subtype.  Both NECA and CGS 21680, which are available as radioligands for this subtype, have lower affinity at human than at rat receptor.  The 2-alkynylNECA derivs. HENECA an PHPNECA showed high affinity also at human A3 receptors.  In particular, (S)-PHPNECA displayed Kis in the low nanomolar range at A1, A2A, and A3 subtypes and an EC50 of 220 nM at human A2B receptor.  It is now well known that the coronary vasodilation induced by Ado in different species is mediated by activation of A2AAR and a compd. capable of producing coronary vasodilation through activation of A2AAR, but that is devoid of A1-and A3-agonist activity would have advantage over Ado for use in myocardial perfusion imaging studies.  Other potential therapeutic applications of selective A2AAR agonists are as anti-aggregatory, anti-inflammatory, anti-psychotic, and anti-Huntington's disease agents.  This review is aimed at presenting a complete overview of the medicinal chem. development of A2A adenosine receptor agonists and at stressing the strong need for more selective ligands at A2A human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZ9WytCwyQLVg90H21EOLACvtfcHk0lhR-GIubxNmZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D&md5=4d2aef4b8cb3f1f30efe8d4f839e01d1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F1568026033392282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392282%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520adenosine%2520A2A%2520receptor%2520agonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><div class="note"><p class="first last">D5W: 5% dextrose in water.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=D5W%3A+5%25+dextrose+in+water."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bergström, C. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassvik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubatsch, I.</span><span> </span><span class="NLM_article-title">Poorly Soluble Marketed Drugs Display Solvation Limited Solubility</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5858</span><span class="NLM_x">–</span> <span class="NLM_lpage">5862</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0706416" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5858-5862&author=C.+A.+S.+Bergstr%C3%B6mauthor=C.+M.+Wassvikauthor=K.+Johanssonauthor=I.+Hubatsch&title=Poorly+Soluble+Marketed+Drugs+Display+Solvation+Limited+Solubility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0706416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0706416%26sid%3Dliteratum%253Aachs%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DC.%2BA.%2BS.%26aulast%3DWassvik%26aufirst%3DC.%2BM.%26aulast%3DJohansson%26aufirst%3DK.%26aulast%3DHubatsch%26aufirst%3DI.%26atitle%3DPoorly%2520Soluble%2520Marketed%2520Drugs%2520Display%2520Solvation%2520Limited%2520Solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5858%26epage%3D5862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Rasenack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, B. W.</span><span> </span><span class="NLM_article-title">Poorly Water-Soluble Drugs for Oral Delivery: A Challenge for Pharmaceuctical Development. Part I: Physicochemical and Biopharmaceutical Background/Strategies in Pharmaceutical Development</span> <span class="citation_source-journal">Pharm. Ind.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800851u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVWrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=323-326&author=N.+Rasenackauthor=B.+W.+Mueller&title=Poorly+Water-Soluble+Drugs+for+Oral+Delivery%3A+A+Challenge+for+Pharmaceuctical+Development.+Part+I%3A+Physicochemical+and+Biopharmaceutical+Background%2FStrategies+in+Pharmaceutical+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Poorly water-soluble drugs for oral delivery - A challenge for pharmaceutical development: Part I: Physicochemical and biopharmaceutical background / strategies in pharmaceutical development</span></div><div class="casAuthors">Rasenack, Norbert; Mueller, Bernd W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmazeutische Industrie</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-326</span>CODEN:
                <span class="NLM_cas:coden">PHINAN</span>;
        ISSN:<span class="NLM_cas:issn">0031-711X</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">A review.  Several New Chem. Entities (NCEs) in pharmaceutical research are poorly water-sol. which often results in an insufficient bioavailability from common oral dosage forms.  This presents a challenge to develop suitable drug delivery systems for oral use which ensure that the drug has sufficient bioavailability.  Several technologies exist for increasing the dissoln. rate and/or the soly.  This review series in three parts presents pharmaceutical technologies and points out advantages and disadvantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoOdXxQTbtHbVg90H21EOLACvtfcHk0lhR-GIubxNmZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVWrsrw%253D&md5=4a413110ec42b92e21a3424ce832915e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRasenack%26aufirst%3DN.%26aulast%3DMueller%26aufirst%3DB.%2BW.%26atitle%3DPoorly%2520Water-Soluble%2520Drugs%2520for%2520Oral%2520Delivery%253A%2520A%2520Challenge%2520for%2520Pharmaceuctical%2520Development.%2520Part%2520I%253A%2520Physicochemical%2520and%2520Biopharmaceutical%2520Background%252FStrategies%2520in%2520Pharmaceutical%2520Development%26jtitle%3DPharm.%2520Ind.%26date%3D2005%26volume%3D67%26spage%3D323%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><div class="note"><p class="first last">Metabolic oxidation of <i>N</i>-arylmorpholines to form reactive metabolites has been described:</p></div><span class="NLM_contrib-group">Wu, Y.-J.; Davis, C. D.; Dworetzky, S.; Fitzpatrick, W. C.; Harden, D.; He, H.; Knox, R. J.; Newton, A. E.; Philip, T.; Polson, C.; Sivarao, D. V.; Sun, L.-Q.; Tertyshnikova, S.; Weaver, D.; Yeola, S.; Zoeckler, M.; Sinz, M. W.</span>, <span> </span><span class="NLM_article-title">Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition: Identification of (<i>S</i>)-<i>N</i>-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3-(4-fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent Inhibition</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3778</span>− <span class="NLM_lpage">3781</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm034111v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3778-3781&author=Y.-J.+Wu&author=C.+D.+Davis&author=S.+Dworetzky&author=W.+C.+Fitzpatrick&author=D.+Harden&author=H.+He&author=R.+J.+Knox&author=A.+E.+Newton&author=T.+Philip&author=C.+Polson&author=D.+V.+Sivarao&author=L.-Q.+Sun&author=S.+Tertyshnikova&author=D.+Weaver&author=S.+Yeola&author=M.+Zoeckler&author=M.+W.+Sinz&title=Fluorine+Substitution+Can+Block+CYP3A4+Metabolism-Dependent+Inhibition%3A+Identification+of+%28S%29-N-%5B1-%284-Fluoro-3-+morpholin-4-ylphenyl%29ethyl%5D-3-%284-fluorophenyl%29acrylamide+as+an+Orally+Bioavailable+KCNQ2+Opener+Devoid+of+CYP3A4+Metabolism-Dependent+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm034111v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034111v%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26atitle%3DFluorine%2520Substitution%2520Can%2520Block%2520CYP3A4%2520Metabolism-Dependent%2520Inhibition%253A%2520Identification%2520of%2520%2528S%2529-N-%255B1-%25284-Fluoro-3-%2520morpholin-4-ylphenyl%2529ethyl%255D-3-%25284-fluorophenyl%2529acrylamide%2520as%2520an%2520Orally%2520Bioavailable%2520KCNQ2%2520Opener%2520Devoid%2520of%2520CYP3A4%2520Metabolism-Dependent%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3778%26epage%3D3781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><div class="note"><p class="first last">TPGS: <span class="smallcaps smallerCapital">d</span>-alpha-tocopheryl polyethylene glycol 1000 succinate, a water soluble derivative of Vitamin E.</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TPGS%3A+d-alpha-tocopheryl+polyethylene+glycol+1000+succinate%2C+a+water+soluble+derivative+of+Vitamin+E.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a href="/doi/suppl/10.1021/jm800851u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_64715"></div></div></div></div></div><hr /></hr><p class="last">Copies of NMR and LCMS data are available for key final compounds, along with detailed descriptions of HPLC conditions for compound analysis. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800851u/suppl_file/jm800851u_si_001.pdf">jm800851u_si_001.pdf (2.82 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800851u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm800851u%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800851u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                271KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a2185b1d3cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
